0001096906-21-001108.txt : 20210513 0001096906-21-001108.hdr.sgml : 20210513 20210513170205 ACCESSION NUMBER: 0001096906-21-001108 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 67 CONFORMED PERIOD OF REPORT: 20210331 FILED AS OF DATE: 20210513 DATE AS OF CHANGE: 20210513 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CYNERGISTEK, INC CENTRAL INDEX KEY: 0001011432 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] IRS NUMBER: 880350448 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-38011 FILM NUMBER: 21920593 BUSINESS ADDRESS: STREET 1: 11940 JOLLYVILLE ROAD STREET 2: SUITE 300-N CITY: AUSTIN STATE: TX ZIP: 78759 BUSINESS PHONE: 9496140700 MAIL ADDRESS: STREET 1: 11940 JOLLYVILLE ROAD STREET 2: SUITE 300-N CITY: AUSTIN STATE: TX ZIP: 78759 FORMER COMPANY: FORMER CONFORMED NAME: AUXILIO INC DATE OF NAME CHANGE: 20040622 FORMER COMPANY: FORMER CONFORMED NAME: PEOPLEVIEW INC DATE OF NAME CHANGE: 20040329 FORMER COMPANY: FORMER CONFORMED NAME: E PERCEPTION INC DATE OF NAME CHANGE: 20020118 10-Q 1 ctek_10q.htm CYNERGISTEK, INC. 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

[X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2021

[ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _______ to _______

Commission file number 000-27507

CYNERGISTEK, INC.

(Exact name of registrant as specified in its charter)

Delaware	37-1867101
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

11940 Jollyville Road, Suite 300-N

Austin, Texas 78759

(Address of principal executive offices, zip code)

(949) 614-0700

(Issuer’s telephone number)

N/A
(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class	Trading Symbol(s)	Name of Each Exchange on Which Registered
Common Stock, $.001 par value per share	CTEK	NYSE American

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No o.

Indicated by check mark whether the registrant has submitted electronically every Interactive Date File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes þ No o.

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer o	Accelerated filer o
Non-accelerated filer þ	Smaller reporting company þ
Emerging growth company ¨

Indicate by check mark whether the registrant is a shell company (as defined by Section 12b-2 of the Exchange Act).

Yes ¨ No þ.

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standard provided pursuant to Section 13(a) of the Exchange Act.

The number of shares of the issuer’s common stock, $0.001 par value, outstanding as of May 13, 2021, was 12,120,698.

CYNERGISTEK, INC.

FORM 10-Q

TABLE OF CONTENTS

	Page
PART I – FINANCIAL INFORMATION	4
ITEM 1. FINANCIAL STATEMENTS.	4
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.	18
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.	26
ITEM 4. CONTROLS AND PROCEDURES.	26
PART II - OTHER INFORMATION	26
ITEM 1A. RISK FACTORS.	26
ITEM 6. EXHIBITS.	27

Table of Contents

PART I – FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS.

CYNERGISTEK, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

	March 31, 2021 (unaudited)	December 31, 2020
ASSETS
Current assets:
Cash and cash equivalents	`$4,443,140`	`$5,613,654`
Accounts receivable, net of allowance for doubtful accounts	`1,949,858`	`2,063,136`
Unbilled services	`557,487`	`566,713`
Prepaid and other current assets	`1,806,340`	`2,032,420`
Income taxes receivable	`1,952,532`	`1,680,866`
Total current assets	`10,709,357`	`11,956,789`

Property and equipment, net	`380,843`	`541,525`
Deposits	`64,586`	`64,586`
Deferred income taxes	`4,995,830`	`4,959,125`
Intangible assets, net	`5,723,089`	`6,063,617`
Goodwill	`8,394,483`	`8,394,483`
Total assets	`$30,268,188`	`$31,980,125`
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable and accrued expenses	`$930,937`	`$1,326,919`
Accrued compensation and benefits	`531,524`	`814,830`
Deferred revenue	`1,208,074`	`1,265,864`
Current portion of promissory note to related parties	`562,500`	`562,500`
Current portion of operating lease liability	`129,233`	`252,398`
Total current liabilities	`3,362,268`	`4,222,511`

Long-term liabilities:
Earnout liability	`1,300,000`	`1,300,000`
Promissory note to related party, less current portion	`-`	`140,625`
Paycheck Protection Program loan	`2,825,500`	`2,825,500`
Operating lease liability, less current portion	`15,002`	`40,031`
Total long-term liabilities	`4,140,502`	`4,306,156`
Commitments and contingencies
Stockholders’ equity:
Common stock, par value at $0.001, 33,333,333 shares authorized, 12,120,698 shares issued and outstanding at March 31, 2021 and 12,024,967 shares issued and outstanding at December 31, 2020	`12,120`	`12,024`
Additional paid-in capital	`38,792,861`	`38,564,520`
Accumulated deficit	`(16,039,563)`	`(15,125,086)`
Total stockholders’ equity	`22,765,418`	`23,451,458`
Total liabilities and stockholders’ equity	`$30,268,188`	`$31,980,125`

The accompanying notes are an integral part of these condensed consolidated financial statements.

Table of Contents

CYNERGISTEK, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(UNAUDITED)

	Three Months Ended March 31,
	2021	2020
Net revenues	`$4,173,520`	`$5,115,827`
Cost of revenues	`2,090,834`	`3,423,532`
Gross profit	`2,082,686`	`1,692,295`
Operating expenses:
Sales and marketing expenses	`1,212,379`	`1,487,347`
General and administrative expenses	`1,676,658`	`2,104,844`
Depreciation	`47,696`	`47,600`
Amortization of acquisition-related intangibles	`340,528`	`416,191`
Total operating expenses	`3,277,261`	`4,055,982`
Loss from operations	`(1,194,575)`	`(2,363,687)`
Other (expense) income:
Interest income	`-`	`6,068`
Interest expense	`(20,001)`	`(24,288)`
Total other expense	`(20,001)`	`(18,220)`

Loss before income tax benefit	`(1,214,576)`	`(2,381,907)`
Income tax benefit	`300,099`	`531,284`
Net loss	`(914,477)`	`(1,850,623)`
Deemed dividends from warrant anti-dilution provisions	`(5,834)`	`-`
Net loss attributable to common shareholders	`$(920,311)`	`$(1,850,623)`

Net loss per share:
Basic	`$(0.08)`	`$(0.18)`
Diluted	`$(0.08)`	`$(0.18)`

Number of weighted average shares outstanding:
Basic	`12,041,074`	`10,374,497`
Diluted	`12,041,074`	`10,374,497`

The accompanying notes are an integral part of these condensed consolidated financial statements.

Table of Contents

CYNERGISTEK, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

THREE MONTHS ENDED MARCH 31, 2021 and 2020

(UNAUDITED)

			Additional		Total
	Common Stock		Paid-in	Accumulated	Stockholders’
	Shares	Amount	Capital	Deficit	Equity
Balance at December 31, 2020	`12,024,967`	`$12,024`	`$38,564,520`	`$(15,125,086)`	`$23,451,458`
Stock compensation expense for equity awards granted to employees and directors	`-`	`-`	`228,437`	`-`	`228,437`
Restricted stock units exercised	`95,731`	`96`	`(96)`	`-`	`-`
Deemed dividend	`-`	`-`	`-`	`-`	`-`
Net income	`-`	`-`	`-`	`(914,477)`	`(914,477)`
Balance at March 31, 2021	`12,120,698`	`$12,120`	`$38,792,861`	`$(16,039,563)`	`$22,765,418`

			Additional		Total
	Common Stock		Paid-in	Retained	Stockholders’
	Shares	Amount	Capital	Earnings	Equity
Balance at December 31, 2019	`10,359,164`	`$10,359`	`$34,821,863`	`$3,343,402`	`$38,175,624`
Stock compensation expense for equity awards granted to employees and directors	`-`	`-`	`411,007`	`-`	`411,007`
Restricted stock units exercised	`20,000`	`20`	`(20)`	`-`	`-`
Net income	`-`	`-`	`-`	`(1,850,623)`	`(1,850,623)`
Balance at March 31, 2020	`10,379,164`	`$10,379`	`$35,232,850`	`$1,492,779`	`$36,736,008`

The accompanying notes are an integral part of these condensed consolidated financial statements.

Table of Contents

CYNERGISTEK, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

	Three Months Ended March 31,
	2021	2020
Cash flows from operating activities:
Net loss	`$(914,477)`	`$(1,850,623)`
Adjustments to reconcile net loss to net cash used for operating activities:
Depreciation	`47,696`	`47,600`
Amortization of intangible assets	`340,528`	`416,191`
Change in net deferred tax assets	`(36,705)`	`(21,806)`
Bad debt expense	`-`	`30,000`
Stock compensation for equity awards granted to employees and directors	`228,437`	`411,007`
Other	`(15,500)`	`(12,149)`
Changes in operating assets and liabilities:
Accounts receivable	`113,278`	`(151,100)`
Unbilled services	`9,226`	`(77,651)`
Prepaid and other current assets	`226,080`	`(447,636)`
Income taxes receivable	`(271,666)`	`(456,128)`
Accounts payable and accrued expenses	`(395,982)`	`36,950`
Accrued compensation and benefits	`(283,306)`	`(613,183)`
Deferred revenue	`(57,790)`	`650,047`
Income taxes payable	`-`	`(31,976)`
Net cash used for operating activities	`(1,010,181)`	`(2,070,457)`
Cash flows from investing activities:
Purchases of property and equipment	`(19,708)`	`(51,912)`
Net cash used for investing activities	`(19,708)`	`(51,912)`
Cash flows from financing activities:
Payments on promissory note to related parties	`(140,625)`	`(140,625)`
Payments on capital leases	`-`	`(4)`
Net cash used for financing activities	`(140,625)`	`(140,629)`
Net change in cash and cash equivalents	`(1,170,514)`	`(2,262,998)`
Cash and cash equivalents, beginning of period	`5,613,654`	`5,328,726`
Cash and cash equivalents, end of period	`$4,443,140`	`$3,065,728`

The accompanying notes are an integral part of these condensed consolidated financial statements.

Table of Contents

CYNERGISTEK, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (CONTINUED)

(UNAUDITED)

	Three Months Ended March 31,
	2021	2020
Supplemental disclosure of cash flow information:
Interest paid	`$12,914`	`$84,606`
Income taxes paid	`$8,272`	`$209,834`

Non-cash investing and financing activities:
Capitalized right-to-use asset resulting from an extension of an operating lease commitment	`$-`	`$185,454`
Capitalized operating lease liability resulting from an extension of an operating lease commitment	`$-`	`$185,454`

The accompanying notes are an integral part of these condensed consolidated financial statements.

Table of Contents

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

THREE MONTHS ENDED MARCH 31, 2021 AND 2020

(UNAUDITED)

1.BASIS OF PRESENTATION

The accompanying unaudited condensed consolidated financial statements of CynergisTek, Inc. and its subsidiaries (the “Company,” “we,” “us,” or “CynergisTek”) have been prepared in accordance with generally accepted accounting principles of the United States of America (“GAAP”) for interim financial statements pursuant to the rules and regulations of the Securities and Exchange Commission. Accordingly, these financial statements do not include all of the information and notes required by GAAP for complete financial statements. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2020, as filed with the Securities and Exchange Commission (“SEC”) on March 25, 2021.

The unaudited condensed consolidated financial statements included herein reflect all adjustments (which include only normal, recurring adjustments) that are, in the opinion of management, necessary to state fairly our financial position and results of operations as of and for the periods presented. The results for such periods are not necessarily indicative of the results to be expected for the full year.

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. As a result, actual results could differ from those estimates.

The accompanying unaudited condensed consolidated financial statements include the accounts of CynergisTek and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated.

Based on our integration strategies, and an analysis of how our Chief Operating Decision Makers review, manage and are compensated, we have determined that the Company operates as one segment. For the periods presented, all revenues were derived from domestic operations.

We have performed an evaluation of subsequent events through the date of filing these unaudited condensed consolidated financial statements with the SEC.

Liquidity and Capital Resources

As of March 31, 2021, our cash balance was $4.4 million, current assets minus current liabilities was positive $7.3 million and our non-current debt and lease obligations, excluding contingent earnout liability of $1.3 million, totaled $2.8 million. This $2.8 million of debt is related to the U.S. Small Business Administration (“SBA”) Paycheck Protection Program loan (the “PPP Loan”), received pursuant to the Coronavirus Aid, Relief and Economic Security Act (the “CARES Act”), that we anticipate will be fully forgiven as described in Note 9. The level of additional cash needed to fund operations and our ability to conduct business for the next twelve months will be influenced primarily by the following factors:

·our ability to manage our operating expenses and maintain gross margins while attracting, recruiting and retaining cybersecurity privacy professionals;

·demand for our services from healthcare providers; the near-term impact of the COVID-19 on our customers allocation of time and resources to security and privacy, and their ability to pay for existing services as well as enter into new contractual arrangements during a period of crisis;

·general economic conditions and changes in healthcare reimbursement and regulatory environment, including effects of the COVID-19 epidemic; and

T able of Contents

·our ability to collect accounts receivable from health care customers whose operations and cash flow have been significantly impacted by COVID-19 pandemic.

We have historically funded our operating costs, acquisition activities, working capital requirements and capital expenditures with cash from operations, proceeds from the issuances of our common stock and other financing arrangements. We are currently operating in a cash flow negative position while we seek to maintain and grow our cybersecurity business and cover our public company expenses during this uncertain time. In connection with our most recent results for the three months ended March 31, 2021, we reported a loss from operations of $1.2 million. After excluding $0.6 million of non-cash items for depreciation, amortization of intangibles and stock-based compensation, our adjusted loss from operations was $0.6 million. Cash used in operating activities was $1.0 million for the three months ended March 31, 2021.

In late 2019, a novel strain of coronavirus (COVID-19) was first detected in Wuhan, China. Following the outbreak of this virus, governments throughout the world, including in the United States of America, have quarantined certain affected regions, restricted travel and imposed significant limitations on other economic activities. Our customer base is heavily concentrated in the healthcare provider space. This part of the healthcare industry has indicated that they are seeing significant financial losses, have furloughed employees and are expressing uncertainty as to the short and long-term financial stability of their businesses. Our operations team is closely monitoring the impact to the Company’s business, including its cash flows, customers and employees. We have heard and are working with a number of our active customers since the outbreak began providing relief in the form of extended payment terms and other contractual restructurings. If the situation continues to impact our customers cash flow or resources available for cybersecurity and privacy projects, our cash flows, financial position and operating results for fiscal year 2021 and beyond will be negatively impacted.

We did experience a negative financial impact from March 2020 through March 2021 that management anticipates will continue to impact revenue and earnings for the foreseeable future due to COVID-19, primarily because many of the initial economic effects of the early stages of the COVID-19 pandemic resulting from the various shelter-in-place and other social distancing orders occurred towards the end of our first quarter of 2020. The severity and duration of the COVID-19 pandemic is uncertain, and such uncertainty will likely continue in the near term. We will continue to actively monitor the situation taking into account the impact to our employees, customers and partners.

At the end of 2019 and through the first quarter of 2021, we reduced staffing levels to reduce expenses that included permanent and temporary cost reductions, the precise extent of which will depend on the duration of the COVID-19 disruptions to our customers and our short-term financial performance. In addition, we received a $2.8 million PPP loan pursuant to the CARES Act, which we anticipate will be fully forgiven and we anticipate having approximately $0.7 million in quarterly employee retention tax credits in the first and second quarters of 2021. With the proceeds from the PPP Loan and the employee retention tax credits, we have tried to minimize staff reductions in the areas of Sales and Delivery, our primary customer facing roles, to lessen the impact to our customers during this time of heightened security risks for the healthcare industry. If necessary, we could further reduce personnel and other variable and semi-variable costs to conserve cash and operate as a going concern. However, those actions if required, could negatively impact the long-term outlook of the business.

On November 12, 2020, we entered into the Equity Distribution Agreement with Craig-Hallum Capital Group LLC (the “Agent”), under which we may offer and sell, from time to time at our sole discretion, shares of our common stock having an aggregate offering price of up to $5.0 million in an “at-the-market” or ATM offering, to or through the Agent. The Company agreed to pay the Agent a commission of three percent (3.0%) of the gross sales price per share of any common stock sold through the Agent under the Equity Distribution Agreement.

During November and December of 2020, the Company received gross proceeds under the Equity Distribution agreement of $2,027,000 from the issuance of 1,315,000 shares of our common stock and paid an aggregate of $61,000 to the Agent in commissions and $123,000 in other offering-related expenses, yielding net proceeds of $1,843,000.

T able of Contents

projected capital needs for at least the next twelve months. As we execute our plans over the next twelve months, we intend to carefully monitor the impact on our operating expenses, working capital needs and cash balances relative to the availability of cost-effective debt and equity financing. In the event that capital is not available, we may then have to scale back operations, reduce expenses, and/or curtail future plans to manage our liquidity and capital resources. However, we cannot provide assurance that we will be able to raise additional capital. The COVID-19 pandemic will likely continue to create uncertainty and volatility in the financial markets which may impact our operations and our ability to access capital and/or the terms under which we can do so.

The impact of the COVID-19 pandemic on the economy and our operations is fluid and constantly evolving; we will continue to assess a variety of measures to improve our financial performance and liquidity.

The accompanying consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

2.RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS

Recently Issued Accounting Pronouncements Adopted

In January 2020, the Financial Accounting Standards Board (the “FASB”) issued an amendment clarifying the interaction between accounting standards related to equity securities, equity method investments and certain derivatives. The guidance was effective for fiscal years beginning after December 15, 2020. The adoption of this guidance did not have a material impact on our consolidated financial statements.

In December 2019, the FASB issued an amendment to the guidance on income taxes which is intended to simplify the accounting for income taxes. The amendment eliminates certain exceptions related to the approach for intra-period tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of the deferred tax liabilities for outside basis differences. The amendment also clarifies existing guidance related to the recognition of franchise tax, the evaluation of a step up in the tax basis of goodwill, and the effects of enacted changes in tax laws or rates in the effective tax rate computation, among other clarifications. The guidance was effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. The adoption of this guidance did not have a material impact on our consolidated financial statements.

Recently Issued Accounting Pronouncements Not Yet Adopted

In June 2016, the FASB issued an amendment to the guidance on the measurement of credit losses on financial instruments. The amendment updates the guidance for measuring and recording credit losses on financial assets measured and amortized cost by replacing the “incurred loss” model with an “expected loss” model. Accordingly, these financial assets will be presented at the net amount expected to be collected. The amendment also requires that credit losses related to available-for-sale debt securities be recorded as an allowance through net income rather than reducing the carrying amount under the current, other-than-temporary-impairment model. The guidance is effective for smaller reporting companies for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. Early adoption is permitted for annual periods after December 15, 2018. Management does not expect the impact from this guidance will have a material impact on our consolidated financial statements.

T able of Contents

3.ACCOUNTS RECEIVABLE

A summary of accounts receivable is as follows:

	March 31, 2021	December 31, 2020
Trade receivables	`$1,970,483`	`$2,083,761`
Allowance for doubtful accounts	`(20,625)`	`(20,625)`
Total accounts receivable, net	`$1,949,858`	`$2,063,136`

4.DEFERRED COMMISSIONS

Our incremental costs of obtaining a contract, which consist of sales commissions, are deferred and amortized over the period of contract performance. Deferred commissions are included in prepaid and other current assets in our consolidated balance sheets. We had $708,000 and $758,000 of unamortized deferred commissions as of March 31, 2021 and 2020, respectively. We had $183,000 and $165,000 of commissions expense for the three months ended March 31, 2021 and 2020, respectively.

5.PROPERTY AND EQUIPMENT

A summary of property and equipment follows:

	March 31, 2021	December 31, 2020
Furniture and fixtures	`$235,245`	`$235,245`
Computers and office equipment	`797,932`	`792,181`
Right of use assets	`1,499,394`	`1,843,818`
Property and equipment at cost	`2,532,571`	`2,871,244`
Less accumulated depreciation and amortization	`(2,151,728)`	`(2,329,719)`
	`$380,843`	`$541,525`

6.LEASES

We previously leased approximately 9,600 square feet of office space in Austin, Texas. In March 2020, we amended this lease reducing the office space to 5,000 square feet and extended the lease term to May 31, 2022. We lease approximately 3,700 square feet of office space in Minneapolis, Minnesota. This lease terminates on July 31, 2021, and we expect to renew on a month-to-month or other short-term basis under one year. We leased approximately 18,000 square feet of office space in Mission Viejo, California. This lease terminated in April 2021. During the first quarter of 2019, we subleased this space to two subtenants. The terms of these subleases ended concurrently with the end of our lease obligation in April 2021.

We used a discount rate of 5.5% in determining our operating lease liabilities which represented our incremental borrowing rate. Short-term leases with initial terms of twelve months or less are not capitalized.

Right-of-use assets and liabilities are recognized based on the present value of future minimum lease payments over the expected lease term at commencement date. Certain lease agreements contain extension options; however, we have not included such options as part of right-of-use assets and lease liabilities because we originally did not expect to extend the leases. We measure and record a right-of-use asset and lease liability based on the discount rate implicit in the lease, if known. In cases where the discount rate implicit in the lease is not known, we measure the right-of-use assets and lease liabilities using a discount rate equal to our estimated incremental borrowing rate for loans with similar collateral and duration.

T able of Contents

Operating lease expense was comprised of the following:

	Three Months Ended March 31,
	2021	2020
Operating lease cost	`$183,795`	`$205,452`
Sublet income	`(128,537)`	`(115,949)`
Net operating lease cost	`$55,258`	`$89,503`

Maturities of lease liabilities are as follows:

	Operating Leases
2021 (remaining fiscal year)	$ 108,280
2022	41,690
Total lease payments	149,970
Less imputed interest	(5,735)
Total lease liabilities	144,235
Less current portion of lease liabilities	(129,233)
Long-term lease liabilities	$ 15,002

7.INTANGIBLE ASSETS

Intangible assets are amortized over expected useful lives ranging from 1.5 to 10 years and consist of the following:

	March 31, 2021			December 31, 2020
	Carrying Amount	Accumulated Amortization and Impairment	Net Book Value	Carrying Amount	Accumulated Amortization and Impairment	Net Book Value
Acquired technology	`$10,100,000`	`$(5,154,662)`	`$4,945,338`	`$10,100,000`	`$(4,934,720)`	`$5,165,280`
Customer relationships	`4,650,000`	`(4,463,088)`	`186,912`	`4,650,000`	`(4,445,000)`	`205,000`
Trademarks	`2,300,000`	`(1,709,161)`	`590,839`	`2,300,000`	`(1,606,663)`	`693,337`
Total	`$17,050,000`	`$(11,326,911)`	`$5,723,089`	`$17,050,000`	`$(10,986,383)`	`$6,063,617`

8.DEFERRED REVENUE

We record deferred revenues when amounts are billed to customers, or cash is received from customers, in advance of our performance. During the three months ended March 31, 2021 and 2020, $738,000 and $884,000, respectively, of managed services revenues were recognized, that were included in deferred revenue at the beginning of the respective periods. During the three months ended March 31, 2021 and 2020, $225,000 and $142,000, respectively, of consulting and professional services revenues were recognized, that were included in deferred revenue at the beginning of the respective periods.

T able of Contents

9.PAYCHECK PROTECTION PROGRAM LOAN

On April 20, 2020, we received $2,825,500 in loan funding from the Small Business Administration (“SBA”) Paycheck Protection Program (“PPP”), established pursuant to the Coronavirus Aid, Relief and Economic Security Act (the “CARES Act”). The unsecured loan (the “PPP Loan”) is evidenced by a promissory note issued by the Company (the “Note”) in favor of BMO Harris Bank N.A.

The Company used the PPP Loan proceeds to cover payroll costs, rent and utilities in accordance with the relevant terms and conditions of the CARES Act.

Under the terms of the Note and the PPP Loan, interest accrues on the outstanding principal at the rate of 1.0% per annum. The term of the Note is two years, unless sooner provided in connection with an event of default under the Note. To the extent the Loan amount is not forgiven under the PPP, the Company is obligated to make equal monthly payments of principal and interest, beginning seven months from the date of the Note, until the maturity date. The Company has not started making interest payments as it awaits the forgiveness decision from the SBA. Details regarding the Note can be found in our 8-K filed on April 20, 2020.

The Company recognized interest charges associated with the PPP Loan of approximately $7,000 for the three months ended March 31, 2021. To the extent the principal balance is forgiven, the related interest would be forgiven as well. Management anticipates that the loan will be fully forgiven.

10.PROMISSORY NOTES

In connection with the acquisition of CTEK Security, Inc. (formerly CynergisTek, Inc.), we issued a promissory note totaling $4.5 million to Michael McMillan (“Seller Note,”).In March, 2018, the Company repaid $2,250,000 plus accrued interest on the Seller Note and agreed to amend and restate the Seller Note in the remaining principal amount of $2,250,000. The Seller Note bears interest at a rate of 8% per annum, provides for quarterly payments of principal and interest and matures on March 31, 2022. As of March 31, 2021, and December 31, 2020, the outstanding principal balance due under the Seller Note was $562,500 and $703,125, respectively.

Interest charges associated with the Seller Note totaled approximately $13,000 and $24,000, for the three months ended March 31, 2021 and 2020, respectively.

11.REVENUES

Below is a summary of our revenues disaggregated by revenue source.

	Three Months Ended March 31,
	2021	2020
Managed services	`$2,424,609`	`$3,001,012`
Consulting and professional services	`1,748,911`	`2,114,815`
Net revenues	`$4,173,520`	`$5,115,827`

12.WARRANTS, OPTIONS AND RESTRICTED STOCK UNITS

Warrant Issued for Securities Purchase Agreement

On April 3, 2020, we entered into a Securities Purchase Agreement with Horton Capital Management, LLC (“Horton”) which provided that Horton was committed to purchase up to an aggregate of $2,500,000 of shares of the Company’s common stock over the term of the agreement, at the election of the Company, which terminated on March 31, 2021. Additionally, if and when the Company sold shares to Horton under the commitment, the Company agreed to grant to Horton a warrant, with the same number of shares of common stock purchased by Horton in the particular funding, with an exercise price equal to 125% of the purchase price of the shares of common stock sold in such funding, with a 10-year term. No purchases were made under the Securities Purchase Agreement.

T able of Contents

Upon signing the agreement, the Company issued Horton a warrant (the “Horton Warrant”) to purchase up to 500,000 shares of common stock in consideration of Horton’s obligation to purchase the shares, at an exercise price of $2.50 per share, subject to certain anti-dilution adjustments as set forth in the warrant. The fair value of this warrant of $390,000 was determined using the Black-Scholes option-pricing model and was expensed during the second quarter of 2020.

At the end of 2020 the Company issued common stock under an equity distribution agreement receiving net proceeds of $1,843,000 from the issuance of 1,315,000 shares of our common stock that resulted in a Q1 2021 anti-dilution adjustment increasing the number of shares under the Horton Warrant to 518,915 and reducing the exercise price to $2.41. The resulting difference in fair value of the Horton Warrant with the new exercise price was $6,000 and determined using the Black-Scholes option-pricing model and recorded as a deemed dividend in our consolidated statements of stockholders’ equity. As the Company has an accumulated deficit, the deemed dividend was recorded within additional paid-in capital.

The detailed terms and conditions of the Horton Securities Purchase Agreement and the Horton Warrant can be found in the documents themselves, which were filed with the SEC on April 7, 2020.

Below is a summary of warrant activities during the three-month period ended March 31, 2021:

Warrants	Shares	Weighted Average Exercise Price	Weighted Average Remaining Term in Years	Aggregate Intrinsic Value
Outstanding at December 31, 2020	577,779	`$2.57`	8.29	`$-`
Granted	18,915	`$2.41`	9.00	`$-`
Exercised	-	`-`
Cancelled	-	`-`
Outstanding at March 31, 2021	596,694	`$2.49`	8.07	`$-`
Exercisable at March 31, 2021	596,694	`$2.49`	8.07	`$-`

2020 Equity Incentive Plan

The 2020 Equity Incentive Plan provides for a total number of shares available for issuance of 3,745,621 shares of our common stock, and it provides for the granting of stock options, stock appreciation rights, and restricted stock to our employees, members of the Board of Directors and service providers.

Below is a summary of stock option activities during the three-month period ended March 31, 2021:

Options	Number of Shares	Weighted Average Exercise Price	Weighted Average Remaining Term in Years	Aggregate Intrinsic Value
Outstanding at December 31, 2020	1,040,839	`$3.27`	9.66	`$46,750`
Granted	100,000	`$2.75`
Exercised	-	`-`
Cancelled	(12,833)	`1.77`
Outstanding at March 31, 2021	1,128,006	`$3.25`	8.15	`$-`
Exercisable at March 31, 2021	304,673	`$3.95`	5.79	`$-`

During the three months ended March 31, 2021, we granted 100,000 options to an employee to purchase shares of our common stock at an exercise price of $2.75 per share. The exercise price equals the fair value of our stock on the grant date. The options have graded vesting annually over three years. The fair value of the options of approximately $135,000 was determined using the Black-Scholes option-pricing model.

T able of Contents

Below is a summary of restricted stock unit activity during the three-month period ended March 31, 2021:

Restricted Stock Units	Shares	Weighted Average Grant Date Fair Value per Share	Weighted Average Vesting Period in Years
Non-vested at December 31, 2020	555,350	`$3.38`	1.24
Granted	285,000	`2.37`
Vested	(30,000)	`3.01`
Cancelled and forfeited	(42,500)	`3.35`
Non-vested at March 31, 2021	767,850	`$3.02`	1.05

There are 100,000 shares of restricted stock units which have vested but had not yet been issued as of March 31, 2021.

For the three months ended March 31, 2021 and 2020, stock-based compensation and other equity instrument related expenses recognized in the consolidated statements of operations were as follows:

	Three Months Ended March 31,
	2021	2020
Cost of revenues	$ (42,193)	$ 79,282
Sales and marketing	28,981	77,293
General and administrative expense	241,649	254,432
Total stock-based compensation expense	$ 228,437	$ 411,007

13.BASIC AND DILUTED NET LOSS PER SHARE

Basic net loss per share is calculated using the weighted average number of shares of our common stock issued and outstanding during a certain period and is calculated by dividing net loss by the weighted average number of shares of our common stock issued and outstanding during such period. Diluted net loss per share is calculated using the weighted average number of common and potentially dilutive common shares outstanding during the period, using the as-if-converted method for secured convertible notes, and the treasury stock method for options and warrants. Diluted net loss per share does not include potentially dilutive securities because such inclusion in the computation would be anti-dilutive.

For the three months ended March 31, 2021, potentially dilutive securities consisted of options and warrants to purchase 1,724,700 shares of common stock at prices ranging from $1.08 to $4.86 per share. Of these potentially dilutive securities, none of the shares to purchase common stock from the options and warrants are included in the computation of diluted earnings per share, because the effect of including the remaining instruments would be anti-dilutive. Also excluded from potentially dilutive securities are 767,850 shares of non-vested restricted stock units and 100,000 shares of restricted stock units which vested but had not been issued as of March 31, 2021.

For the three months ended March 31, 2020, potentially dilutive securities consisted of options and warrants to purchase 797,325 shares of common stock at prices ranging from $2.28 to $4.86 per share. Of these potentially dilutive securities, none of the shares to purchase common stock from the options and warrants are included in the computation of diluted earnings per share because the effect of including these instruments would be anti-dilutive. Also excluded from potentially dilutive securities are 1,088,000 shares of non-vested restricted stock units and 60,000 shares of restricted stock units which vested but had not been issued as of March 31, 2020.

T able of Contents

	Three Months Ended March 31,
	2021	2020
Numerators:
Net loss attributable to common shareholders	`$(920,311)`	`$(1,850,623)`

Denominator:
Denominator for basic calculation weighted average shares	`12,041,074`	`10,374,497`

Dilutive common stock equivalents:
Options and warrants	`-`	`-`
Restricted stock units vested but not issued	`-`	`-`
Denominator for diluted calculation weighted average shares	`12,041,074`	`10,374,497`

Net loss per share:
Basic net loss per share	`$(0`.08)	`$(0`.18)
Diluted net loss per share	`$(0`.08)	`$(0`.18)

14.REMAINING PERFORMANCE OBLIGATIONS

We had remaining performance obligations of approximately $17.4 million as of March 31, 2021. Our remaining performance obligations represent the amount of transaction price for which work has not been performed and revenue has not been recognized. When applying Accounting Standards Codification (“ASC”) Topic 606, with only the non-cancelable portion of these contracts included in our performance obligations we had approximately $15.1 million as of March 31, 2021. We expect to recognize revenue on approximately 81% of the remaining non-cancelable portion of these performance obligations over the next 24 months, with the balance thereafter.

15.CONCENTRATIONS

Cash Concentrations

At times, cash balances held in financial institutions are in excess of federally insured limits. Management performs periodic evaluations of the relative credit standing of financial institutions and limits the amount of risk by selecting financial institutions with a strong credit standing.

Major Customers

Our largest customer accounted for approximately 13% and 12% of our revenues for the three months ended March 31, 2021 and 2020, respectively. Our largest customer had accounts receivable totaling approximately $195,000 and $74,000 as of March 31, 2021, and December 31, 2020, respectively.

16.EARNOUT LIABILITY – BACKBONE ENTERPRISES

In 2019, we entered into a Stock Purchase Agreement (the “Backbone Purchase Agreement”) with Backbone Enterprises Inc., a Minnesota corporation (“Backbone”), and its stockholders, (the “Stockholders”), pursuant to which we acquired 100% of the issued and outstanding shares of common stock (the “Shares”) of Backbone from the Stockholders. Pursuant to the Backbone Purchase Agreement, the aggregate purchase price for the Shares included an earn-out, pursuant to which the Stockholders may be entitled to an additional $4,000,000 based upon the post-closing financial performance of Backbone, to be calculated based upon revenue generated by the Backbone business during the three-year earn-out period. There was no earnout earned for the first year of the agreement. As of March 31, 2021, the estimated fair value of the earnout is $1,300,000 for the remaining 2 years of the agreement.

T able of Contents

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

The following discussion of the financial condition and results of operations of the Company should be read in conjunction with the condensed consolidated financial statements and the related notes thereto included elsewhere in this Quarterly Report on Form 10-Q. This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and Section 27A of the Securities Act, and is subject to the safe harbors created by those sections. Words such as “anticipates,” “expects,” “intends,” “plans,” “believes,” “seeks,” “estimates,” “may,” “will” and variations of these words or similar expressions are intended to identify forward-looking statements. In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. These statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions that are difficult to predict. Therefore, our actual results could differ materially and adversely from those expressed in any forward-looking statements as a result of various factors. We undertake no obligation to revise or publicly release the results of any revisions to these forward-looking statements.

Due to possible uncertainties and risks, readers are cautioned not to place undue reliance on the forward-looking statements contained in this Quarterly Report, which speak only as of the date of this Quarterly Report, or to make predictions about future performance based solely on historical financial performance. We disclaim any obligation to update forward-looking statements contained in this Quarterly Report.

Readers should carefully review the risk factors described in other documents we file from time to time with the SEC, including our Form 10-K for the fiscal year ended December 31, 2020. You should interpret many of the risks identified in these reports as being heightened as a result of the ongoing and numerous adverse impacts of the COVID-19 pandemic. Our filings with the SEC, including our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and amendments to those filings, pursuant to Sections 13(a) and 15(d) of the Exchange Act, are available free of charge at www.CynergisTek.com, when such reports are available via the EDGAR system maintained by the SEC at www.sec.gov.

OVERVIEW

We are engaged in the business of helping U.S. based companies in highly regulated industries, including healthcare, be prepared to handle unforeseen cyber threats, comply with regulations, and gain the confidence that their efforts are strengthening their security posture and building resilience. This is achieved through our cybersecurity, privacy and compliance services.

CynergisTek was born in healthcare and is one of the few consulting and advisory companies focused on converging security and privacy with a methodology to validate the rigor and effectiveness of their programs. We believe that our years of experience of understanding our clients’ unique challenges allows us to provide our customers with services designed around industry best practices to improve security controls, policies and procedures and to protect sensitive information. Our team of subject matter experts and consultants are comprised of knowledgeable professionals who have learned their craft both in the classroom and through years of practical on-the-job experience, including as policy makers, attorneys and leaders in cybersecurity, privacy and compliance.

Our services are categorized into four service groups, which are: assess, build, manage, and validate. These services are designed to meet the client where they are in their security journey as recurring managed services under long-term contracts structured to provide a sustainable and growing program, or under shorter duration consulting or professional services engagements.

·Assess – identify, measure, and test security and privacy risk of an organization’s readiness and verify and validate their programs meet compliance and business objectives through IT audits, technical testing, and risk and program assessments.

·Build – develop policies and procedures and playbooks to help build out a fully comprehensive risk management program and provide resources to help organizations prioritize, implement and execute initiatives to strengthen their security and privacy programs.

T able of Contents

·Manage - provide on-going management and oversight of specific components of an organization’s security and privacy programs to address or give alerts when an issue arises and to offer our expertise that they need to accelerate the effectiveness of their programs.

·Validate – verify the processes, people, and technology are working effectively and provide insight to the ROI of an organization’s security investment through advanced services requiring highly experienced resources and/or technology to deliver.

For sophisticated organizations our Managed Security Validation® program encompasses a bundle of services from the assess, build, manage, and validate categories to deliver clarity and guidance as a consistent partner helping maintain and grow their security infrastructure.

Impact of COVID-19 Pandemic

In December 2019, a novel strain of the coronavirus (COVID-19) surfaced, which spread globally and was declared a pandemic by the World Health Organization in March 2020. The challenges posed by the COVID-19 pandemic on the global economy increased significantly in the first several months of 2020. In response to COVID-19, national and local governments around the world instituted certain measures, including travel bans, prohibitions on group events and gatherings, shutdowns of certain businesses, curfews, shelter-in-place orders and recommendations to practice social distancing.

In planning for the possible disruption of our business, we have taken steps to reduce expenses throughout the Company. This included substantially reducing Company travel for a period of time, as well as our participation in trade shows and other business meetings and decreasing expenditures. We also implemented workforce reductions during 2020 and the beginning of 2021, decreasing employment and related expenses. Continued progression of the pandemic could result in a decline in customer orders, as our customers could shift purchases to lower-priced or other perceived value offerings or reduce their purchases of our services due to decreased budgets, reduced access to credit or various other factors, which could have a material adverse impact on our results of operations and cash flow. While the current impacts of COVID-19 are reflected in our results of operations, we cannot at this time separate the direct COVID-19 impacts from other factors that cause our performance to vary from year to year. The ultimate duration and impact of the COVID-19 pandemic on our business, results of operations, financial condition and cash flows is dependent on future developments, including the duration and severity of the pandemic, and the related length of its impact on the global economy, which are uncertain and, given the daily evolution of the COVID-19 pandemic and the global responses to curb its spread, cannot be predicted at this time. Even after the COVID-19 pandemic has subsided, we may continue to experience an adverse impact to our business as a result of its national and, to some extent, global economic impact, including any recession that has occurred or may occur in the future. Furthermore, the extent to which our mitigation efforts are successful, if at all, is not presently ascertainable. However, we anticipate that our results of operations in future periods may continue to be adversely impacted by the COVID-19 pandemic and its negative effects on global economic conditions.

Our common stock currently trades on the NYSE American exchange under the stock symbol “CTEK”.

Where appropriate, references to “CynergisTek,” the “Company,” “Redspin,” “we,” “us,” or “our” include CynergisTek, Inc., a Delaware corporation and its wholly-owned subsidiaries, CTEK Solutions, Inc., a California corporation, CTEK Security, Inc., a Texas corporation, Delphiis, Inc., a California corporation and, Backbone Enterprises, Inc., a Minnesota corporation.

T able of Contents

RESULTS OF OPERATIONS

For the Three Months Ended March 31, 2021, Compared to the Three Months Ended March 31, 2020

Revenue

Revenue decreased $0.9 million to $4.2 million for the three months ended March 31, 2021, as compared to the same period in 2020. Managed Services revenue decreased $0.6 million due to the impact of some customers canceling contracts, delaying renewals and a slowdown in net new customers due to COVID-19 and customers holding off on purchasing or trying to reduce budgets. Consulting and professional services decreased $0.3 million due to lower revenue from two customers who completed contract work in the first half of 2020 and less business as a result of COVID-19 and our customers minimizing spend with third-party contractors.

Cost of Revenue

Cost of revenue consists primarily of salaries and related expenses of direct labor and indirect support staff. Cost of revenue was $2.1 million for the three months ended March 31, 2021, as compared to $3.4 million for the same period in 2020. We reduced salary and related costs associated with our reduction in force by approximately $0.9 million due to the lower revenue from COVID-19 and $0.4 million benefit from the employee retention credit provided under the CARES Act.

Gross margin was 50% of revenue for the three months ended March 31, 2021. After adjusting for the benefit from the employee retention tax credit, gross margin was 39%, compared to 33% for the same period in 2020. Margins improved as a result of targeted expense reductions we made over the last few quarters in reaction to the lower revenue due to COVID-19.

Sales and Marketing

Sales and marketing expenses include salaries, commissions and expenses for sales and marketing personnel, travel and entertainment, and other selling and marketing costs. Sales and marketing expenses decreased to $1.2 million for the three months ended March 31, 2021, as compared to $1.5 million for the same period in 2020. This decrease was due to $0.2 million in lower marketing and sales support payroll and benefit costs from the headcount reductions due to COVID-19, $0.1 million less travel costs due to COVID-19 related travel restrictions and $0.1 million of employee retention tax credits provided under the CARES Act offset by $0.1 million in recruiting costs to bring on a new sales leader and additional direct sales leads.

General and Administrative

General and administrative expenses include personnel costs for finance, administration, information systems, general management, facilities expenses, professional fees, legal expenses and other administrative costs including those required to be a publicly traded company. General and administrative expenses decreased $0.4 million to $1.7 million for the three months ended March 31, 2021, compared to $2.1 million for the three months ended March 31, 2020. The decrease is due to $0.1 million in lower payroll and benefit related costs due to the expense reduction efforts taken in reaction to the lower revenue from COVID-19, $0.1 million less travel costs due to COVID-19 related travel restrictions, $0.1 million less in professional fees due to 2020 being higher due to strategic advisory and recruiting costs, and $0.1 million of employee retention tax credits provided under the CARES Act.

Depreciation

Depreciation expense was consistent at $48,000 for the three months ended March 31, 2021 and 2020.

T able of Contents

Amortization of Acquisition-Related Intangibles

Amortization of acquisition-related intangibles was $0.3 million for the three months ended March 31, 2021, compared to $0.4 million for the three months ended March 31, 2020. Amortization expense decreased over the comparable periods as a portion of the intangible assets became fully amortized and an impairment loss of $0.9 million that was recognized at the end of 2020.

Net Interest Expense

Net interest expense for the three months ended March 31, 2021 was $20,000, compared to net interest expense of $18,000 for the same period in 2020. The increase was due to lower interest income from a lower outstanding cash balance and lower interest rate earned on cash on hand partially offset by lower interest expense due to the lower outstanding debt balance from the paydown of the promissory note.

Income Tax Benefit

Income tax benefit for the three months ended March 31, 2021 was $0.3 million, compared to $0.5 million for the same period in 2020. These amounts were based on estimated annual income tax rates we anticipate for the year.

Liquidity and Capital Resources

·our ability to manage our operating expenses and maintain gross margins while attracting, recruiting and retaining cybersecurity privacy professionals;

·general economic conditions and changes in healthcare reimbursement and regulatory environment, including effects of the COVID-19 epidemic; and

·our ability to collect accounts receivable from health care customers whose operations and cash flow have been significantly impacted by COVID-19 pandemic.

We have historically funded our operating costs, acquisition activities, working capital requirements and capital expenditures with cash from operations, proceeds from the issuances of our common stock and other financing arrangements. We are currently operating in a cash flow negative position while we seek to maintain and grow our cybersecurity business and cover our public company expenses during this uncertain time. In connection with our most recent results for the most three months ended March 31, 2021, we reported a loss from operations of $1.2 million. After excluding $0.6 million of non-cash items for depreciation, amortization of intangibles and stock-based compensation, our adjusted loss from operations was $0.6 million. Cash used in operating activities was $1.0 million for the three months ended March 31, 2021.

T able of Contents

base is heavily concentrated in the healthcare provider space. This part of the healthcare industry has indicated that they are seeing significant financial losses, have furloughed employees and are expressing uncertainty as to the short and long-term financial stability of their businesses. Our operations team is closely monitoring the impact to the Company’s business, including its cash flows, customers and employees. We have heard and are working with a number of our active customers since the outbreak began providing relief in the form of extended payment terms and other contractual restructurings. If the situation continues to impact our customers cash flow or resources available for cybersecurity and privacy projects, our cash flows, financial position and operating results for fiscal year 2021 and beyond will be negatively impacted.

We believe that our existing sources of liquidity, including cash and cash equivalents, the proceeds from the PPP loan and employee retention tax credits, the ability to raise equity under our shelf registration (including via the Equity Distribution Agreement) and future operating cash flows, and other assets will be sufficient to meet our projected capital needs for at least the next twelve months. As we execute our plans over the next twelve months, we intend to carefully monitor the impact on our operating expenses, working capital needs and cash balances relative to the availability of cost-effective debt and equity financing. In the event that capital is not available, we may then have to scale back operations, reduce expenses, and/or curtail future plans to manage our liquidity and capital resources. However, we cannot provide assurance that we will be able to raise additional capital. The COVID-19 pandemic will likely continue to create uncertainty and volatility in the financial markets which may impact our operations and our ability to access capital and/or the terms under which we can do so.

Application of Critical Accounting Policies

The SEC defines critical accounting policies as those that are, in management’s view, most important to the portrayal of our financial condition and results of operations and most demanding of our judgment. The discussion

T able of Contents

and analysis of our financial condition and results of operations are based upon our financial statements, which were prepared in accordance with accounting principles generally accepted in the U.S., which is referred to as “GAAP.” The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosures of contingent assets and liabilities. On an on-going basis, we evaluate these estimates, including those related to stock-based compensation, customer programs and incentives, bad debts, intangible assets, income taxes, contingencies and litigation. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.

We consider the following accounting policies to be those most important to the portrayal of our financial condition and those that require the most subjective judgment:

Revenue Recognition and Deferred Revenue

We operate under a consolidated strategy and management structure, deriving revenue from the following sources:

·Managed services

·Consulting and professional services

Revenue is recognized pursuant to ASC Topic 606, “Revenue from Contracts with Customers”. Accordingly, revenue is recognized at an amount that reflects the consideration to which we expect to be entitled in exchange for transferring goods or services to a customer. This principle is applied using the following 5-step process:

1.Identify the contract with the customer - A contract with a customer exists when (i) we enter into an enforceable contract with a customer that defines each party’s rights regarding the services to be transferred and identifies the payment terms related to these services, (ii) the contract has commercial substance and the parties are committed to perform, and (iii) we determine that collection of substantially all consideration to which it will be entitled in exchange for services that will be transferred is probable based on the customer’s intent and ability to pay the promised consideration.

2.Identify the performance obligations in the contract - Performance obligations promised in a contract are identified based on the services that will be transferred to the customer that are both capable of being distinct, whereby the customer can benefit from the service either on its own or together with other resources that are readily available from third parties or from us, and are distinct in the context of the contract, whereby the transfer of the services is separately identifiable from other promises in the contract. To the extent a contract includes multiple promised services, we apply judgment to determine whether promised services are capable of being distinct and distinct in the context of the contract. If these criteria are not met the promised services are accounted for as a combined performance obligation.

3.Determine the transaction price - The transaction price is determined based on the consideration to which we will be entitled in exchange for transferring services to the customer.

4.Allocate the transaction price to the performance obligations in the contract - If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. Contracts that contain multiple performance obligations require an allocation of the transaction price to each performance obligation based on a relative standalone selling price (“SSP“) basis. Determination of SSP requires judgment. We determine standalone selling price taking into account available information such as historical selling prices of the performance obligation, overall strategic pricing objective, market conditions and internally approved pricing guidelines related to the performance obligations.

T able of Contents

5.Recognize revenue when (or as) each performance obligation is satisfied - We satisfy performance obligations over time. Revenue is recognized over the time the related performance obligation is satisfied by transferring a promised service to a customer.

Managed Services

Managed services contracts are typically long-term contracts lasting three years. Revenue is earned monthly during the term of the contract, as services are provided at a fixed fee and is recognized ratably over the contract term beginning on the commencement date of the contract. Revenue related to managed services provided is recognized based on the customer utilization of such resources, which management estimates to occur ratably over the customer contract term.

Consulting and Professional Services

Consulting and professional services contracts are typically short-term, project-based services rendered on either a fixed fee or a time and materials basis. These contracts are normally for a duration of less than one year. For fixed fee arrangements, revenue is normally recognized ratably over the term of the project. For time and materials arrangements, revenues are recognized as the services are rendered.

Deferred and Unbilled Revenue

We receive payments from customers based on billing schedules established in our contracts. Deferred revenue primarily consists of billings or payments received in advance of the amount of revenue recognized and such amounts are recognized as the revenue recognition criteria are met. Unbilled revenue reflects our conditional right to receive payment from customers for our completed performance under contracts.

Accounts Receivable Valuation and Related Reserves

We estimate the losses that may result from that portion of our accounts receivable that may not be collectible as a result of the inability of our customers to make required payments. Management specifically analyzes customer concentration, customer creditworthiness, current economic trends, COVID-19 developments and changes in customer payment terms when evaluating the adequacy of the allowance for doubtful accounts. We review past due accounts on a monthly basis and record an allowance for doubtful accounts where we deem appropriate.

Impairment Review of Goodwill and Intangible Assets

We periodically evaluate our intangible assets and goodwill relating to acquisitions for impairment. Goodwill is not amortized but is evaluated at least annually at year end for any impairment in the carrying value. We review our intangible assets for impairment whenever events or changes in circumstances indicate that the carrying value of such assets may not be recoverable. Factors we consider important which could trigger an impairment review include, but are not limited to, the following: significant underperformance relative to expected historical or projected future operating results; significant changes in the manner of our use of the acquired assets or the strategy for our overall business; and a significant negative industry or economic trend for a sustained period. Goodwill and intangible asset impairment assessments are generally determined based on fair value techniques, including determining the estimated future discounted and undiscounted cash flows over the remaining useful life of the asset. Those models require estimates of future revenue, profits, capital expenditures and working capital for each reporting unit. We estimate these amounts by evaluating historical trends, the current state of the Company’s industries and the economy, current budgets, and operating plans. Determining the fair value of reporting units and goodwill includes significant judgment by management and different judgments could yield different results. Any resulting impairment loss could have a material impact on our financial condition and results of operations.

Stock-Based Compensation

Under the fair value recognition provisions of the authoritative guidance, stock-based compensation cost granted to employees is measured at the grant date based on the fair value of the award and is recognized as expense over the requisite service or performance period, which is the vesting period. Stock options and warrants issued to

T able of Contents

consultants and other non-employees as compensation for services to be provided to us are accounted for based upon the fair value of the services provided or the estimated fair value of the option or warrant, whichever can be more clearly determined. We currently use the Black-Scholes option pricing model to determine the fair value of stock options and warrants. The determination of the fair value of stock-based payment awards on the date of grant using an option-pricing model is affected by our stock price as well as assumptions regarding a number of complex and subjective variables. These variables include our expected stock price volatility over the term of the awards, the expected term of the award, the risk-free interest rate and any expected dividends. Compensation cost associated with grants of restricted stock units are also measured at fair value on the date of the grant. We evaluate the assumptions used to value restricted stock units on a quarterly basis. When factors change, including the market price of the stock, stock-based compensation expense may differ significantly from what has been recorded in the past. If there are any modifications or cancellations of the underlying unvested securities, we may be required to accelerate, increase or cancel any remaining unearned stock-based compensation expense.

Income Taxes

Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial reporting requirements and those imposed under federal and state tax laws. Deferred taxes are provided for timing differences in the recognition of revenue and expenses for income tax and financial reporting purposes and are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Deferred income tax expense represents the change during the period in the deferred tax assets and liabilities. Realization of the deferred tax asset is largely dependent on generating sufficient taxable income in future years. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all the deferred tax assets will not be realized. Use of our net operating loss deferred assets may be limited by changes in our ownership.

Reference is made to our Annual Report on Form 10-K for the fiscal year ended December 31, 2020, filed with the SEC on March 25, 2021, for additional discussion of our critical accounting policies.

OFF-BALANCE SHEET ARRANGEMENTS

As of March 31, 2021, we did not have any other relationships with unconsolidated entities or financial partners, such as entities often referred to as structured finance or special purpose entities, which would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes.

CONTRACTUAL OBLIGATIONS AND CONTINGENT LIABILITIES AND COMMITMENTS

As of March 31, 2021, expected future cash payments related to contractual obligations and commercial commitments were as follows:

	Payments Due by Period
	Total	Less than 1 year	1-3 years	3-5 years	More than 5 years
Promissory notes	`$590,733`	`$590,733`	`$-`	`$-`	`$-`
Paycheck Protection Program loan	`2,870,121`	`2,634,559`	`235,562`	`-`	`-`
Operating leases	`149,970`	`133,294`	`16,676`	`-`	`-`
Total	`$3,610,824`	`$3,358,586`	`$252,238`	`$-`	`$-`

Management anticipates full forgiveness of the debt related to the Paycheck Protection Program loan as described in Note 9.

T able of Contents

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

As a “smaller reporting company” as defined by Rule 229.10(f)(1), we are not required to provide the information required by this Item 3.

ITEM 4. CONTROLS AND PROCEDURES.

We maintain disclosure controls and procedures (as defined in Rules 13a-15(c) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) that are designed to ensure that information required to be disclosed in our reports under the Exchange Act, is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

We carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer (principal executive officer) and Chief Financial Officer (principal financial officer), of the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act), as of the end of the period covered by this Quarterly Report. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of the end of the period covered by this Quarterly Report to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities Exchange Commission’s rules and forms, and that such information is accumulated and communicated to our management, including each of such officers as appropriate to allow timely decisions regarding required disclosure.

No change in our internal control over financial reporting that occurred during our last fiscal quarter that has materially affected or is reasonably likely to materially affect our internal control over financial reporting.

PART II - OTHER INFORMATION

ITEM 1A. RISK FACTORS.

As of the date of this filing, except as set forth herein, there have been no material changes to the Risk Factors included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2020, filed with the Commission on March 25, 2021 (the “2020 Form 10-K”). The Risk Factors set forth in the 2020 Form 10-K should be read carefully in connection with evaluating our business and in connection with the forward-looking statements contained in this Quarterly Report on Form 10-Q. Any of the risks described in the 2020 Form 10-K, could materially adversely affect our business, financial condition or future results and the actual outcome of matters as to which forward-looking statements are made. These are not the only risks we face. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or operating results.

T able of Contents

ITEM 6. EXHIBITS.

No.		Item
31.1		Certification of the Chief Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended. †
31.2		Certification of the Chief Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended. †
32.1		Certification of the CEO and CFO pursuant to Rule 13a-14(b) and Rule 15d-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350. +
101.INS		XBRL Instance Document*
101.SCH		XBRL Taxonomy Extension Schema Document*
101.CAL		XBRL Taxonomy Extension Calculation Linkbase Document*
101.DEF		XBRL Taxonomy Extension Definition Linkbase Document*
101.LAB		XBRL Taxonomy Extension Label Linkbase Document*
101.PRE		XBRL Taxonomy Extension Presentation Linkbase Document*

†Filed herewith.

+Furnished herewith. In accordance with Item 601(b)(32)(ii) of Regulation S-K, this exhibit shall not be deemed “filed” for the purposes of Section 18 of the Securities and Exchange Act of 1934 or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934.

*Pursuant to Rule 406T of Regulation S-T, this XBRL information will not be deemed “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liability of that section, nor will it be deemed filed or made a part of a registration statement or prospectus for purposes of Sections 11 and 12 of the Securities Act of 1933, or otherwise subject to liability under those sections.

T able of Contents

SIGNATURES

In accordance with the requirements of the Securities Exchange Act of 1934, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	CYNERGISTEK, INC.


Date: May 13, 2021	By:	/s/ Caleb Barlow
		Caleb Barlow
		President and Chief Executive Officer (Principal Executive Officer)

Date: May 13, 2021	By:	/s/ Paul T. Anthony
		Paul T. Anthony
		Chief Financial Officer (Principal Accounting Officer)

EX-31.1 2 ctek_ex31z1.htm CERTIFICATION

EXHIBIT 31.1

CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO RULE 13A-14(A) AND RULE 15D-14(A) OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED

I, Caleb Barlow, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of CynergisTek, Inc. (the “Registrant”);

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated: May 13, 2021

/s/ Caleb Barlow
Caleb Barlow,
Chief Executive Officer
(Principal Executive Officer)

EX-31.2 3 ctek_ex31z2.htm CERTIFICATION

EXHIBIT 31.2

CERTIFICATION OF THE CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13A-14(A) AND RULE 15D-14(A) OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED

I, Paul T. Anthony, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of CynergisTek, Inc. (the “Registrant”);

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated: May 13, 2021

/s/ Paul T. Anthony
Paul Anthony,
Chief Financial Officer
(Principal Financial Officer)

EX-32.1 4 ctek_ex32z1.htm CERTIFICATION

EXHIBIT 32.1

CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13A-14(B) AND RULE 15D-14(B) OF THE SECURITIES EXCHANGE ACT OF 1934 AND 18 U.S.C. SECTION 1350

In connection with the Quarterly Report of CynergisTek, Inc. (the “Company”) on Form 10-Q for the quarter ended March 31, 2021, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), we, Caleb Barlow, Chief Executive Officer and Paul T. Anthony, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of our knowledge:

(1)The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition of the Company as of the dates presented and the results of operations of the Company for the periods presented.

Date: May 13, 2021

	By:	/s/ Caleb Barlow
		Caleb Barlow,
		Chief Executive Officer

	By:	/s/ Paul T. Anthony
		Paul Anthony,
		Chief Financial Officer

A signed original of this written statement required by section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

This certification accompanies the Quarterly Report pursuant to Rule 13a-14(b) or Rule 15d-14(b) under the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350 and shall not be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934.

EX-101.CAL 5 ctek-20210331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 6 ctek-20210331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.INS 7 ctek-20210331.xml XBRL INSTANCE DOCUMENT 0001011432 2021-03-31 0001011432 2020-12-31 0001011432 2021-01-01 2021-03-31 0001011432 2020-01-01 2020-03-31 0001011432 us-gaap:CostOfSalesMember 2021-03-31 0001011432 us-gaap:CostOfSalesMember 2020-12-31 0001011432 us-gaap:FurnitureAndFixturesMember 2021-03-31 0001011432 us-gaap:FurnitureAndFixturesMember 2020-12-31 0001011432 us-gaap:OfficeEquipmentMember 2021-03-31 0001011432 us-gaap:OfficeEquipmentMember 2020-12-31 0001011432 srt:MinimumMember 2021-01-01 2021-03-31 0001011432 srt:MaximumMember 2021-01-01 2021-03-31 0001011432 us-gaap:TechnologyBasedIntangibleAssetsMember 2021-03-31 0001011432 us-gaap:CustomerRelationshipsMember 2021-03-31 0001011432 us-gaap:TrademarksMember 2021-03-31 0001011432 us-gaap:TechnologyBasedIntangibleAssetsMember 2020-12-31 0001011432 us-gaap:CustomerRelationshipsMember 2020-12-31 0001011432 us-gaap:TrademarksMember 2020-12-31 0001011432 ctek:ManagedServicesRevenuesMember 2021-03-31 0001011432 ctek:ConsultingAndProfessionalServicesRevenuesMember 2021-03-31 0001011432 ctek:SellerNotesMember 2020-01-01 2020-03-31 0001011432 ctek:SellerNotesMember ctek:MichaelMcmillanMember 2021-01-01 2021-03-31 0001011432 ctek:SellerNotesMember ctek:MichaelMcmillanMember 2021-03-31 0001011432 ctek:SellerNotesMember ctek:MichaelMcmillanMember 2020-12-31 0001011432 ctek:SellerNotesMember 2021-01-01 2021-03-31 0001011432 ctek:ManagedServicesRevenuesMember 2021-01-01 2021-03-31 0001011432 ctek:ConsultingAndProfessionalServicesRevenuesMember 2021-01-01 2021-03-31 0001011432 ctek:ManagedServicesRevenuesMember 2020-01-01 2020-03-31 0001011432 ctek:ConsultingAndProfessionalServicesRevenuesMember 2020-01-01 2020-03-31 0001011432 us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-03-31 0001011432 us-gaap:RestrictedStockUnitsRSUMember 2020-12-31 0001011432 us-gaap:RestrictedStockUnitsRSUMember 2021-03-31 0001011432 us-gaap:CostOfSalesMember 2021-01-01 2021-03-31 0001011432 us-gaap:SellingAndMarketingExpenseMember 2021-01-01 2021-03-31 0001011432 us-gaap:GeneralAndAdministrativeExpenseMember 2021-01-01 2021-03-31 0001011432 us-gaap:CostOfSalesMember 2020-01-01 2020-03-31 0001011432 us-gaap:SellingAndMarketingExpenseMember 2020-01-01 2020-03-31 0001011432 us-gaap:GeneralAndAdministrativeExpenseMember 2020-01-01 2020-03-31 0001011432 ctek:OptionsAndWarrantsMember srt:MinimumMember 2021-03-31 0001011432 ctek:OptionsAndWarrantsMember srt:MaximumMember 2021-03-31 0001011432 us-gaap:RestrictedStockUnitsRSUMember 2021-03-31 0001011432 ctek:OptionsAndWarrantsMember 2021-01-01 2021-03-31 0001011432 ctek:OptionsAndWarrantsMember 2020-01-01 2020-03-31 0001011432 us-gaap:CustomerConcentrationRiskMember 2021-03-31 0001011432 us-gaap:CustomerConcentrationRiskMember 2020-12-31 0001011432 ctek:StockPurchaseAgreementMember ctek:BackboneEnterprisesMember 2019-10-01 2019-10-31 0001011432 ctek:StockPurchaseAgreementMember ctek:BackboneEnterprisesMember 2021-01-01 2021-03-31 0001011432 ctek:SecuritiesPurchaseAgreementMember ctek:HortonCapitalManagementMember 2020-04-01 2020-04-03 0001011432 2020-04-01 2020-04-20 0001011432 ctek:OptionsAndWarrantsMember srt:MinimumMember 2020-03-31 0001011432 ctek:OptionsAndWarrantsMember srt:MaximumMember 2020-03-31 0001011432 us-gaap:RestrictedStockUnitsRSUMember 2020-03-31 0001011432 ctek:ManagedServicesRevenuesMember 2020-03-31 0001011432 ctek:ConsultingAndProfessionalServicesRevenuesMember 2020-03-31 0001011432 us-gaap:RestrictedStockUnitsRSUMember 2020-01-01 2020-12-31 0001011432 2020-01-01 2020-12-31 0001011432 us-gaap:OptionMember ctek:EmployeeMember 2021-01-01 2021-03-31 0001011432 ctek:N2020EquityIncentivePlanMember 2020-06-15 0001011432 ctek:PPPLoanMember 2021-01-01 2021-03-31 0001011432 2021-05-13 0001011432 2019-12-31 0001011432 2020-03-31 0001011432 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001011432 us-gaap:CommonStockMember 2020-01-01 2020-03-31 0001011432 us-gaap:CommonStockMember 2020-12-31 0001011432 us-gaap:CommonStockMember 2021-03-31 0001011432 us-gaap:CommonStockMember 2019-12-31 0001011432 us-gaap:CommonStockMember 2020-03-31 0001011432 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001011432 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-03-31 0001011432 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001011432 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001011432 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001011432 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0001011432 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001011432 us-gaap:RetainedEarningsMember 2020-01-01 2020-03-31 0001011432 us-gaap:RetainedEarningsMember 2020-12-31 0001011432 us-gaap:RetainedEarningsMember 2021-03-31 0001011432 us-gaap:RetainedEarningsMember 2019-12-31 0001011432 us-gaap:RetainedEarningsMember 2020-03-31 xbrli:pure iso4217:USD xbrli:shares iso4217:USD xbrli:shares

0.001

33333333

10-Q 2021-03-31 false CYNERGISTEK, INC. 0001011432 --12-31 Yes 2021 Q1 11940 Jollyville Road Suite 300-N, Austin 78759 949 614-0700 Non-accelerated Filer false true 000-27507 DE TX 37-1867101 false Yes

12120698

12024967

12120698

12024967

1949858

2063136

195000

74000

4173520

5115827

2424609

1748911

3001012

2114815

1970483

2083761

20625

708000

758000

183000

165000

0.055

183795

205452

128537

115949

55258

89503

P1Y6M

P10Y

17400000

738000

225000

884000

142000

24000

13000

4500000

2022-03-31

0.08

7000

2250000

562500 703125

596694

577779

100000

60000

18915

285000

42500

P8Y26D

P1Y18D

P1Y2M27D

P8Y3M15D

555350

767850

1088000

3.38

3.02

1724700 797325

1.08

4.86

2.28

4.86

We expect to recognize revenue on approximately 81% of the remaining non-cancelable portion of these performance obligations over the next 24 months, with the balance thereafter.

0.13

0.17

4000000 1300000

2500000

500000

2.50

2825500

0.010

7300000

2800000

2.37

3.01

30000

3.35

390000

Black-Scholes option-pricing model

0.0005

0.0016

0.6185

0.000

P3Y

3745621

135000

P2Y

15002

144235

149970

41690

108280

228437

411007

-42193

28981

241649

79282

77293

254432

2.49 2.57 2.41 P9Y

0 0 0 0 596694 2.49 P8Y26D 0

2.75

2532571

2871244

235245

797932

792181

2151728

2329719

1499394

1843818

12120698 0 0

3.25

3.27

1128006

1040839

2.75

100000

1.77

12833

P8Y1M24D

P9Y7M28D

46750

304673

3.95

P5Y9M14D

1843000

1315000

5723089

6063617

4945338

186912

590839

5165280

205000

693337

11326911

10986383

5154662

4463088

1709161

4934720

4445000

1606663

17050000

10100000

4650000

2300000

10100000

4650000

2300000

5735

1300000

61000 123000

30268188

31980125

22765418

23451458

38175624

36736008

12024

12120

10359

10379

38564520

38792861

34821863

35232850

-15125086

-16039563

3343402

1492779

-16039563

-15125086

38792861

38564520

12120

12024

4140502

4306156

15002

40031

2825500

140625

1300000 1300000

3362268

4222511

129233

252398

562500

1208074

1265864

531524

814830

930937

1326919

30268188

31980125

8394483

5723089

6063617

4995830

4959125

64586

380843

541525

10709357

11956789

1952532

1680866

1806340

2032420

557487

566713

12041074

10374497

12041074

10374497

-0.08

-0.18

-0.08

-0.18

-920311

-1850623

-1214576

-2381907

-20001

-18220

20001

24288

6068

-1194575

-2363687

3277261

4055982

340528

416191

47696

47600

1676658

2104844

1212379

1487347

2082686

1692295

2090834

3423532

-5834 0

-300099

-531284

-140625

-140629

140625

-19708

-51912

19708

51912

-1010181

-2070457

-31976

-57790

650047

-283306

-613183

-395982

36950

271666

456128

226080

447636

9226

77651

113278

151100

15500

12149

228437

411007

30000

36705

21806

340528

416191

47696

47600

-914477

-1850623

-914477

-1850623

4443140

5613654

5328726

3065728

-1170514

-2262998

0 185454 0 185454

8272

209834

12914

84606

12024967

12120698

10359164

10379164

228437

411007

228437

411007

95731 20000 96 20 -96 -20

1.       BASIS OF PRESENTATION   The accompanying unaudited condensed consolidated financial statements of CynergisTek, Inc. and its subsidiaries (the “Company,” “we,” “us,” or “CynergisTek”) have been prepared in accordance with generally accepted accounting principles of the United States of America (“GAAP”) for interim financial statements pursuant to the rules and regulations of the Securities and Exchange Commission. Accordingly, these financial statements do not include all of the information and notes required by GAAP for complete financial statements. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2020, as filed with the Securities and Exchange Commission (“SEC”) on March 25, 2021.   The unaudited condensed consolidated financial statements included herein reflect all adjustments (which include only normal, recurring adjustments) that are, in the opinion of management, necessary to state fairly our financial position and results of operations as of and for the periods presented. The results for such periods are not necessarily indicative of the results to be expected for the full year.   The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. As a result, actual results could differ from those estimates.   The accompanying unaudited condensed consolidated financial statements include the accounts of CynergisTek and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated.   Based on our integration strategies, and an analysis of how our Chief Operating Decision Makers review, manage and are compensated, we have determined that the Company operates as one segment. For the periods presented, all revenues were derived from domestic operations.   We have performed an evaluation of subsequent events through the date of filing these unaudited condensed consolidated financial statements with the SEC.   Liquidity and Capital Resources   As of March 31, 2021, our cash balance was $4.4 million, current assets minus current liabilities was positive $7.3 million and our non-current debt and lease obligations, excluding contingent earnout liability of $1.3 million, totaled $2.8 million. This $2.8 million of debt is related to the U.S. Small Business Administration (“SBA”) Paycheck Protection Program loan (the “PPP Loan”), received pursuant to the Coronavirus Aid, Relief and Economic Security Act (the “CARES Act”), that we anticipate will be fully forgiven as described in Note 9. The level of additional cash needed to fund operations and our ability to conduct business for the next twelve months will be influenced primarily by the following factors:   <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 36pt"></td><td style="width: 18pt">·</td><td style="text-align: justify">our ability to manage our operating expenses and maintain gross margins while attracting, recruiting and retaining cybersecurity privacy professionals;</td></tr></table>   <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 36pt"></td><td style="width: 18pt">·</td><td style="text-align: justify">demand for our services from healthcare providers; the near-term impact of the COVID-19 on our customers allocation of time and resources to security and privacy, and their ability to pay for existing services as well as enter into new contractual arrangements during a period of crisis;</td></tr></table>   <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 36pt"></td><td style="width: 18pt">·</td><td style="text-align: justify">general economic conditions and changes in healthcare reimbursement and regulatory environment, including effects of the COVID-19 epidemic; and</td></tr></table>   <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 36pt"></td><td style="width: 18pt">·</td><td style="text-align: justify">our ability to collect accounts receivable from health care customers whose operations and cash flow have been significantly impacted by COVID-19 pandemic.</td></tr></table>   We have historically funded our operating costs, acquisition activities, working capital requirements and capital expenditures with cash from operations, proceeds from the issuances of our common stock and other financing arrangements. We are currently operating in a cash flow negative position while we seek to maintain and grow our cybersecurity business and cover our public company expenses during this uncertain time. In connection with our most recent results for the three months ended March 31, 2021, we reported a loss from operations of $1.2 million. After excluding $0.6 million of non-cash items for depreciation, amortization of intangibles and stock-based compensation, our adjusted loss from operations was $0.6 million. Cash used in operating activities was $1.0 million for the three months ended March 31, 2021.   In late 2019, a novel strain of coronavirus (COVID-19) was first detected in Wuhan, China. Following the outbreak of this virus, governments throughout the world, including in the United States of America, have quarantined certain affected regions, restricted travel and imposed significant limitations on other economic activities. Our customer base is heavily concentrated in the healthcare provider space. This part of the healthcare industry has indicated that they are seeing significant financial losses, have furloughed employees and are expressing uncertainty as to the short and long-term financial stability of their businesses. Our operations team is closely monitoring the impact to the Company’s business, including its cash flows, customers and employees. We have heard and are working with a number of our active customers since the outbreak began providing relief in the form of extended payment terms and other contractual restructurings. If the situation continues to impact our customers cash flow or resources available for cybersecurity and privacy projects, our cash flows, financial position and operating results for fiscal year 2021 and beyond will be negatively impacted.   We did experience a negative financial impact from March 2020 through March 2021 that management anticipates will continue to impact revenue and earnings for the foreseeable future due to COVID-19, primarily because many of the initial economic effects of the early stages of the COVID-19 pandemic resulting from the various shelter-in-place and other social distancing orders occurred towards the end of our first quarter of 2020. The severity and duration of the COVID-19 pandemic is uncertain, and such uncertainty will likely continue in the near term. We will continue to actively monitor the situation taking into account the impact to our employees, customers and partners.   At the end of 2019 and through the first quarter of 2021, we reduced staffing levels to reduce expenses that included permanent and temporary cost reductions, the precise extent of which will depend on the duration of the COVID-19 disruptions to our customers and our short-term financial performance. In addition, we received a $2.8 million PPP loan pursuant to the CARES Act, which we anticipate will be fully forgiven and we anticipate having approximately $0.7 million in quarterly employee retention tax credits in the first and second quarters of 2021. With the proceeds from the PPP Loan and the employee retention tax credits, we have tried to minimize staff reductions in the areas of Sales and Delivery, our primary customer facing roles, to lessen the impact to our customers during this time of heightened security risks for the healthcare industry. If necessary, we could further reduce personnel and other variable and semi-variable costs to conserve cash and operate as a going concern. However, those actions if required, could negatively impact the long-term outlook of the business.   On November 12, 2020, we entered into the Equity Distribution Agreement with Craig-Hallum Capital Group LLC (the “Agent”), under which we may offer and sell, from time to time at our sole discretion, shares of our common stock having an aggregate offering price of up to $5.0 million in an “at-the-market” or ATM offering, to or through the Agent. The Company agreed to pay the Agent a commission of three percent (3.0%) of the gross sales price per share of any common stock sold through the Agent under the Equity Distribution Agreement.   During November and December of 2020, the Company received gross proceeds under the Equity Distribution agreement of $2,027,000 from the issuance of 1,315,000 shares of our common stock and paid an aggregate of $61,000 to the Agent in commissions and $123,000 in other offering-related expenses, yielding net proceeds of $1,843,000.   We believe that our existing sources of liquidity, including cash and cash equivalents, the proceeds from the PPP loan and employee retention tax credits, the ability to raise equity under our shelf registration (including via the Equity Distribution Agreement) and future operating cash flows, and other assets will be sufficient to meet our projected capital needs for at least the next twelve months. As we execute our plans over the next twelve months, we intend to carefully monitor the impact on our operating expenses, working capital needs and cash balances relative to the availability of cost-effective debt and equity financing. In the event that capital is not available, we may then have to scale back operations, reduce expenses, and/or curtail future plans to manage our liquidity and capital resources. However, we cannot provide assurance that we will be able to raise additional capital. The COVID-19 pandemic will likely continue to create uncertainty and volatility in the financial markets which may impact our operations and our ability to access capital and/or the terms under which we can do so.   The impact of the COVID-19 pandemic on the economy and our operations is fluid and constantly evolving; we will continue to assess a variety of measures to improve our financial performance and liquidity.   The accompanying consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

2.       RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS   Recently Issued Accounting Pronouncements Adopted   In January 2020, the Financial Accounting Standards Board (the “FASB”) issued an amendment clarifying the interaction between accounting standards related to equity securities, equity method investments and certain derivatives. The guidance was effective for fiscal years beginning after December 15, 2020. The adoption of this guidance did not have a material impact on our consolidated financial statements.   In December 2019, the FASB issued an amendment to the guidance on income taxes which is intended to simplify the accounting for income taxes. The amendment eliminates certain exceptions related to the approach for intra-period tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of the deferred tax liabilities for outside basis differences. The amendment also clarifies existing guidance related to the recognition of franchise tax, the evaluation of a step up in the tax basis of goodwill, and the effects of enacted changes in tax laws or rates in the effective tax rate computation, among other clarifications. The guidance was effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. The adoption of this guidance did not have a material impact on our consolidated financial statements.   Recently Issued Accounting Pronouncements Not Yet Adopted   In June 2016, the FASB issued an amendment to the guidance on the measurement of credit losses on financial instruments. The amendment updates the guidance for measuring and recording credit losses on financial assets measured and amortized cost by replacing the “incurred loss” model with an “expected loss” model. Accordingly, these financial assets will be presented at the net amount expected to be collected. The amendment also requires that credit losses related to available-for-sale debt securities be recorded as an allowance through net income rather than reducing the carrying amount under the current, other-than-temporary-impairment model. The guidance is effective for smaller reporting companies for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. Early adoption is permitted for annual periods after December 15, 2018. Management does not expect the impact from this guidance will have a material impact on our consolidated financial statements.

3.       ACCOUNTS RECEIVABLE   A summary of accounts receivable is as follows:   <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="vertical-align: top; width: 70%; padding-right: 0.5pt; padding-left: 0.5pt"> </td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 15%; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">March 31, 2021</td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 15%; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">December 31, 2020</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt; text-indent: 41.3pt">Trade receivables</td> <td style="text-align: right; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt">	$	1,970,483 </td> <td style="text-align: right; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt">	$	2,083,761 </td></tr> <tr> <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt">Allowance for doubtful accounts</td> <td style="border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt">	(20,625)</td> <td style="border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt">	(20,625)</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt">	Total accounts receivable, net</td> <td style="border-bottom: Black 1.5pt double; text-align: right; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt">	$	1,949,858 </td> <td style="border-bottom: Black 1.5pt double; text-align: right; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt">	$	2,063,136 </td></tr> </table>

4.       DEFERRED COMMISSIONS   Our incremental costs of obtaining a contract, which consist of sales commissions, are deferred and amortized over the period of contract performance. Deferred commissions are included in prepaid and other current assets in our consolidated balance sheets. We had $708,000 and $758,000 of unamortized deferred commissions as of March 31, 2021 and 2020, respectively. We had $183,000 and $165,000 of commissions expense for the three months ended March 31, 2021 and 2020, respectively.

5.       PROPERTY AND EQUIPMENT   A summary of property and equipment follows: <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="width: 70%"> </td> <td style="border-bottom: Black 1pt solid; width: 15%; text-align: center">March 31, 2021</td> <td style="border-bottom: Black 1pt solid; width: 15%; text-align: center">December 31, 2020</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Furniture and fixtures</td> <td style="text-align: right">	$	235,245 </td> <td style="text-align: right">	$	235,245 </td></tr> <tr style="vertical-align: bottom"> <td>Computers and office equipment</td> <td style="text-align: right">	797,932 </td> <td style="text-align: right">	792,181 </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Right of use assets</td> <td style="text-align: right">	1,499,394 </td> <td style="text-align: right">	1,843,818 </td></tr> <tr style="vertical-align: bottom"> <td>	Property and equipment at cost</td> <td style="border-top: Black 1pt solid; text-align: right">	2,532,571 </td> <td style="border-top: Black 1pt solid; text-align: right">	2,871,244 </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Less accumulated depreciation and amortization</td> <td style="border-bottom: Black 1pt solid; text-align: right">	(2,151,728)</td> <td style="border-bottom: Black 1pt solid; text-align: right">	(2,329,719)</td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="border-bottom: Black 1.5pt double; text-align: right">	$	380,843 </td> <td style="border-bottom: Black 1.5pt double; text-align: right">	$	541,525 </td></tr> </table>

6.       LEASES   We previously leased approximately 9,600 square feet of office space in Austin, Texas. In March 2020, we amended this lease reducing the office space to 5,000 square feet and extended the lease term to May 31, 2022. We lease approximately 3,700 square feet of office space in Minneapolis, Minnesota. This lease terminates on July 31, 2021, and we expect to renew on a month-to-month or other short-term basis under one year. We leased approximately 18,000 square feet of office space in Mission Viejo, California. This lease terminated in April 2021. During the first quarter of 2019, we subleased this space to two subtenants. The terms of these subleases ended concurrently with the end of our lease obligation in April 2021.   We used a discount rate of 5.5% in determining our operating lease liabilities which represented our incremental borrowing rate. Short-term leases with initial terms of twelve months or less are not capitalized.   Right-of-use assets and liabilities are recognized based on the present value of future minimum lease payments over the expected lease term at commencement date. Certain lease agreements contain extension options; however, we have not included such options as part of right-of-use assets and lease liabilities because we originally did not expect to extend the leases. We measure and record a right-of-use asset and lease liability based on the discount rate implicit in the lease, if known. In cases where the discount rate implicit in the lease is not known, we measure the right-of-use assets and lease liabilities using a discount rate equal to our estimated incremental borrowing rate for loans with similar collateral and duration.   Operating lease expense was comprised of the following:   <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="padding-right: 0.5pt; padding-left: 0.5pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">Three Months Ended March 31,</td></tr> <tr style="vertical-align: top"> <td style="width: 70%; padding-right: 0.5pt; padding-left: 0.5pt"> </td> <td style="border-bottom: Black 1pt solid; width: 15%; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">2021</td> <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 15%; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">2020</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt">Operating lease cost</td> <td style="text-align: right; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt">	$	183,795 </td> <td style="text-align: right; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt">	$	205,452 </td></tr> <tr> <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt">Sublet income</td> <td style="border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt">	(128,537)</td> <td style="border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt">	(115,949)</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt">	Net operating lease cost</td> <td style="border-bottom: Black 1.5pt double; text-align: right; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt">	$	55,258 </td> <td style="border-bottom: Black 1.5pt double; text-align: right; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt">	$	89,503 </td></tr> </table>   Maturities of lease liabilities are as follows:   <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 68%; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 32%; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Operating Leases</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">2021 (remaining fiscal year)</td> <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">	$	108,280 </td></tr> <tr> <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">2022</td> <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">	41,690 </td></tr> <tr> <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left">Total lease payments</td> <td style="border-top: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">	149,970 </td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left">Less imputed interest</td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">	(5,735)</td></tr> <tr> <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left">Total lease liabilities</td> <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">	144,235 </td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left">Less current portion of lease liabilities</td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">	(129,233)</td></tr> <tr> <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left">Long-term lease liabilities</td> <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">	$	15,002  </td></tr> </table>

7.       INTANGIBLE ASSETS   Intangible assets are amortized over expected useful lives ranging from 1.5 to 10 years and consist of the following:   <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="vertical-align: top; padding-left: 8.8pt; text-indent: -8.8pt"> </td> <td colspan="3" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center">March 31, 2021</td> <td colspan="3" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center">December 31, 2020</td></tr> <tr> <td style="vertical-align: top; width: 24%; padding-left: 8.8pt; text-indent: -8.8pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom; width: 13%"> Carrying Amount</td> <td style="border-top: Black 1pt solid; text-align: right; border-bottom: Black 1pt solid; vertical-align: bottom; width: 14%"> Accumulated Amortization and Impairment</td> <td style="border-top: Black 1pt solid; text-align: right; border-bottom: Black 1pt solid; vertical-align: bottom; width: 11%"> Net Book Value</td> <td style="border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom; width: 13%"> Carrying Amount</td> <td style="border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom; width: 13%"> Accumulated Amortization and Impairment</td> <td style="border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom; width: 12%"> Net Book Value</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top; padding-left: 8.8pt; text-indent: -8.8pt">Acquired technology</td> <td style="text-align: right; vertical-align: bottom">	$	10,100,000</td> <td style="text-align: right; vertical-align: bottom">	$	(5,154,662)</td> <td style="text-align: right; vertical-align: bottom">	$	4,945,338</td> <td style="text-align: right; vertical-align: bottom">	$	10,100,000</td> <td style="text-align: right; vertical-align: bottom">$	(4,934,720)</td> <td style="text-align: right; vertical-align: bottom">	$	5,165,280</td></tr> <tr> <td style="vertical-align: top; padding-left: 8.8pt; text-indent: -8.8pt">Customer relationships</td> <td style="text-align: right; vertical-align: bottom">	4,650,000</td> <td style="text-align: right; vertical-align: bottom">	(4,463,088)</td> <td style="text-align: right; vertical-align: bottom">	186,912</td> <td style="text-align: right; vertical-align: bottom">	4,650,000</td> <td style="text-align: right; vertical-align: bottom">	(4,445,000)</td> <td style="text-align: right; vertical-align: bottom">	205,000</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top; padding-left: 8.8pt; text-indent: -8.8pt">Trademarks</td> <td style="text-align: right; vertical-align: bottom">	2,300,000</td> <td style="text-align: right; vertical-align: bottom">	(1,709,161)</td> <td style="text-align: right; vertical-align: bottom">	590,839</td> <td style="text-align: right; vertical-align: bottom">	2,300,000</td> <td style="text-align: right; vertical-align: bottom">	(1,606,663)</td> <td style="text-align: right; vertical-align: bottom">	693,337</td></tr> <tr> <td style="vertical-align: top">	Total</td> <td style="border-top: Black 1pt solid; text-align: right; border-bottom: Black 1pt solid; vertical-align: bottom">	$	17,050,000</td> <td style="border-top: Black 1pt solid; text-align: right; border-bottom: Black 1pt solid; vertical-align: bottom">	$	(11,326,911)</td> <td style="border-top: Black 1pt solid; text-align: right; border-bottom: Black 1pt solid; vertical-align: bottom">	$	5,723,089</td> <td style="border-top: Black 1pt solid; text-align: right; border-bottom: Black 1pt solid; vertical-align: bottom">	$	17,050,000</td> <td style="border-top: Black 1pt solid; text-align: right; border-bottom: Black 1pt solid; vertical-align: bottom">$	(10,986,383)</td> <td style="border-top: Black 1pt solid; text-align: right; border-bottom: Black 1pt solid; vertical-align: bottom">	$	6,063,617</td></tr> </table>

8.       DEFERRED REVENUE   We record deferred revenues when amounts are billed to customers, or cash is received from customers, in advance of our performance. During the three months ended March 31, 2021 and 2020, $738,000 and $884,000, respectively, of managed services revenues were recognized, that were included in deferred revenue at the beginning of the respective periods. During the three months ended March 31, 2021 and 2020, $225,000 and $142,000, respectively, of consulting and professional services revenues were recognized, that were included in deferred revenue at the beginning of the respective periods.

9.       PAYCHECK PROTECTION PROGRAM LOAN   On April 20, 2020, we received $2,825,500 in loan funding from the Small Business Administration (“SBA”) Paycheck Protection Program (“PPP”), established pursuant to the Coronavirus Aid, Relief and Economic Security Act (the “CARES Act”). The unsecured loan (the “PPP Loan”) is evidenced by a promissory note issued by the Company (the “Note”) in favor of BMO Harris Bank N.A.   The Company used the PPP Loan proceeds to cover payroll costs, rent and utilities in accordance with the relevant terms and conditions of the CARES Act.   Under the terms of the Note and the PPP Loan, interest accrues on the outstanding principal at the rate of 1.0% per annum. The term of the Note is two years, unless sooner provided in connection with an event of default under the Note. To the extent the Loan amount is not forgiven under the PPP, the Company is obligated to make equal monthly payments of principal and interest, beginning seven months from the date of the Note, until the maturity date. The Company has not started making interest payments as it awaits the forgiveness decision from the SBA. Details regarding the Note can be found in our 8-K filed on April 20, 2020.   The Company recognized interest charges associated with the PPP Loan of approximately $7,000 for the three months ended March 31, 2021. To the extent the principal balance is forgiven, the related interest would be forgiven as well. Management anticipates that the loan will be fully forgiven.

10.       PROMISSORY NOTES   In connection with the acquisition of CTEK Security, Inc. (formerly CynergisTek, Inc.), we issued a promissory note totaling $4.5 million to Michael McMillan (“Seller Note,”).In March, 2018, the Company repaid $2,250,000 plus accrued interest on the Seller Note and agreed to amend and restate the Seller Note in the remaining principal amount of $2,250,000. The Seller Note bears interest at a rate of 8% per annum, provides for quarterly payments of principal and interest and matures on March 31, 2022. As of March 31, 2021, and December 31, 2020, the outstanding principal balance due under the Seller Note was $562,500 and $703,125, respectively.   Interest charges associated with the Seller Note totaled approximately $13,000 and $24,000, for the three months ended March 31, 2021 and 2020, respectively.

11.       REVENUES   Below is a summary of our revenues disaggregated by revenue source.   <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="padding-right: 0.5pt; padding-left: 0.5pt">	</td> <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">Three Months Ended March 31,</td></tr> <tr style="vertical-align: top"> <td style="width: 70%; padding-right: 0.5pt; padding-left: 0.5pt"> </td> <td style="border-bottom: Black 1pt solid; width: 15%; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">2021</td> <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 15%; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">2020</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt">Managed services</td> <td style="text-align: right; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt">	$	2,424,609</td> <td style="text-align: right; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt">	$	3,001,012</td></tr> <tr> <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt">Consulting and professional services</td> <td style="border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt">	1,748,911</td> <td style="border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt">	2,114,815</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt">	Net revenues</td> <td style="border-bottom: Black 1.5pt double; text-align: right; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt">	$	4,173,520</td> <td style="border-bottom: Black 1.5pt double; text-align: right; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt">	$	5,115,827</td></tr> </table>

12.       WARRANTS, OPTIONS AND RESTRICTED STOCK UNITS   Warrant Issued for Securities Purchase Agreement   On April 3, 2020, we entered into a Securities Purchase Agreement with Horton Capital Management, LLC (“Horton”) which provided that Horton was committed to purchase up to an aggregate of $2,500,000 of shares of the Company’s common stock over the term of the agreement, at the election of the Company, which terminated on March 31, 2021. Additionally, if and when the Company sold shares to Horton under the commitment, the Company agreed to grant to Horton a warrant, with the same number of shares of common stock purchased by Horton in the particular funding, with an exercise price equal to 125% of the purchase price of the shares of common stock sold in such funding, with a 10-year term. No purchases were made under the Securities Purchase Agreement.   Upon signing the agreement, the Company issued Horton a warrant (the “Horton Warrant”) to purchase up to 500,000 shares of common stock in consideration of Horton’s obligation to purchase the shares, at an exercise price of $2.50 per share, subject to certain anti-dilution adjustments as set forth in the warrant. The fair value of this warrant of $390,000 was determined using the Black-Scholes option-pricing model and was expensed during the second quarter of 2020.   At the end of 2020 the Company issued common stock under an equity distribution agreement receiving net proceeds of $1,843,000 from the issuance of 1,315,000 shares of our common stock that resulted in a Q1 2021 anti-dilution adjustment increasing the number of shares under the Horton Warrant to 518,915 and reducing the exercise price to $2.41. The resulting difference in fair value of the Horton Warrant with the new exercise price was $6,000 and determined using the Black-Scholes option-pricing model and recorded as a deemed dividend in our consolidated statements of stockholders’ equity. As the Company has an accumulated deficit, the deemed dividend was recorded within additional paid-in capital.   The detailed terms and conditions of the Horton Securities Purchase Agreement and the Horton Warrant can be found in the documents themselves, which were filed with the SEC on April 7, 2020.   Below is a summary of warrant activities during the three-month period ended March 31, 2021:   <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; width: 34%; padding-right: 5.4pt; padding-left: 5.4pt"> Warrants</td> <td style="border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt"> Shares</td> <td style="border-bottom: Black 1pt solid; text-align: right; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt"> Weighted Average Exercise Price</td> <td style="border-bottom: Black 1pt solid; width: 19%; padding-right: 5.4pt; padding-left: 5.4pt"> Weighted Average Remaining Term in Years</td> <td style="border-bottom: Black 1pt solid; text-align: right; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt"> Aggregate Intrinsic Value</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt">Outstanding at December 31, 2020</td> <td style="vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">	577,779</td> <td style="text-align: right; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt">	$	2.57</td> <td style="vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">8.29</td> <td style="text-align: right; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt">	$	-</td></tr> <tr> <td style="vertical-align: top; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt">	Granted</td> <td style="vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">	18,915</td> <td style="text-align: right; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt">	$	2.41</td> <td style="vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">9.00</td> <td style="text-align: right; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt">	$	-</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt">	Exercised</td> <td style="vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">	-</td> <td style="text-align: right; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt">	-</td> <td style="vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"> </td> <td style="text-align: right; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt"> </td></tr> <tr> <td style="vertical-align: top; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt">	Cancelled</td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">	-</td> <td style="border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt">	-</td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"> </td> <td style="border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt"> </td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt">Outstanding at March 31, 2021</td> <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">	596,694</td> <td style="border-bottom: Black 1.5pt double; text-align: right; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt">	$	2.49</td> <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">	8.07</td> <td style="border-bottom: Black 1.5pt double; text-align: right; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt">	$	-</td></tr> <tr> <td style="vertical-align: top; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt">Exercisable at March 31, 2021</td> <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">	596,694</td> <td style="border-bottom: Black 1.5pt double; text-align: right; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt">	$	2.49</td> <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">	8.07</td> <td style="border-bottom: Black 1.5pt double; text-align: right; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt">	$	-</td></tr> </table>   2020 Equity Incentive Plan   The 2020 Equity Incentive Plan provides for a total number of shares available for issuance of 3,745,621 shares of our common stock, and it provides for the granting of stock options, stock appreciation rights, and restricted stock to our employees, members of the Board of Directors and service providers.   Below is a summary of stock option activities during the three-month period ended March 31, 2021:   <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> Options</td> <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> Number of Shares</td> <td style="border-bottom: Black 1pt solid; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"> Weighted Average Exercise Price</td> <td style="border-bottom: Black 1pt solid; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"> Weighted Average Remaining Term in Years</td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"> Aggregate Intrinsic Value</td></tr> <tr> <td style="vertical-align: top; width: 34%; background-color: #CCEEFF; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">Outstanding at December 31, 2020</td> <td style="vertical-align: bottom; width: 14%; background-color: #CCEEFF; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">	1,040,839 </td> <td style="text-align: right; vertical-align: bottom; width: 16%; background-color: #CCEEFF; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt">	$	3.27</td> <td style="vertical-align: bottom; width: 19%; background-color: #CCEEFF; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">9.66</td> <td style="text-align: right; vertical-align: bottom; width: 16%; background-color: #CCEEFF; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt">	$	46,750</td> <td style="text-align: right; width: 1%"> </td></tr> <tr> <td style="vertical-align: top; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">	Granted</td> <td style="vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">	100,000 </td> <td style="text-align: right; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt">	$	2.75</td> <td style="vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"> </td> <td style="text-align: right; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="text-align: right"> </td></tr> <tr> <td style="vertical-align: top; background-color: #CCEEFF; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">	Exercised</td> <td style="vertical-align: bottom; background-color: #CCEEFF; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">	- </td> <td style="text-align: right; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt">	-</td> <td style="vertical-align: bottom; background-color: #CCEEFF; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"> </td> <td style="text-align: right; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="text-align: right"> </td></tr> <tr> <td style="vertical-align: top; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">	Cancelled</td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">	(12,833)</td> <td style="border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt">	1.77</td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"> </td> <td style="border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="text-align: right"> </td></tr> <tr> <td style="vertical-align: top; background-color: #CCEEFF; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">Outstanding at March 31, 2021</td> <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">	1,128,006 </td> <td style="border-bottom: Black 1.5pt double; text-align: right; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt">	$	3.25</td> <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">8.15</td> <td style="border-bottom: Black 1.5pt double; text-align: right; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt">	$	-</td> <td style="text-align: right"> </td></tr> <tr> <td style="vertical-align: top; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">Exercisable at March 31, 2021</td> <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">	304,673 </td> <td style="border-bottom: Black 1.5pt double; text-align: right; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt">	$	3.95</td> <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">5.79</td> <td style="border-bottom: Black 1.5pt double; text-align: right; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt">	$	-</td> <td style="text-align: right"> </td></tr> </table>   During the three months ended March 31, 2021, we granted 100,000 options to an employee to purchase shares of our common stock at an exercise price of $2.75 per share. The exercise price equals the fair value of our stock on the grant date. The options have graded vesting annually over three years. The fair value of the options of approximately $135,000 was determined using the Black-Scholes option-pricing model.   Below is a summary of restricted stock unit activity during the three-month period ended March 31, 2021:   <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; width: 41%; padding-right: 5.4pt; padding-left: 5.4pt"> Restricted Stock Units</td> <td style="border-bottom: Black 1pt solid; text-align: center; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt"> Shares</td> <td style="border-bottom: Black 1pt solid; text-align: right; width: 19%; padding-right: 5.4pt; padding-left: 5.4pt"> Weighted Average Grant Date Fair Value per Share</td> <td style="border-bottom: Black 1pt solid; text-align: right; width: 23%; padding-right: 5.4pt; padding-left: 5.4pt"> Weighted Average Vesting Period in Years</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt">Non-vested at December 31, 2020</td> <td style="vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">	555,350 </td> <td style="text-align: right; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt">	$	3.38</td> <td style="vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">1.24</td></tr> <tr> <td style="vertical-align: top; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt">	Granted</td> <td style="vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">	285,000 </td> <td style="text-align: right; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt">	2.37</td> <td style="vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"> </td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt">	Vested</td> <td style="vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">	(30,000)</td> <td style="text-align: right; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt">	3.01</td> <td style="vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"> </td></tr> <tr> <td style="vertical-align: top; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt">	Cancelled and forfeited</td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">	(42,500)</td> <td style="border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt">	3.35</td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"> </td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt">Non-vested at March 31, 2021</td> <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">	767,850 </td> <td style="border-bottom: Black 1.5pt double; text-align: right; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt">	$	3.02</td> <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">1.05</td></tr> </table>   There are 100,000 shares of restricted stock units which have vested but had not yet been issued as of March 31, 2021.   For the three months ended March 31, 2021 and 2020, stock-based compensation and other equity instrument related expenses recognized in the consolidated statements of operations were as follows:   <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"> Three Months Ended March 31,</td></tr> <tr style="vertical-align: top"> <td style="width: 55%; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: right; width: 21%; padding-right: 5.4pt; padding-left: 5.4pt"> 2021</td> <td style="border-top: Black 1pt solid; text-align: right; border-bottom: Black 1pt solid; width: 24%; padding-right: 5.4pt; padding-left: 5.4pt"> 2020</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">Cost of revenues</td> <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">$	(42,193)</td> <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">$	79,282</td></tr> <tr> <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">Sales and marketing</td> <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">	28,981 </td> <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">	77,293</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">General and administrative expense</td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">	241,649 </td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">	254,432</td></tr> <tr> <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">Total stock-based compensation expense   </td> <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">$	228,437 </td> <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">$	411,007</td></tr> </table>

13.       BASIC AND DILUTED NET LOSS PER SHARE   Basic net loss per share is calculated using the weighted average number of shares of our common stock issued and outstanding during a certain period and is calculated by dividing net loss by the weighted average number of shares of our common stock issued and outstanding during such period. Diluted net loss per share is calculated using the weighted average number of common and potentially dilutive common shares outstanding during the period, using the as-if-converted method for secured convertible notes, and the treasury stock method for options and warrants. Diluted net loss per share does not include potentially dilutive securities because such inclusion in the computation would be anti-dilutive.   For the three months ended March 31, 2021, potentially dilutive securities consisted of options and warrants to purchase 1,724,700 shares of common stock at prices ranging from $1.08 to $4.86 per share. Of these potentially dilutive securities, none of the shares to purchase common stock from the options and warrants are included in the computation of diluted earnings per share, because the effect of including the remaining instruments would be anti-dilutive. Also excluded from potentially dilutive securities are 767,850 shares of non-vested restricted stock units and 100,000 shares of restricted stock units which vested but had not been issued as of March 31, 2021.   For the three months ended March 31, 2020, potentially dilutive securities consisted of options and warrants to purchase 797,325 shares of common stock at prices ranging from $2.28 to $4.86 per share. Of these potentially dilutive securities, none of the shares to purchase common stock from the options and warrants are included in the computation of diluted earnings per share because the effect of including these instruments would be anti-dilutive. Also excluded from potentially dilutive securities are 1,088,000 shares of non-vested restricted stock units and 60,000 shares of restricted stock units which vested but had not been issued as of March 31, 2020. <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td colspan="4" style="border-bottom: Black 1pt solid; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"> Three Months Ended March 31,</td></tr> <tr style="vertical-align: top"> <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"> 2021</td> <td colspan="2" style="border-top: Black 1pt solid; text-align: right; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> 2020</td></tr> <tr style="vertical-align: top; background-color: #CCEEFF"> <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt">Numerators:</td> <td colspan="2" style="text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td colspan="2" style="text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"> </td></tr> <tr> <td colspan="2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">	Net loss attributable to common shareholders</td> <td colspan="2" style="border-bottom: Black 1.5pt double; text-align: right; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">	$	(920,311)</td> <td colspan="2" style="border-bottom: Black 1.5pt double; text-align: right; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">	$	(1,850,623)</td></tr> <tr style="background-color: #CCEEFF"> <td colspan="2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td colspan="2" style="text-align: right; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td colspan="2" style="text-align: right; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td></tr> <tr> <td colspan="2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">Denominator:</td> <td colspan="2" style="text-align: right; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td colspan="2" style="text-align: right; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td></tr> <tr style="background-color: #CCEEFF"> <td colspan="2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">	Denominator for basic calculation weighted average shares</td> <td colspan="2" style="text-align: right; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">	12,041,074</td> <td colspan="2" style="text-align: right; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">	10,374,497</td></tr> <tr> <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td colspan="2" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td colspan="2" style="text-align: right; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="text-align: right"> </td></tr> <tr style="background-color: #CCEEFF"> <td colspan="2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">Dilutive common stock equivalents:</td> <td colspan="2" style="text-align: right; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td colspan="2" style="text-align: right; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td></tr> <tr> <td colspan="2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">	Options and warrants </td> <td colspan="2" style="text-align: right; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">	-</td> <td colspan="2" style="text-align: right; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">	-</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt">	Restricted stock units vested but not issued</td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt">	-</td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt">	-</td></tr> <tr> <td colspan="2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">	Denominator for diluted calculation weighted average shares</td> <td colspan="2" style="border-bottom: Black 1.5pt double; text-align: right; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">	12,041,074</td> <td colspan="2" style="border-bottom: Black 1.5pt double; text-align: right; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">	10,374,497</td></tr> <tr> <td colspan="2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td colspan="2" style="text-align: right; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td colspan="2" style="text-align: right; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td></tr> <tr style="background-color: #CCEEFF"> <td colspan="2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">Net loss per share:</td> <td colspan="2" style="text-align: right; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td colspan="2" style="text-align: right; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td></tr> <tr> <td colspan="2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">	Basic net loss per share</td> <td colspan="2" style="border-bottom: Black 1.5pt double; text-align: right; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">	$	(0.08)</td> <td colspan="2" style="border-bottom: Black 1.5pt double; text-align: right; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">	$	(0.18)</td></tr> <tr style="background-color: #CCEEFF"> <td colspan="2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">	Diluted net loss per share</td> <td colspan="2" style="border-bottom: Black 1.5pt double; text-align: right; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">	$	(0.08)</td> <td colspan="2" style="border-bottom: Black 1.5pt double; text-align: right; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">	$	(0.18)</td></tr> <tr> <td style="width: 55%"> </td> <td style="width: 2%"> </td> <td style="text-align: right; width: 22%"> </td> <td style="text-align: right; width: 1%"> </td> <td style="text-align: right; width: 19%"> </td> <td style="text-align: right; width: 1%"> </td></tr> </table>

14.       REMAINING PERFORMANCE OBLIGATIONS   We had remaining performance obligations of approximately $17.4 million as of March 31, 2021. Our remaining performance obligations represent the amount of transaction price for which work has not been performed and revenue has not been recognized. When applying Accounting Standards Codification (“ASC”) Topic 606, with only the non-cancelable portion of these contracts included in our performance obligations we had approximately $15.1 million as of March 31, 2021. We expect to recognize revenue on approximately 81% of the remaining non-cancelable portion of these performance obligations over the next 24 months, with the balance thereafter.

15.       CONCENTRATIONS   Cash Concentrations   At times, cash balances held in financial institutions are in excess of federally insured limits. Management performs periodic evaluations of the relative credit standing of financial institutions and limits the amount of risk by selecting financial institutions with a strong credit standing.   Major Customers   Our largest customer accounted for approximately 13% and 12% of our revenues for the three months ended March 31, 2021 and 2020, respectively. Our largest customer had accounts receivable totaling approximately $195,000 and $74,000 as of March 31, 2021, and December 31, 2020, respectively.

16.       EARNOUT LIABILITY – BACKBONE ENTERPRISES   In 2019, we entered into a Stock Purchase Agreement (the “Backbone Purchase Agreement”) with Backbone Enterprises Inc., a Minnesota corporation (“Backbone”), and its stockholders, (the “Stockholders”), pursuant to which we acquired 100% of the issued and outstanding shares of common stock (the “Shares”) of Backbone from the Stockholders. Pursuant to the Backbone Purchase Agreement, the aggregate purchase price for the Shares included an earn-out, pursuant to which the Stockholders may be entitled to an additional $4,000,000 based upon the post-closing financial performance of Backbone, to be calculated based upon revenue generated by the Backbone business during the three-year earn-out period. There was no earnout earned for the first year of the agreement. As of March 31, 2021, the estimated fair value of the earnout is $1,300,000 for the remaining 2 years of the agreement.

A summary of accounts receivable is as follows:   <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="vertical-align: top; width: 70%; padding-right: 0.5pt; padding-left: 0.5pt"> </td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 15%; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">March 31, 2021</td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 15%; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">December 31, 2020</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt; text-indent: 41.3pt">Trade receivables</td> <td style="text-align: right; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt">	$	1,970,483 </td> <td style="text-align: right; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt">	$	2,083,761 </td></tr> <tr> <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt">Allowance for doubtful accounts</td> <td style="border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt">	(20,625)</td> <td style="border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt">	(20,625)</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt">	Total accounts receivable, net</td> <td style="border-bottom: Black 1.5pt double; text-align: right; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt">	$	1,949,858 </td> <td style="border-bottom: Black 1.5pt double; text-align: right; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt">	$	2,063,136 </td></tr> </table>

A summary of property and equipment follows: <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="width: 70%"> </td> <td style="border-bottom: Black 1pt solid; width: 15%; text-align: center">March 31, 2021</td> <td style="border-bottom: Black 1pt solid; width: 15%; text-align: center">December 31, 2020</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Furniture and fixtures</td> <td style="text-align: right">	$	235,245 </td> <td style="text-align: right">	$	235,245 </td></tr> <tr style="vertical-align: bottom"> <td>Computers and office equipment</td> <td style="text-align: right">	797,932 </td> <td style="text-align: right">	792,181 </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Right of use assets</td> <td style="text-align: right">	1,499,394 </td> <td style="text-align: right">	1,843,818 </td></tr> <tr style="vertical-align: bottom"> <td>	Property and equipment at cost</td> <td style="border-top: Black 1pt solid; text-align: right">	2,532,571 </td> <td style="border-top: Black 1pt solid; text-align: right">	2,871,244 </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Less accumulated depreciation and amortization</td> <td style="border-bottom: Black 1pt solid; text-align: right">	(2,151,728)</td> <td style="border-bottom: Black 1pt solid; text-align: right">	(2,329,719)</td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="border-bottom: Black 1.5pt double; text-align: right">	$	380,843 </td> <td style="border-bottom: Black 1.5pt double; text-align: right">	$	541,525 </td></tr> </table>

Operating lease expense was comprised of the following:   <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="padding-right: 0.5pt; padding-left: 0.5pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">Three Months Ended March 31,</td></tr> <tr style="vertical-align: top"> <td style="width: 70%; padding-right: 0.5pt; padding-left: 0.5pt"> </td> <td style="border-bottom: Black 1pt solid; width: 15%; padding-right: 0.5pt; padding-left: 0.5pt; text-align: right">2021</td> <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 15%; padding-right: 0.5pt; padding-left: 0.5pt; text-align: right">2020</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt">Operating lease cost</td> <td style="text-align: right; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt">	$	183,795 </td> <td style="text-align: right; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt">	$	205,452 </td></tr> <tr> <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt">Sublet income</td> <td style="border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt">	(128,537)</td> <td style="border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt">	(115,949)</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt">	Net operating lease cost</td> <td style="border-bottom: Black 1.5pt double; text-align: right; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt">	$	55,258 </td> <td style="border-bottom: Black 1.5pt double; text-align: right; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt">	$	89,503 </td></tr> </table>

Maturities of lease liabilities are as follows:   <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 68%; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 32%; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Operating Leases</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">2021 (remaining fiscal year)</td> <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">	$	108,280 </td></tr> <tr> <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">2022</td> <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">	41,690 </td></tr> <tr> <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left">Total lease payments</td> <td style="border-top: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">	149,970 </td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left">Less imputed interest</td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">	(5,735)</td></tr> <tr> <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left">Total lease liabilities</td> <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">	144,235 </td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left">Less current portion of lease liabilities</td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">	(129,233)</td></tr> <tr> <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left">Long-term lease liabilities</td> <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">	$	15,002  </td></tr> </table>

Intangible assets are amortized over expected useful lives ranging from 1.5 to 10 years and consist of the following:   <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="vertical-align: top; padding-left: 8.8pt; text-indent: -8.8pt"> </td> <td colspan="3" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center">March 31, 2021</td> <td colspan="3" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center">December 31, 2020</td></tr> <tr> <td style="vertical-align: top; width: 24%; padding-left: 8.8pt; text-indent: -8.8pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom; width: 13%"> Carrying Amount</td> <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom; width: 14%"> Accumulated Amortization and Impairment</td> <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom; width: 11%"> Net Book Value</td> <td style="border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom; width: 13%"> Carrying Amount</td> <td style="border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom; width: 13%"> Accumulated Amortization and Impairment</td> <td style="border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom; width: 12%"> Net Book Value</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top; padding-left: 8.8pt; text-indent: -8.8pt">Acquired technology</td> <td style="text-align: right; vertical-align: bottom">	$	10,100,000</td> <td style="text-align: right; vertical-align: bottom">	$	(5,154,662)</td> <td style="text-align: right; vertical-align: bottom">	$	4,945,338</td> <td style="text-align: right; vertical-align: bottom">	$	10,100,000</td> <td style="text-align: right; vertical-align: bottom">$	(4,934,720)</td> <td style="text-align: right; vertical-align: bottom">	$	5,165,280</td></tr> <tr> <td style="vertical-align: top; padding-left: 8.8pt; text-indent: -8.8pt">Customer relationships</td> <td style="text-align: right; vertical-align: bottom">	4,650,000</td> <td style="text-align: right; vertical-align: bottom">	(4,463,088)</td> <td style="text-align: right; vertical-align: bottom">	186,912</td> <td style="text-align: right; vertical-align: bottom">	4,650,000</td> <td style="text-align: right; vertical-align: bottom">	(4,445,000)</td> <td style="text-align: right; vertical-align: bottom">	205,000</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top; padding-left: 8.8pt; text-indent: -8.8pt">Trademarks</td> <td style="text-align: right; vertical-align: bottom">	2,300,000</td> <td style="text-align: right; vertical-align: bottom">	(1,709,161)</td> <td style="text-align: right; vertical-align: bottom">	590,839</td> <td style="text-align: right; vertical-align: bottom">	2,300,000</td> <td style="text-align: right; vertical-align: bottom">	(1,606,663)</td> <td style="text-align: right; vertical-align: bottom">	693,337</td></tr> <tr> <td style="vertical-align: top">	Total</td> <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom">	$	17,050,000</td> <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom">	$	(11,326,911)</td> <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom">	$	5,723,089</td> <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom">	$	17,050,000</td> <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom">$	(10,986,383)</td> <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom">	$	6,063,617</td></tr> </table>

Below is a summary of our revenues disaggregated by revenue source.   <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="padding-right: 0.5pt; padding-left: 0.5pt">	</td> <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">Three Months Ended March 31,</td></tr> <tr style="vertical-align: top"> <td style="width: 70%; padding-right: 0.5pt; padding-left: 0.5pt"> </td> <td style="border-bottom: Black 1pt solid; width: 15%; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">2021</td> <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 15%; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">2020</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt">Managed services</td> <td style="text-align: right; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt">	$	2,424,609</td> <td style="text-align: right; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt">	$	3,001,012</td></tr> <tr> <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt">Consulting and professional services</td> <td style="border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt">	1,748,911</td> <td style="border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt">	2,114,815</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt">	Net revenues</td> <td style="border-bottom: Black 1.5pt double; text-align: right; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt">	$	4,173,520</td> <td style="border-bottom: Black 1.5pt double; text-align: right; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt">	$	5,115,827</td></tr> </table>

Below is a summary of warrant activities during the three-month period ended March 31, 2021:   <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; width: 34%; padding-right: 5.4pt; padding-left: 5.4pt"> Warrants</td> <td style="border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt"> Shares</td> <td style="border-bottom: Black 1pt solid; text-align: right; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt"> Weighted Average Exercise Price</td> <td style="border-bottom: Black 1pt solid; width: 19%; padding-right: 5.4pt; padding-left: 5.4pt"> Weighted Average Remaining Term in Years</td> <td style="border-bottom: Black 1pt solid; text-align: right; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt"> Aggregate Intrinsic Value</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt">Outstanding at December 31, 2020</td> <td style="vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">	577,779</td> <td style="text-align: right; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt">	$	2.57</td> <td style="vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">8.29</td> <td style="text-align: right; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt">	$	-</td></tr> <tr> <td style="vertical-align: top; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt">	Granted</td> <td style="vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">	18,915</td> <td style="text-align: right; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt">	$	2.41</td> <td style="vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">9.00</td> <td style="text-align: right; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt">	$	-</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt">	Exercised</td> <td style="vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">	-</td> <td style="text-align: right; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt">	-</td> <td style="vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"> </td> <td style="text-align: right; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt"> </td></tr> <tr> <td style="vertical-align: top; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt">	Cancelled</td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">	-</td> <td style="border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt">	-</td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"> </td> <td style="border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt"> </td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt">Outstanding at March 31, 2021</td> <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">	596,694</td> <td style="border-bottom: Black 1.5pt double; text-align: right; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt">	$	2.49</td> <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">	8.07</td> <td style="border-bottom: Black 1.5pt double; text-align: right; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt">	$	-</td></tr> <tr> <td style="vertical-align: top; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt">Exercisable at March 31, 2021</td> <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">	596,694</td> <td style="border-bottom: Black 1.5pt double; text-align: right; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt">	$	2.49</td> <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">	8.07</td> <td style="border-bottom: Black 1.5pt double; text-align: right; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt">	$	-</td></tr> </table>

Below is a summary of stock option activities during the three-month period ended March 31, 2021:   <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> Options</td> <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> Number of Shares</td> <td style="border-bottom: Black 1pt solid; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"> Weighted Average Exercise Price</td> <td style="border-bottom: Black 1pt solid; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"> Weighted Average Remaining Term in Years</td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"> Aggregate Intrinsic Value</td></tr> <tr> <td style="vertical-align: top; width: 34%; background-color: #CCEEFF; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">Outstanding at December 31, 2020</td> <td style="vertical-align: bottom; width: 14%; background-color: #CCEEFF; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">	1,040,839 </td> <td style="text-align: right; vertical-align: bottom; width: 16%; background-color: #CCEEFF; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt">	$	3.27</td> <td style="vertical-align: bottom; width: 19%; background-color: #CCEEFF; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">9.66</td> <td style="text-align: right; vertical-align: bottom; width: 16%; background-color: #CCEEFF; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt">	$	46,750</td> <td style="text-align: right; width: 1%"> </td></tr> <tr> <td style="vertical-align: top; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">	Granted</td> <td style="vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">	100,000 </td> <td style="text-align: right; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt">	$	2.75</td> <td style="vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"> </td> <td style="text-align: right; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="text-align: right"> </td></tr> <tr> <td style="vertical-align: top; background-color: #CCEEFF; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">	Exercised</td> <td style="vertical-align: bottom; background-color: #CCEEFF; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">	- </td> <td style="text-align: right; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt">	-</td> <td style="vertical-align: bottom; background-color: #CCEEFF; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"> </td> <td style="text-align: right; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="text-align: right"> </td></tr> <tr> <td style="vertical-align: top; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">	Cancelled</td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">	(12,833)</td> <td style="border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt">	1.77</td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"> </td> <td style="border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="text-align: right"> </td></tr> <tr> <td style="vertical-align: top; background-color: #CCEEFF; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">Outstanding at March 31, 2021</td> <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">	1,128,006 </td> <td style="border-bottom: Black 1.5pt double; text-align: right; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt">	$	3.25</td> <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">8.15</td> <td style="border-bottom: Black 1.5pt double; text-align: right; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt">	$	-</td> <td style="text-align: right"> </td></tr> <tr> <td style="vertical-align: top; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">Exercisable at March 31, 2021</td> <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">	304,673 </td> <td style="border-bottom: Black 1.5pt double; text-align: right; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt">	$	3.95</td> <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">5.79</td> <td style="border-bottom: Black 1.5pt double; text-align: right; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt">	$	-</td> <td style="text-align: right"> </td></tr> </table>

Below is a summary of restricted stock unit activity during the three-month period ended March 31, 2021:   <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; width: 41%; padding-right: 5.4pt; padding-left: 5.4pt"> Restricted Stock Units</td> <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt"> Shares</td> <td style="border-bottom: Black 1pt solid; text-align: right; width: 19%; padding-right: 5.4pt; padding-left: 5.4pt"> Weighted Average Grant Date Fair Value per Share</td> <td style="border-bottom: Black 1pt solid; text-align: right; width: 23%; padding-right: 5.4pt; padding-left: 5.4pt"> Weighted Average Vesting Period in Years</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt">Non-vested at December 31, 2020</td> <td style="vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">	555,350 </td> <td style="text-align: right; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt">	$	3.38</td> <td style="vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">1.24</td></tr> <tr> <td style="vertical-align: top; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt">	Granted</td> <td style="vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">	285,000 </td> <td style="text-align: right; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt">	2.37</td> <td style="vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"> </td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt">	Vested</td> <td style="vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">	(30,000)</td> <td style="text-align: right; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt">	3.01</td> <td style="vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"> </td></tr> <tr> <td style="vertical-align: top; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt">	Cancelled and forfeited</td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">	(42,500)</td> <td style="border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt">	3.35</td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"> </td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt">Non-vested at March 31, 2021</td> <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">	767,850 </td> <td style="border-bottom: Black 1.5pt double; text-align: right; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt">	$	3.02</td> <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">1.05</td></tr> </table>

For the three months ended March 31, 2021 and 2020, stock-based compensation and other equity instrument related expenses recognized in the consolidated statements of operations were as follows:   <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> Three Months Ended March 31,</td></tr> <tr style="vertical-align: top"> <td style="width: 55%; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="border-bottom: Black 1pt solid; width: 21%; padding-right: 5.4pt; padding-left: 5.4pt"> 2021</td> <td style="border-top: Black 1pt solid; width: 24%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> 2020</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">Cost of revenues</td> <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">$	(42,193)</td> <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">$	79,282</td></tr> <tr> <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">Sales and marketing</td> <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">	28,981 </td> <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">	77,293</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">General and administrative expense</td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">	241,649 </td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">	254,432</td></tr> <tr> <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">Total stock-based compensation expense   </td> <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">$	228,437 </td> <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">$	411,007</td></tr> </table>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td colspan="4" style="border-bottom: Black 1pt solid; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"> Three Months Ended March 31,</td></tr> <tr style="vertical-align: top"> <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"> 2021</td> <td colspan="2" style="border-top: Black 1pt solid; text-align: right; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> 2020</td></tr> <tr style="vertical-align: top; background-color: #CCEEFF"> <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt">Numerators:</td> <td colspan="2" style="text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td colspan="2" style="text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"> </td></tr> <tr> <td colspan="2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">	Net loss attributable to common shareholders</td> <td colspan="2" style="border-bottom: Black 1.5pt double; text-align: right; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">	$	(920,311)</td> <td colspan="2" style="border-bottom: Black 1.5pt double; text-align: right; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">	$	(1,850,623)</td></tr> <tr style="background-color: #CCEEFF"> <td colspan="2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td colspan="2" style="text-align: right; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td colspan="2" style="text-align: right; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td></tr> <tr> <td colspan="2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">Denominator:</td> <td colspan="2" style="text-align: right; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td colspan="2" style="text-align: right; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td></tr> <tr style="background-color: #CCEEFF"> <td colspan="2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">	Denominator for basic calculation weighted average shares</td> <td colspan="2" style="text-align: right; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">	12,041,074</td> <td colspan="2" style="text-align: right; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">	10,374,497</td></tr> <tr> <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td colspan="2" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td colspan="2" style="text-align: right; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="text-align: right"> </td></tr> <tr style="background-color: #CCEEFF"> <td colspan="2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">Dilutive common stock equivalents:</td> <td colspan="2" style="text-align: right; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td colspan="2" style="text-align: right; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td></tr> <tr> <td colspan="2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">	Options and warrants </td> <td colspan="2" style="text-align: right; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">	-</td> <td colspan="2" style="text-align: right; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">	-</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt">	Restricted stock units vested but not issued</td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt">	-</td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt">	-</td></tr> <tr> <td colspan="2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">	Denominator for diluted calculation weighted average shares</td> <td colspan="2" style="border-bottom: Black 1.5pt double; text-align: right; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">	12,041,074</td> <td colspan="2" style="border-bottom: Black 1.5pt double; text-align: right; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">	10,374,497</td></tr> <tr> <td colspan="2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td colspan="2" style="text-align: right; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td colspan="2" style="text-align: right; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td></tr> <tr style="background-color: #CCEEFF"> <td colspan="2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">Net loss per share:</td> <td colspan="2" style="text-align: right; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td colspan="2" style="text-align: right; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td></tr> <tr> <td colspan="2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">	Basic net loss per share</td> <td colspan="2" style="border-bottom: Black 1.5pt double; text-align: right; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">	$	(0.08)</td> <td colspan="2" style="border-bottom: Black 1.5pt double; text-align: right; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">	$	(0.18)</td></tr> <tr style="background-color: #CCEEFF"> <td colspan="2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">	Diluted net loss per share</td> <td colspan="2" style="border-bottom: Black 1.5pt double; text-align: right; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">	$	(0.08)</td> <td colspan="2" style="border-bottom: Black 1.5pt double; text-align: right; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">	$	(0.18)</td></tr> <tr> <td style="width: 55%"> </td> <td style="width: 2%"> </td> <td style="text-align: right; width: 22%"> </td> <td style="text-align: right; width: 1%"> </td> <td style="text-align: right; width: 19%"> </td> <td style="text-align: right; width: 1%"> </td></tr></table>

EX-101.LAB 8 ctek-20210331_lab.xml XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT Income Statement Location [Axis] Cost of Sales Property, Plant and Equipment, Type [Axis] Furniture and Fixtures Computers and office equipment Range [Axis] Minimum Maximum Finite-Lived Intangible Assets by Major Class [Axis] Acquired technology Customer Relationships Trademarks Deferred Revenue Arrangement Type [Axis] Managed services revenues Consulting and professional services revenues Debt Instrument [Axis] Seller Notes Related Party [Axis] Michael Mcmillan Award Type [Axis] Restricted Stock Units (RSUs) Sales and marketing {1} General and administrative expense Antidilutive Securities [Axis] Options And Warrants Concentration Risk Type [Axis] Customer Concentration Risk Type of Arrangement and Non-arrangement Transactions [Axis] Stock Purchase Agreement Business Acquisition [Axis] Backbone Enterprises Securities Purchase Agreement Horton Capital Management Option Employee 2020 Equity Incentive Plan Credit Facility [Axis] PPP Loan Equity Components [Axis] Common Stock Additional Paid-In Capital Accumulated Deficit Document and Entity Information: Entity Registrant Name Document Type Document Period End Date Amendment Flag Entity Central Index Key Current Fiscal Year End Date Entity Common Stock, Shares Outstanding Entity a Well-known Seasoned Issuer Entity a Voluntary Filer Entity's Reporting Status Current Entity Filer Category Entity Emerging Growth Company Entity Small Business Entity Shell Company Entity Interactive Data Current Document Fiscal Year Focus Document Fiscal Period Focus Entity File Number Tax Identification Number (TIN) Entity Incorporation, State Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, State or Province Entity Address, Postal Zip Code City Area Code Local Phone Number Statement of Financial Position [Abstract] ASSETS Current assets: Cash and cash equivalents Accounts receivable , net of allowance for doubtful accounts Unbilled services Prepaid and other current assets Income taxes receivable Total current assets Property and equipment, net Deposits Deferred income taxes Intangible assets, net Goodwill Total assets LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Accounts payable and accrued expenses Accrued compensation and benefits Deferred revenue Current portion of promissory note to related parties Current portion of operating lease liability Total current liabilities Long-term liabilities: Earnout liability Promissory note to related party, less current portion Paycheck Protection Program loan Operating lease liability, less current portion Total long-term liabilities Commitments and contingencies Stockholders' equity: Common stock, par value at $0.001, 33,333,333 shares authorized, 12,120,698 shares issued and outstanding at March 31, 2021 and 12,024,967 shares issued and outstanding at December 31, 2020 Additional paid-in capital Accumulated deficit Total stockholders' equity Total liabilities and stockholders' equity Common Stock, par or stated value Common Stock, shares authorized Common Stock, shares issued Common Stock, shares outstanding Income Statement [Abstract] Net revenues Cost of revenues Gross profit Operating expenses: Sales and marketing expenses General and administrative expenses Depreciation Amortization of acquisition-related intangibles Total operating expenses Loss from operations Other (expense) income: Interest income Interest expense Total other expense Loss before income tax benefit Income tax benefit Net loss Deemed dividends from warrant anti-dilution provisions Net loss attributable to common shareholders Net loss per share: Basic Diluted Number of weighted average shares outstanding: Basic Diluted Statement [Table] Statement [Line Items] Equity Balance, beginning of period, Value Equity Balance, beginning of period, Shares Stock compensation expense for equity awards granted to employees and directors Restricted stock units exercised, Value Restricted stock units exercised, Shares Deemed dividend Net income Equity Balance, end of period, Value Equity Balance, end of period, Shares Statement of Cash Flows [Abstract] Cash flows from operating activities: Net loss Adjustments to reconcile net loss to net cash used for operating activities: Depreciation Amortization of intangible assets Change in net deferred tax assets Bad debt expense Stock compensation for equity awards granted to employees and directors Other Changes in operating assets and liabilities: Accounts receivable Unbilled services Prepaid and other current assets Income taxes receivable Accounts payable and accrued expenses Accrued compensation and benefits Deferred revenue Income taxes payable Net cash used for operating activities Cash flows from investing activities: Purchases of property and equipment Net cash used for investing activities Cash flows from financing activities: Payments on promissory note to related parties Payments on capital leases Net cash used for financing activities Net change in cash and cash equivalents Cash and cash equivalents, beginning of period Cash and cash equivalents, end of period Supplemental disclosure of cash flow information: Interest paid Income taxes paid Non-cash investing and financing activities: Capitalized right-to-use asset resulting from an extension of an operating lease commitment Capitalized operating lease liability resulting from an extension of an operating lease commitment Disclosure Text Block [Abstract] 1. BASIS OF PRESENTATION Organization, Consolidation and Presentation of Financial Statements [Abstract] 2. RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS 3. ACCOUNTS RECEIVABLE 4. DEFERRED COMMISSIONS 5. PROPERTY AND EQUIPMENT Leases [Abstract] 6. LEASES 7. INTANGIBLE ASSETS 8. Deferred Revenue 9. Paycheck Protection Program Loan 10. Promissory Notes EX-101.PRE 9 ctek-20210331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT EX-101.SCH 10 ctek-20210331.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - 1. BASIS OF PRESENTATION link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - 2. RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - 3. ACCOUNTS RECEIVABLE link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - 4. DEFERRED COMMISSIONS link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - 5. PROPERTY AND EQUIPMENT link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - 6. LEASES link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - 7. INTANGIBLE ASSETS link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - 8. DEFERRED REVENUE link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - 9. PAYCHECK PROTECTION PROGRAM LOAN link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - 10. PROMISSORY NOTES link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - 11. REVENUES link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - 12. WARRANTS, OPTIONS AND RESTRICTED STOCK UNITS link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - 13. BASIC AND DILUTED NET LOSS PER SHARE link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - 14. REMAINING PERFORMANCE OBLIGATIONS link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - 15. CONCENTRATIONS link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - 16. Earnout Liability – Backbone Enterprises link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - 3. ACCOUNTS RECEIVABLE (Tables) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - 5. PROPERTY AND EQUIPMENT (Tables) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - 6. LEASES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - 7. INTANGIBLE ASSETS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - 11. REVENUES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - 12. WARRANTS, OPTIONS AND RESTRICTED STOCK UNITS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - 13. BASIC AND DILUTED NET LOSS PER SHARE (Tables) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - 1. BASIS OF PRESENTATION (Details) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - 3. ACCOUNTS RECEIVABLE: Schedule of Accounts Receivable (Details) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - 4. DEFERRED COMMISSIONS (Details) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - 5. PROPERTY AND EQUIPMENT : Property, Plant and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - 6. LEASES (Details) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - 6. LEASES: Operating lease expense (Details) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - 6. LEASES: Maturities of lease liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - 7. INTANGIBLE ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - 7. INTANGIBLE ASSETS : Schedule of Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - 8. DEFERRED REVENUE (Details) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - 9. PAYCHECK PROTECTION PROGRAM LOAN (Details) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - 10. PROMISSORY NOTES (Details) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - 11. REVENUES: Schedule of Revenue (Details) link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - 12. WARRANTS, OPTIONS AND RESTRICTED STOCK UNITS (Details) link:presentationLink link:calculationLink link:definitionLink 00000044 - Disclosure - 12. WARRANTS, OPTIONS AND RESTRICTED STOCK UNITS: Warrant Activity (Details) link:presentationLink link:calculationLink link:definitionLink 00000045 - Disclosure - 12. WARRANTS, OPTIONS AND RESTRICTED STOCK UNITS: Schedule of Share-based Compensation, Stock Options, Activity (Details) link:presentationLink link:calculationLink link:definitionLink 00000046 - Disclosure - 12 WARRANTS, OPTIONS AND RESTRICTED STOCK UNITS: Schedule of Restricted Stock Units, Activity (Details) link:presentationLink link:calculationLink link:definitionLink 00000047 - Disclosure - 12. WARRANTS, OPTIONS AND RESTRICTED STOCK UNITS: Schedule of Share-based Compensation expenses (Details) link:presentationLink link:calculationLink link:definitionLink 00000048 - Disclosure - 13. BASIC AND DILUTED NET LOSSPER SHARE (Details) link:presentationLink link:calculationLink link:definitionLink 00000049 - Disclosure - 13. BASIC AND DILUTED NET LOSSPER SHARE : Schedule of Earnings Per Share, Basic and Diluted (Details) link:presentationLink link:calculationLink link:definitionLink 00000050 - Disclosure - 14. REMAINING PERFORMANCE OBLIGATIONS (Details) link:presentationLink link:calculationLink link:definitionLink 00000051 - Disclosure - 15. CONCENTRATIONS (Details) link:presentationLink link:calculationLink link:definitionLink 00000052 - Disclosure - 16. EARNOUT LIABILITY - BACKBONE ENTERPRISES (Details) link:presentationLink link:calculationLink link:definitionLink XML 11 R1.htm IDEA: XBRL DOCUMENT

Document and Entity Information - shares	3 Months Ended
Document and Entity Information - shares	Mar. 31, 2021	May 13, 2021
Document and Entity Information:
Entity Registrant Name	CYNERGISTEK, INC.
Document Type	10-Q
Document Period End Date	Mar. 31, 2021
Amendment Flag	false
Entity Central Index Key	0001011432
Current Fiscal Year End Date	--12-31
Entity Common Stock, Shares Outstanding		12,120,698
Entity's Reporting Status Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Emerging Growth Company	false
Entity Small Business	true
Entity Shell Company	false
Entity Interactive Data Current	Yes
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q1
Entity File Number	000-27507
Tax Identification Number (TIN)	37-1867101
Entity Incorporation, State Country Code	DE
Entity Address, Address Line One	11940 Jollyville Road
Entity Address, Address Line Two	Suite 300-N, Austin
Entity Address, State or Province	TX
Entity Address, Postal Zip Code	78759
City Area Code	949
Local Phone Number	614-0700

XML 12 R2.htm IDEA: XBRL DOCUMENT

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)	Mar. 31, 2021	Dec. 31, 2020
Current assets:
Cash and cash equivalents	$ 4,443,140	$ 5,613,654
Accounts receivable , net of allowance for doubtful accounts	1,949,858	2,063,136
Unbilled services	557,487	566,713
Prepaid and other current assets	1,806,340	2,032,420
Income taxes receivable	1,952,532	1,680,866
Total current assets	10,709,357	11,956,789
Property and equipment, net	380,843	541,525
Deposits	64,586	64,586
Deferred income taxes	4,995,830	4,959,125
Intangible assets, net	5,723,089	6,063,617
Goodwill	8,394,483	8,394,483
Total assets	30,268,188	31,980,125
Current liabilities:
Accounts payable and accrued expenses	930,937	1,326,919
Accrued compensation and benefits	531,524	814,830
Deferred revenue	1,208,074	1,265,864
Current portion of promissory note to related parties	562,500	562,500
Current portion of operating lease liability	129,233	252,398
Total current liabilities	3,362,268	4,222,511
Long-term liabilities:
Earnout liability	1,300,000	1,300,000
Promissory note to related party, less current portion	0	140,625
Paycheck Protection Program loan	2,825,500	2,825,500
Operating lease liability, less current portion	15,002	40,031
Total long-term liabilities	4,140,502	4,306,156
Stockholders' equity:
Common stock, par value at $0.001, 33,333,333 shares authorized, 12,120,698 shares issued and outstanding at March 31, 2021 and 12,024,967 shares issued and outstanding at December 31, 2020	12,120	12,024
Additional paid-in capital	38,792,861	38,564,520
Accumulated deficit	(16,039,563)	(15,125,086)
Total stockholders' equity	22,765,418	23,451,458
Total liabilities and stockholders' equity	$ 30,268,188	$ 31,980,125

XML 13 R3.htm IDEA: XBRL DOCUMENT

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) - $ / shares	Mar. 31, 2021	Dec. 31, 2020
Statement of Financial Position [Abstract]
Common Stock, par or stated value	$ 0.001	$ 0.001
Common Stock, shares authorized	33,333,333	33,333,333
Common Stock, shares issued	12,120,698	12,024,967
Common Stock, shares outstanding	12,120,698	12,024,967

XML 14 R4.htm IDEA: XBRL DOCUMENT

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Income Statement [Abstract]
Net revenues	$ 4,173,520	$ 5,115,827
Cost of revenues	2,090,834	3,423,532
Gross profit	2,082,686	1,692,295
Operating expenses:
Sales and marketing expenses	1,212,379	1,487,347
General and administrative expenses	1,676,658	2,104,844
Depreciation	47,696	47,600
Amortization of acquisition-related intangibles	340,528	416,191
Total operating expenses	3,277,261	4,055,982
Loss from operations	(1,194,575)	(2,363,687)
Other (expense) income:
Interest income	0	6,068
Interest expense	(20,001)	(24,288)
Total other expense	(20,001)	(18,220)
Loss before income tax benefit	(1,214,576)	(2,381,907)
Income tax benefit	300,099	531,284
Net loss	(914,477)	(1,850,623)
Deemed dividends from warrant anti-dilution provisions	(5,834)	0
Net loss attributable to common shareholders	$ (920,311)	$ (1,850,623)
Net loss per share:
Basic	$ (0.08)	$ (0.18)
Diluted	$ (0.08)	$ (0.18)
Number of weighted average shares outstanding:
Basic	12,041,074	10,374,497
Diluted	12,041,074	10,374,497

XML 15 R5.htm IDEA: XBRL DOCUMENT

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (UNAUDITED) - USD ($)	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Total
Equity Balance, beginning of period, Value at Dec. 31, 2019	$ 10,359	$ 34,821,863	$ 3,343,402	$ 38,175,624
Equity Balance, beginning of period, Shares at Dec. 31, 2019	10,359,164
Stock compensation expense for equity awards granted to employees and directors		411,007		411,007
Restricted stock units exercised, Value	$ 20	(20)
Restricted stock units exercised, Shares	20,000
Net income			(1,850,623)	(1,850,623)
Equity Balance, end of period, Value at Mar. 31, 2020	$ 10,379	35,232,850	1,492,779	36,736,008
Equity Balance, end of period, Shares at Mar. 31, 2020	10,379,164
Equity Balance, beginning of period, Value at Dec. 31, 2020	$ 12,024	38,564,520	(15,125,086)	23,451,458
Equity Balance, beginning of period, Shares at Dec. 31, 2020	12,024,967
Stock compensation expense for equity awards granted to employees and directors		228,437		228,437
Restricted stock units exercised, Value	$ 96	(96)
Restricted stock units exercised, Shares	95,731
Deemed dividend
Net income			(914,477)	(914,477)
Equity Balance, end of period, Value at Mar. 31, 2021	$ 12,120	$ 38,792,861	$ (16,039,563)	$ 22,765,418
Equity Balance, end of period, Shares at Mar. 31, 2021	12,120,698

- Definition

The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 65
-Paragraph 1
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 235
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-05(b)(2))
-URI http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884

Reference 23: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684

Reference 31: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686

Reference 32: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686

Reference 33: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794

+ Details

- Definition

Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 852
-SubTopic 10
-Section 55
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 4.E)
-URI http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612

Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

+ Details

XML 16 R6.htm IDEA: XBRL DOCUMENT

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Cash flows from operating activities:
Net loss	$ (914,477)	$ (1,850,623)
Adjustments to reconcile net loss to net cash used for operating activities:
Depreciation	47,696	47,600
Amortization of intangible assets	340,528	416,191
Change in net deferred tax assets	(36,705)	(21,806)
Bad debt expense	0	30,000
Stock compensation for equity awards granted to employees and directors	228,437	411,007
Other	(15,500)	(12,149)
Changes in operating assets and liabilities:
Accounts receivable	(113,278)	(151,100)
Unbilled services	(9,226)	(77,651)
Prepaid and other current assets	(226,080)	(447,636)
Income taxes receivable	(271,666)	(456,128)
Accounts payable and accrued expenses	(395,982)	36,950
Accrued compensation and benefits	(283,306)	(613,183)
Deferred revenue	(57,790)	650,047
Income taxes payable	0	(31,976)
Net cash used for operating activities	(1,010,181)	(2,070,457)
Cash flows from investing activities:
Purchases of property and equipment	(19,708)	(51,912)
Net cash used for investing activities	(19,708)	(51,912)
Cash flows from financing activities:
Payments on promissory note to related parties	(140,625)	(140,625)
Payments on capital leases	0	(4)
Net cash used for financing activities	(140,625)	(140,629)
Net change in cash and cash equivalents	(1,170,514)	(2,262,998)
Cash and cash equivalents, beginning of period	5,613,654	5,328,726
Cash and cash equivalents, end of period	4,443,140	3,065,728
Supplemental disclosure of cash flow information:
Interest paid	12,914	84,606
Income taxes paid	8,272	209,834
Non-cash investing and financing activities:
Capitalized right-to-use asset resulting from an extension of an operating lease commitment	0	185,454
Capitalized operating lease liability resulting from an extension of an operating lease commitment	$ 0	$ 185,454

XML 17 R7.htm IDEA: XBRL DOCUMENT

1. BASIS OF PRESENTATION

3 Months Ended

Mar. 31, 2021

Disclosure Text Block [Abstract]

1. BASIS OF PRESENTATION

1. BASIS OF PRESENTATION

We have performed an evaluation of subsequent events through the date of filing these unaudited condensed consolidated financial statements with the SEC.

Liquidity and Capital Resources

our ability to manage our operating expenses and maintain gross margins while attracting, recruiting and retaining cybersecurity privacy professionals;

demand for our services from healthcare providers; the near-term impact of the COVID-19 on our customers allocation of time and resources to security and privacy, and their ability to pay for existing services as well as enter into new contractual arrangements during a period of crisis;

general economic conditions and changes in healthcare reimbursement and regulatory environment, including effects of the COVID-19 epidemic; and

our ability to collect accounts receivable from health care customers whose operations and cash flow have been significantly impacted by COVID-19 pandemic.

XML 18 R8.htm IDEA: XBRL DOCUMENT

2. RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS

3 Months Ended

Mar. 31, 2021

Organization, Consolidation and Presentation of Financial Statements [Abstract]

2. RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS

2. RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS

Recently Issued Accounting Pronouncements Adopted

Recently Issued Accounting Pronouncements Not Yet Adopted

XML 19 R9.htm IDEA: XBRL DOCUMENT

3. ACCOUNTS RECEIVABLE

3 Months Ended

Mar. 31, 2021

Disclosure Text Block [Abstract]

3. ACCOUNTS RECEIVABLE

3. ACCOUNTS RECEIVABLE

A summary of accounts receivable is as follows:

	March 31, 2021	December 31, 2020
Trade receivables	$ 1,970,483	$ 2,083,761
Allowance for doubtful accounts	(20,625)	(20,625)
Total accounts receivable, net	$ 1,949,858	$ 2,063,136

XML 20 R10.htm IDEA: XBRL DOCUMENT

4. DEFERRED COMMISSIONS

3 Months Ended

Mar. 31, 2021

Disclosure Text Block [Abstract]

4. DEFERRED COMMISSIONS

4. DEFERRED COMMISSIONS

XML 21 R11.htm IDEA: XBRL DOCUMENT

5. PROPERTY AND EQUIPMENT

3 Months Ended

Mar. 31, 2021

Disclosure Text Block [Abstract]

5. PROPERTY AND EQUIPMENT

5. PROPERTY AND EQUIPMENT

A summary of property and equipment follows:

	March 31, 2021	December 31, 2020
Furniture and fixtures	$ 235,245	$ 235,245
Computers and office equipment	797,932	792,181
Right of use assets	1,499,394	1,843,818
Property and equipment at cost	2,532,571	2,871,244
Less accumulated depreciation and amortization	(2,151,728)	(2,329,719)
	$ 380,843	$ 541,525

XML 22 R12.htm IDEA: XBRL DOCUMENT

6. LEASES

3 Months Ended

Mar. 31, 2021

Leases [Abstract]

6. LEASES

6. LEASES

Operating lease expense was comprised of the following:

	Three Months Ended March 31,
	2021	2020
Operating lease cost	$ 183,795	$ 205,452
Sublet income	(128,537)	(115,949)
Net operating lease cost	$ 55,258	$ 89,503

Maturities of lease liabilities are as follows:

	Operating Leases
2021 (remaining fiscal year)	$ 108,280
2022	41,690
Total lease payments	149,970
Less imputed interest	(5,735)
Total lease liabilities	144,235
Less current portion of lease liabilities	(129,233)
Long-term lease liabilities	$ 15,002

XML 23 R13.htm IDEA: XBRL DOCUMENT

7. INTANGIBLE ASSETS

3 Months Ended

Mar. 31, 2021

Disclosure Text Block [Abstract]

7. INTANGIBLE ASSETS

7. INTANGIBLE ASSETS

Intangible assets are amortized over expected useful lives ranging from 1.5 to 10 years and consist of the following:

	March 31, 2021			December 31, 2020
	Carrying Amount	Accumulated Amortization and Impairment	Net Book Value	Carrying Amount	Accumulated Amortization and Impairment	Net Book Value
Acquired technology	$ 10,100,000	$ (5,154,662)	$ 4,945,338	$ 10,100,000	$ (4,934,720)	$ 5,165,280
Customer relationships	4,650,000	(4,463,088)	186,912	4,650,000	(4,445,000)	205,000
Trademarks	2,300,000	(1,709,161)	590,839	2,300,000	(1,606,663)	693,337
Total	$ 17,050,000	$ (11,326,911)	$ 5,723,089	$ 17,050,000	$ (10,986,383)	$ 6,063,617

XML 24 R14.htm IDEA: XBRL DOCUMENT

8. DEFERRED REVENUE

3 Months Ended

Mar. 31, 2021

Disclosure Text Block [Abstract]

8. Deferred Revenue

8. DEFERRED REVENUE

XML 25 R15.htm IDEA: XBRL DOCUMENT

9. PAYCHECK PROTECTION PROGRAM LOAN

3 Months Ended

Mar. 31, 2021

Disclosure Text Block [Abstract]

9. Paycheck Protection Program Loan

9. PAYCHECK PROTECTION PROGRAM LOAN

The Company used the PPP Loan proceeds to cover payroll costs, rent and utilities in accordance with the relevant terms and conditions of the CARES Act.

XML 26 R16.htm IDEA: XBRL DOCUMENT

10. PROMISSORY NOTES

3 Months Ended

Mar. 31, 2021

Disclosure Text Block [Abstract]

10. Promissory Notes

10. PROMISSORY NOTES

Interest charges associated with the Seller Note totaled approximately $13,000 and $24,000, for the three months ended March 31, 2021 and 2020, respectively.

- Definition

The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-URI http://asc.fasb.org/topic&trid=2208564

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (h)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1C
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1I
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1I
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(c))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (g)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1C
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1C
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1E
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1I
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (i)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

+ Details

XML 27 R17.htm IDEA: XBRL DOCUMENT

11. REVENUES

3 Months Ended

Mar. 31, 2021

Disclosure Text Block [Abstract]

11. Revenues

11. REVENUES

Below is a summary of our revenues disaggregated by revenue source.

	Three Months Ended March 31,
	2021	2020
Managed services	$ 2,424,609	$ 3,001,012
Consulting and professional services	1,748,911	2,114,815
Net revenues	$ 4,173,520	$ 5,115,827

XML 28 R18.htm IDEA: XBRL DOCUMENT

12. WARRANTS, OPTIONS AND RESTRICTED STOCK UNITS

3 Months Ended

Mar. 31, 2021

Disclosure Text Block [Abstract]

12. Warrants, options and restricted stock units

12. WARRANTS, OPTIONS AND RESTRICTED STOCK UNITS

Warrant Issued for Securities Purchase Agreement

The detailed terms and conditions of the Horton Securities Purchase Agreement and the Horton Warrant can be found in the documents themselves, which were filed with the SEC on April 7, 2020.

Below is a summary of warrant activities during the three-month period ended March 31, 2021:

Warrants	Shares	Weighted Average Exercise Price	Weighted Average Remaining Term in Years	Aggregate Intrinsic Value
Outstanding at December 31, 2020	577,779	$ 2.57	8.29	$ -
Granted	18,915	$ 2.41	9.00	$ -
Exercised	-	-
Cancelled	-	-
Outstanding at March 31, 2021	596,694	$ 2.49	8.07	$ -
Exercisable at March 31, 2021	596,694	$ 2.49	8.07	$ -

2020 Equity Incentive Plan

Below is a summary of stock option activities during the three-month period ended March 31, 2021:

Options	Number of Shares	Weighted Average Exercise Price	Weighted Average Remaining Term in Years	Aggregate Intrinsic Value
Outstanding at December 31, 2020	1,040,839	$ 3.27	9.66	$ 46,750
Granted	100,000	$ 2.75
Exercised	-	-
Cancelled	(12,833)	1.77
Outstanding at March 31, 2021	1,128,006	$ 3.25	8.15	$ -
Exercisable at March 31, 2021	304,673	$ 3.95	5.79	$ -

Below is a summary of restricted stock unit activity during the three-month period ended March 31, 2021:

Restricted Stock Units	Shares	Weighted Average Grant Date Fair Value per Share	Weighted Average Vesting Period in Years
Non-vested at December 31, 2020	555,350	$ 3.38	1.24
Granted	285,000	2.37
Vested	(30,000)	3.01
Cancelled and forfeited	(42,500)	3.35
Non-vested at March 31, 2021	767,850	$ 3.02	1.05

There are 100,000 shares of restricted stock units which have vested but had not yet been issued as of March 31, 2021.

For the three months ended March 31, 2021 and 2020, stock-based compensation and other equity instrument related expenses recognized in the consolidated statements of operations were as follows:

	Three Months Ended March 31,
	2021	2020
Cost of revenues	$ (42,193)	$ 79,282
Sales and marketing	28,981	77,293
General and administrative expense	241,649	254,432
Total stock-based compensation expense	$ 228,437	$ 411,007

XML 29 R19.htm IDEA: XBRL DOCUMENT

13. BASIC AND DILUTED NET LOSS PER SHARE

3 Months Ended

Mar. 31, 2021

Earnings Per Share [Abstract]

13. Basic And Diluted Net Loss Per Share

13. BASIC AND DILUTED NET LOSS PER SHARE

	Three Months Ended March 31,
	2021	2020
Numerators:
Net loss attributable to common shareholders	$ (920,311)	$ (1,850,623)

Denominator:
Denominator for basic calculation weighted average shares	12,041,074	10,374,497

Dilutive common stock equivalents:
Options and warrants	-	-
Restricted stock units vested but not issued	-	-
Denominator for diluted calculation weighted average shares	12,041,074	10,374,497

Net loss per share:
Basic net loss per share	$ (0.08)	$ (0.18)
Diluted net loss per share	$ (0.08)	$ (0.18)

XML 30 R20.htm IDEA: XBRL DOCUMENT

14. REMAINING PERFORMANCE OBLIGATIONS

3 Months Ended

Mar. 31, 2021

Disclosure Text Block [Abstract]

14. Remaining Performance Obligations

14. REMAINING PERFORMANCE OBLIGATIONS

- Definition

The entire disclosure for retirement benefits.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 55
-Paragraph 17
-URI http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section S99
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (d)(i)
-URI http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (o)
-URI http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (p)
-URI http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 70
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-URI http://asc.fasb.org/topic&trid=2235017

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 60
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (d)(iv)(03)
-URI http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (q)
-URI http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (r)(1)
-URI http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (d)(iii)
-URI http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (l)
-URI http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (r)(2)
-URI http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

+ Details

XML 31 R21.htm IDEA: XBRL DOCUMENT

15. CONCENTRATIONS

3 Months Ended

Mar. 31, 2021

Disclosure Text Block [Abstract]

16. Concentrations

15. CONCENTRATIONS

Cash Concentrations

Major Customers

XML 32 R22.htm IDEA: XBRL DOCUMENT

16. Earnout Liability – Backbone Enterprises

3 Months Ended

Mar. 31, 2021

Notes To Financial Statements Abstract

17. Earnout Liability – Backbone Enterprises

16. EARNOUT LIABILITY – BACKBONE ENTERPRISES

XML 33 R23.htm IDEA: XBRL DOCUMENT

3. ACCOUNTS RECEIVABLE (Tables)

3 Months Ended

Mar. 31, 2021

Table Text Block Supplement [Abstract]

Schedule of Accounts Receivable

A summary of accounts receivable is as follows:

	March 31, 2021	December 31, 2020
Trade receivables	$ 1,970,483	$ 2,083,761
Allowance for doubtful accounts	(20,625)	(20,625)
Total accounts receivable, net	$ 1,949,858	$ 2,063,136

XML 34 R24.htm IDEA: XBRL DOCUMENT

5. PROPERTY AND EQUIPMENT (Tables)

3 Months Ended

Mar. 31, 2021

Table Text Block Supplement [Abstract]

Schedule of Property, Plant and Equipment

A summary of property and equipment follows:

	March 31, 2021	December 31, 2020
Furniture and fixtures	$ 235,245	$ 235,245
Computers and office equipment	797,932	792,181
Right of use assets	1,499,394	1,843,818
Property and equipment at cost	2,532,571	2,871,244
Less accumulated depreciation and amortization	(2,151,728)	(2,329,719)
	$ 380,843	$ 541,525

XML 35 R25.htm IDEA: XBRL DOCUMENT

6. LEASES (Tables)

3 Months Ended

Mar. 31, 2021

Leases [Abstract]

Schedule of Operating lease expense

Operating lease expense was comprised of the following:

	Three Months Ended March 31,
	2021	2020
Operating lease cost	$ 183,795	$ 205,452
Sublet income	(128,537)	(115,949)
Net operating lease cost	$ 55,258	$ 89,503

Schedule of Maturities of lease liabilities

Maturities of lease liabilities are as follows:

	Operating Leases
2021 (remaining fiscal year)	$ 108,280
2022	41,690
Total lease payments	149,970
Less imputed interest	(5,735)
Total lease liabilities	144,235
Less current portion of lease liabilities	(129,233)
Long-term lease liabilities	$ 15,002

XML 36 R26.htm IDEA: XBRL DOCUMENT

7. INTANGIBLE ASSETS (Tables)

3 Months Ended

Mar. 31, 2021

Table Text Block Supplement [Abstract]

Schedule of Intangible Assets

Intangible assets are amortized over expected useful lives ranging from 1.5 to 10 years and consist of the following:

	March 31, 2021			December 31, 2020
	Carrying Amount	Accumulated Amortization and Impairment	Net Book Value	Carrying Amount	Accumulated Amortization and Impairment	Net Book Value
Acquired technology	$ 10,100,000	$ (5,154,662)	$ 4,945,338	$ 10,100,000	$ (4,934,720)	$ 5,165,280
Customer relationships	4,650,000	(4,463,088)	186,912	4,650,000	(4,445,000)	205,000
Trademarks	2,300,000	(1,709,161)	590,839	2,300,000	(1,606,663)	693,337
Total	$ 17,050,000	$ (11,326,911)	$ 5,723,089	$ 17,050,000	$ (10,986,383)	$ 6,063,617

XML 37 R27.htm IDEA: XBRL DOCUMENT

11. REVENUES (Tables)

3 Months Ended

Mar. 31, 2021

Table Text Block Supplement [Abstract]

Schedule of Revenue

Below is a summary of our revenues disaggregated by revenue source.

	Three Months Ended March 31,
	2021	2020
Managed services	$ 2,424,609	$ 3,001,012
Consulting and professional services	1,748,911	2,114,815
Net revenues	$ 4,173,520	$ 5,115,827

XML 38 R28.htm IDEA: XBRL DOCUMENT

12. WARRANTS, OPTIONS AND RESTRICTED STOCK UNITS (Tables)

3 Months Ended

Mar. 31, 2021

Table Text Block Supplement [Abstract]

Schedule of Warrant Activity

Below is a summary of warrant activities during the three-month period ended March 31, 2021:

Warrants	Shares	Weighted Average Exercise Price	Weighted Average Remaining Term in Years	Aggregate Intrinsic Value
Outstanding at December 31, 2020	577,779	$ 2.57	8.29	$ -
Granted	18,915	$ 2.41	9.00	$ -
Exercised	-	-
Cancelled	-	-
Outstanding at March 31, 2021	596,694	$ 2.49	8.07	$ -
Exercisable at March 31, 2021	596,694	$ 2.49	8.07	$ -

Schedule of Share-based Compensation, Stock Options, Activity

Below is a summary of stock option activities during the three-month period ended March 31, 2021:

Options	Number of Shares	Weighted Average Exercise Price	Weighted Average Remaining Term in Years	Aggregate Intrinsic Value
Outstanding at December 31, 2020	1,040,839	$ 3.27	9.66	$ 46,750
Granted	100,000	$ 2.75
Exercised	-	-
Cancelled	(12,833)	1.77
Outstanding at March 31, 2021	1,128,006	$ 3.25	8.15	$ -
Exercisable at March 31, 2021	304,673	$ 3.95	5.79	$ -

Schedule of Restricted Stock Units, Activity

Below is a summary of restricted stock unit activity during the three-month period ended March 31, 2021:

Restricted Stock Units	Shares	Weighted Average Grant Date Fair Value per Share	Weighted Average Vesting Period in Years
Non-vested at December 31, 2020	555,350	$ 3.38	1.24
Granted	285,000	2.37
Vested	(30,000)	3.01
Cancelled and forfeited	(42,500)	3.35
Non-vested at March 31, 2021	767,850	$ 3.02	1.05

Schedule of stock-based compensation expense

For the three months ended March 31, 2021 and 2020, stock-based compensation and other equity instrument related expenses recognized in the consolidated statements of operations were as follows:

	Three Months Ended March 31,
	2021	2020
Cost of revenues	$ (42,193)	$ 79,282
Sales and marketing	28,981	77,293
General and administrative expense	241,649	254,432
Total stock-based compensation expense	$ 228,437	$ 411,007

XML 39 R29.htm IDEA: XBRL DOCUMENT

13. BASIC AND DILUTED NET LOSS PER SHARE (Tables)

3 Months Ended

Mar. 31, 2021

Earnings Per Share [Abstract]

Schedule of Earnings Per Share, Basic and Diluted

	Three Months Ended March 31,
	2021	2020
Numerators:
Net loss attributable to common shareholders	$ (920,311)	$ (1,850,623)

Denominator:
Denominator for basic calculation weighted average shares	12,041,074	10,374,497

Dilutive common stock equivalents:
Options and warrants	-	-
Restricted stock units vested but not issued	-	-
Denominator for diluted calculation weighted average shares	12,041,074	10,374,497

Net loss per share:
Basic net loss per share	$ (0.08)	$ (0.18)
Diluted net loss per share	$ (0.08)	$ (0.18)

XML 40 R30.htm IDEA: XBRL DOCUMENT

1. BASIS OF PRESENTATION (Details) - USD ($)	1 Months Ended	3 Months Ended		12 Months Ended
1. BASIS OF PRESENTATION (Details) - USD ($)	Apr. 20, 2020	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2020	Dec. 31, 2019
Disclosure Text Block [Abstract]
Cash and cash equivalents		$ 4,443,140	$ 3,065,728	$ 5,613,654	$ 5,328,726
Working capital		7,300,000
Contingent earnout liability		1,300,000
Debt and lease obligations		2,800,000
Net cash (used for) provided by operating activities		$ (1,010,181)	$ (2,070,457)
Proceeds from loan	$ 2,825,500
Proceeds from issuance of shares				$ 1,843,000
Number of shares issued				1,315,000
Agent commissions				$ 61,000
Offering-related expenses				$ 123,000

XML 41 R31.htm IDEA: XBRL DOCUMENT

3. ACCOUNTS RECEIVABLE: Schedule of Accounts Receivable (Details) - USD ($)	Mar. 31, 2021	Dec. 31, 2020
Text Block [Abstract]
Trade receivables	$ 1,970,483	$ 2,083,761
Allowance for doubtful accounts	(20,625)	(20,625)
Total accounts receivable, net	$ 1,949,858	$ 2,063,136

XML 42 R32.htm IDEA: XBRL DOCUMENT

4. DEFERRED COMMISSIONS (Details) - USD ($)	3 Months Ended
4. DEFERRED COMMISSIONS (Details) - USD ($)	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2020
Sales Commissions and Fees	$ 183,000	$ 165,000
Cost of Sales
Deferred Costs and Other Assets	$ 708,000		$ 758,000

XML 43 R33.htm IDEA: XBRL DOCUMENT

5. PROPERTY AND EQUIPMENT : Property, Plant and Equipment (Details) - USD ($)	Mar. 31, 2021	Dec. 31, 2020
Right of use assets	$ 1,499,394	$ 1,843,818
Property, Plant and Equipment, Gross	2,532,571	2,871,244
Less accumulated depreciation and amortization	(2,151,728)	(2,329,719)
Property and equipment, net	380,843	541,525
Furniture and Fixtures
Property, Plant and Equipment, Gross	235,245	235,245
Computers and office equipment
Property, Plant and Equipment, Gross	$ 797,932	$ 792,181

XML 44 R34.htm IDEA: XBRL DOCUMENT

6. LEASES (Details)	3 Months Ended
6. LEASES (Details)	Mar. 31, 2021
Leases [Abstract]
Leases description	We previously leased approximately 9,600 square feet of office space in Austin, Texas. In March 2020, we amended this lease reducing the office space to 5,000 square feet and extended the lease term to May 31, 2022. We lease approximately 3,700 square feet of office space in Minneapolis, Minnesota. This lease terminates on July 31, 2021.
Discount rate	5.50%

XML 45 R35.htm IDEA: XBRL DOCUMENT

6. LEASES: Operating lease expense (Details) - USD ($)	3 Months Ended
6. LEASES: Operating lease expense (Details) - USD ($)	Mar. 31, 2021	Mar. 31, 2020
Leases [Abstract]
Operating lease cost	$ 183,795	$ 205,452
Sublet income	(128,537)	(115,949)
Net operating lease cost	$ 55,258	$ 89,503

XML 46 R36.htm IDEA: XBRL DOCUMENT

6. LEASES: Maturities of lease liabilities (Details) - USD ($)	Mar. 31, 2021	Dec. 31, 2020
Operating Leases
2021 (remaining fiscal year)	$ 108,280
2021	41,690
Total lease payments	149,970
Less imputed interest	(5,735)
Total lease liabilities	144,235
Less current portion of lease liabilities	(129,233)	$ (252,398)
Long-term lease liabilities	$ 15,002

XML 47 R37.htm IDEA: XBRL DOCUMENT

7. INTANGIBLE ASSETS (Details)	3 Months Ended
7. INTANGIBLE ASSETS (Details)	Mar. 31, 2021
Minimum
Intangible Asset, Useful Life	1 year 6 months
Maximum
Intangible Asset, Useful Life	10 years

XML 48 R38.htm IDEA: XBRL DOCUMENT

7. INTANGIBLE ASSETS : Schedule of Intangible Assets (Details) - USD ($)	Mar. 31, 2021	Dec. 31, 2020
Gross Carrying Amount	$ 17,050,000	$ 17,050,000
Accumulated Amortization	(11,326,911)	(10,986,383)
Net Book Value	5,723,089	6,063,617
Acquired technology
Gross Carrying Amount	10,100,000	10,100,000
Accumulated Amortization	(5,154,662)	(4,934,720)
Net Book Value	4,945,338	5,165,280
Customer Relationships
Gross Carrying Amount	4,650,000	4,650,000
Accumulated Amortization	(4,463,088)	(4,445,000)
Net Book Value	186,912	205,000
Trademarks
Gross Carrying Amount	2,300,000	2,300,000
Accumulated Amortization	(1,709,161)	(1,606,663)
Net Book Value	$ 590,839	$ 693,337

XML 49 R39.htm IDEA: XBRL DOCUMENT

8. DEFERRED REVENUE (Details) - USD ($)	Mar. 31, 2021	Mar. 31, 2020
Deferred Revenue	$ 17,400,000
Managed services revenues
Deferred Revenue	738,000	$ 884,000
Consulting and professional services revenues
Deferred Revenue	$ 225,000	$ 142,000

XML 50 R40.htm IDEA: XBRL DOCUMENT

9. PAYCHECK PROTECTION PROGRAM LOAN (Details) - USD ($)	1 Months Ended	3 Months Ended
9. PAYCHECK PROTECTION PROGRAM LOAN (Details) - USD ($)	Apr. 20, 2020	Mar. 31, 2021
Proceeds from loan	$ 2,825,500
Interest rate	1.00%
Term	2 years
PPP Loan
Interest and Debt Expense		$ 7,000

XML 51 R41.htm IDEA: XBRL DOCUMENT

10. PROMISSORY NOTES (Details) - Seller Notes - USD ($)	3 Months Ended
10. PROMISSORY NOTES (Details) - Seller Notes - USD ($)	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2020
Interest Charges	$ 13,000	$ 24,000
Michael Mcmillan
Debt Instrument, Face Amount	$ 4,500,000
Debt Instrument, Interest Rate, Stated Percentage	8.00%
Repayments of Debt	$ 2,250,000
Outstanding principal balance due	$ 562,500		$ 703,125
Debt Instrument, Maturity Date	Mar. 31, 2022

XML 52 R42.htm IDEA: XBRL DOCUMENT

11. REVENUES: Schedule of Revenue (Details) - USD ($)	3 Months Ended
11. REVENUES: Schedule of Revenue (Details) - USD ($)	Mar. 31, 2021	Mar. 31, 2020
Net revenues	$ 4,173,520	$ 5,115,827
Managed services revenues
Net revenues	2,424,609	3,001,012
Consulting and professional services revenues
Net revenues	$ 1,748,911	$ 2,114,815

- Definition

Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 235
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-05(b)(2))
-URI http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(1))
-URI http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227

+ Details

XML 53 R43.htm IDEA: XBRL DOCUMENT

12. WARRANTS, OPTIONS AND RESTRICTED STOCK UNITS (Details) - USD ($)		3 Months Ended	12 Months Ended
	Apr. 03, 2020	Mar. 31, 2021	Dec. 31, 2020	Jun. 15, 2020	Mar. 31, 2020
Proceeds from issuance of shares			$ 1,843,000
Number of shares issued			1,315,000
Options granted		100,000
Exercise Price		$ 2.75
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number		596,694	577,779
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number		100,000			60,000
Minimum
Risk-free interest rate		0.05%
Maximum
Risk-free interest rate		0.16%
2020 Equity Incentive Plan
Shares available for issuance				3,745,621
Employee \| Option
Determination method		Black-Scholes option-pricing model
Estimated volatility		61.85%
Dividend yield		0.00%
Contractual life		3 years
Fair value of option		$ 135,000
Securities Purchase Agreement \| Horton Capital Management
Common stock issued for operating cash	$ 2,500,000
Initial Warrant	500,000
Exercise price	$ 2.50
Fair value of warrant	$ 390,000

XML 54 R44.htm IDEA: XBRL DOCUMENT

12. WARRANTS, OPTIONS AND RESTRICTED STOCK UNITS: Warrant Activity (Details) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Text Block [Abstract]
Warrants, Outstanding, Beginning Balance	577,779
Outstanding, Weighted Average Exercise Price, Beginning Balance	$ 2.57
Outstanding, Weighted Average Remaining Contractual Life	8 years 26 days	8 years 3 months 15 days
Granted	18,915
Granted, Weighted Average Exercise Price	$ 2.41
Granted, Weighted Average Remaining Contractual Life	9 years
Exercised	0
Exercised, Weighted Average Exercise Price	$ 0
Cancelled	0
Cancelled, Weighted Average Exercise Price	$ 0
Warrants, Outstanding, Ending Balance	596,694	577,779
Outstanding, Weighted Average Exercise Price, Ending Balance	$ 2.49	$ 2.57
Outstanding, Intrinsic Value	$ 0	$ 0
Exercisable	596,694
Exercisable, Weighted Average Exercise Price	$ 2.49
Exercisable, Weighted Average Remaining Contractual Life	8 years 26 days
Exercisable, Intrinsic Value	$ 0

XML 55 R45.htm IDEA: XBRL DOCUMENT

12. WARRANTS, OPTIONS AND RESTRICTED STOCK UNITS: Schedule of Share-based Compensation, Stock Options, Activity (Details) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Text Block [Abstract]
Outstanding, Beginning Balance	1,040,839
Outstanding, Weighted Average Exercise Price, Beginning Balance	$ 3.27
Granted	100,000
Granted, Weighted Average Exercise Price	$ 2.75
Exercised	0
Exercised, Weighted Average Exercise Price	$ 0
Cancelled	(12,833)
Cancelled, Weighted Average Exercise Price	$ 1.77
Outstanding, Ending Balance	1,128,006	1,040,839
Outstanding, Weighted Average Exercise Price, Ending Balance	$ 3.25	$ 3.27
Outstanding, Weighted Average Remaining Term in Years	8 years 1 month 24 days	9 years 7 months 28 days
Outstanding, Aggregate Intrinsic Value	$ 0	$ 46,750
Exercisable	304,673
Exercisable, Weighted Average Exercise Price	$ 3.95
Exercisable, Weighted Average Remaining Term in Years	5 years 9 months 14 days
Exercisable, Aggregate Intrinsic Value	$ 0

XML 56 R46.htm IDEA: XBRL DOCUMENT

12 WARRANTS, OPTIONS AND RESTRICTED STOCK UNITS: Schedule of Restricted Stock Units, Activity (Details) - $ / shares	3 Months Ended	12 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Outstanding, Weighted Average Remaining Term in Years	8 years 26 days	8 years 3 months 15 days
Granted	18,915
Cancelled	0
Restricted Stock Units (RSUs)
Outstanding, Beginning Balance	555,350
Outstanding, Weighted Average Price, Beginning Balance	$ 3.38
Outstanding, Weighted Average Remaining Term in Years	1 year 18 days	1 year 2 months 27 days
Granted	285,000
Granted, Weighted Average Price	$ 2.37
Vested	(30,000)
Vested, Weighted Average Price	$ 3.01
Cancelled	(42,500)
Cancelled, Weighted Average Price	3.35
Outstanding, Ending Balance	767,850	555,350
Outstanding, Weighted Average Price, Ending Balance	$ 3.02	$ 3.38

XML 57 R47.htm IDEA: XBRL DOCUMENT

12. WARRANTS, OPTIONS AND RESTRICTED STOCK UNITS: Schedule of Share-based Compensation expenses (Details) - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Allocated Share-based Compensation Expense	$ 228,437	$ 411,007
Cost of Sales
Allocated Share-based Compensation Expense	(42,193)	79,282
Sales and marketing {1}
Allocated Share-based Compensation Expense	28,981	77,293
General and administrative expense
Allocated Share-based Compensation Expense	$ 241,649	$ 254,432

XML 58 R48.htm IDEA: XBRL DOCUMENT

13. BASIC AND DILUTED NET LOSSPER SHARE (Details) - $ / shares	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2020
Options and warrants	0	0
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number	596,694		577,779
Options And Warrants
Potentially Dilutive Securities	1,724,700	797,325
Options And Warrants \| Minimum
Potentially dilutive securities, exercise price	$ 1.08	$ 2.28
Options And Warrants \| Maximum
Potentially dilutive securities, exercise price	$ 4.86	$ 4.86
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number	100,000	60,000
Non-vested restricted stock units	767,850	1,088,000

XML 59 R49.htm IDEA: XBRL DOCUMENT

13. BASIC AND DILUTED NET LOSSPER SHARE : Schedule of Earnings Per Share, Basic and Diluted (Details) - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Numerator:
Net loss attributable to common shareholders	$ (920,311)	$ (1,850,623)
Denominator for basic calculation weighted averages	12,041,074	10,374,497
Dilutive Common Stock equivalents:
Options and warrants	0	0
Restricted stock units vested but not issued	0	0
Denominator for diluted calculation weighted average shares	12,041,074	10,374,497
Net (loss) income
Basic	$ (0.08)	$ (0.18)
Diluted	$ (0.08)	$ (0.18)

XML 60 R50.htm IDEA: XBRL DOCUMENT

14. REMAINING PERFORMANCE OBLIGATIONS (Details)	3 Months Ended
14. REMAINING PERFORMANCE OBLIGATIONS (Details)	Mar. 31, 2021 USD ($)
Disclosure Text Block [Abstract]
Deferred Revenue	$ 17,400,000
Revenue Recognition, Deferred Revenue description	We expect to recognize revenue on approximately 81% of the remaining non-cancelable portion of these performance obligations over the next 24 months, with the balance thereafter.

XML 61 R51.htm IDEA: XBRL DOCUMENT

15. CONCENTRATIONS (Details) - USD ($)	3 Months Ended
15. CONCENTRATIONS (Details) - USD ($)	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2020
Concentration Risk, Percentage	13.00%	17.00%
Accounts receivable, net	$ 1,949,858		$ 2,063,136
Customer Concentration Risk
Accounts receivable, net	$ 195,000		$ 74,000

XML 62 R52.htm IDEA: XBRL DOCUMENT

16. EARNOUT LIABILITY - BACKBONE ENTERPRISES (Details) - Stock Purchase Agreement - Backbone Enterprises - USD ($)	1 Months Ended	3 Months Ended
	Oct. 31, 2019	Mar. 31, 2021
Post-closing financial performance	$ 4,000,000
Estimated fair value of earnout		$ 1,300,000

EXCEL 63 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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
6Z,M]#2>24UU#I)P47)5%Z M*G:NK 60K065S,6>%[LEH963S>W:O[VRBRXV;PF.UB#>JSOA9ZY/X8E,&:(M(T_':?32QK@\?B-_:O-KK-LB(0E M9[_I5NT73N*@+12D8>J!'[Y!ER,K"4X0BE"88N!)@2,L0%E3EAZ!6(&#RO MEBVV;*;FGC/?2W"BTST/N A[%^&[+H;46E1TI!;Z<3HB%O5BT5FQGUSIA.T7 M4Y-77>1*#HE')^)^F*:S$?6X5X_/JM^"E(B6=:-@BVBE0(!40_+QB?PDF@71 ML/JL5Y]]./M1M0SISP;BAWC,0-(;2-Z/GS="Z%-'-1>V.PX5$"EY/1(?)SB M(.@]M569G'RD$QSA($V&O:>]]_2\=U[M)OJ%E1]SFYZ62N1Y^#\/[E$W-'\B MW7)VM)):HM X;SK3<47;W=N)XK5MD!NN=+NUP[W^(8(P&_3S@G/U-C$]M__% M9G\!4$L#!!0 ( #J(K5+Q_T,R%0( #8% 9 >&PO=V]R:W-H965T MK76S8WOJ[P& MAM5,-,#-2BDDP]J$LO)5(P$7KHA1/PJ"V&>8<"]+W-Q.9HEH-24<=A*IEC$L MW]9 19=ZH7>:>")5K>V$GR4-KF /^J7921/Y(Z4@#+@B@B,)9>JMPIMU;/-= MP@\"G3H;(^OD(,2K#;9%Z@56$%#(M25@\_D-MT"I!1D9OP:F-VYI"\_')_I7 MY]UX.6 %MX+^)(6N4^^+APHH<4OUD^B^P^!G:7FYH,K]HJ[/G9L=\U9IP89B M$S/"^R\^#N=P5A#&%PJBH2!RNON-G,H[K'&62-$A:;,-S0Z<55=MQ!%N_Y2] MEF:5F#J=7<_0]O%Y]?AMN[[?H-5^OWG>HT]WH#&AZG/B:[.'S?3S@;?N>=$% MWAP]"*YKA3:\@.+O>M]H&P5&)X'K:!+X@.4,S<,K% 51.,&;CX;GCK>XQ".< ML)9-D!8C:3%)VG*->44.%-!**=!7Z$5!V5)T3TKXZ.2F<2%Z RQ1C)@[P F! MRU'@]?U',U:D(5XA":4J#V;4Y+MEW:1]HT;C.. AM^LP-:_.P@;0)9KT40I\" MN\'X5&;O4$L#!!0 ( #J(K5)&>J8.< , &8, 9 >&PO=V]R:W-H M965TD^*FU5U73; MLTN\\$:#ZMZ-&@UD M:00OV(T"NLQSJIXNF)#KH8>\YQNW?+$T[H8_&JSH@DV9^;ZZ47;E-R@SGK-" M9#;XS.)XBXA"KB!V=KO7,-7"GW4OYRBZO9T(..$1,L,PZ"VH\'-F%" M."3+XW<-ZC5[NL3=ZV?T3U7QMIA[JME$BI]\9I9#+_' C,UI*:3/M:-V$E X9&$H$X(3DW =0*N"MTP MJ\JZI(:.!DJN@7+1%LU=5+VILFTUO'!?X]0H^Y3;/#.*S\#5]=WX^O/5Q=>/ M8#R=?KR;@G,PM7*9E8(!.0=7A:'%@M_;U5AK9C1X>\D,Y4*_ Q_ ]^DE>/OF MW< WEHW#]+-ZYXO-SL&1G;]1=08P>@\"&*".]$E_^B7+FG2XG^[;'C2-")I& M!!5>> 3OLY):@PE5ZHD7"S#.95F8KJHV,*2"<2_)PPC%,(+V;^ _[/(_(7"/ M*6Z8XEZFXRPK\U)0PV:.IC+\#W6O1!?9#5*TP^$#0C@@*4(MMEV1,$T(3G W MW;"A&_;2O;9>=&%?8_"#BI)UD0P/MH[B ,,D;5$\C".08(+B;H)10S!ZH9^_ M2ZYL,PW+EH44.%?1JHJJA]L42$NL M[>^L.S*,CA/>VC_J]_^7A54#[+V B772MO0[X@+80W'K^ZC?^.\4G=DAS@YX M?7+:^C+J-^;3Y71HO-:>N^3T9V1]DPA MY,B9A[;NC_KM_P0YD8/Y($IA@MNG7D<<23'&[5//WQD"W01NYZL%+S00;&X3 MX5ELRU2;H7:S,')5S87WTEC'JBZ7]H< 4R[ /I]+:9X7;M1L?EJ,_@)02P,$ M% @ .HBM4C_'5/DZ @ W@4 !D !X;"]W;W)K&ULI51M;YLP$/XK%MJ'5MK"2PB)*H*TAE3;AU814;K/#AS!JK&9[23= MOY]M"&+*BSJ5#^"S[WGNGL-W\9&+-UD!*/1>4R;G3J54\^"Z,J^@QG+$&V#Z MI.2BQDJ;8N?*1@ N+*BF;N!YD5MCPIPDMGLKD<1\KRAAL!)([NL:BS^/0/EQ M[OC.:2,CNTJ9#3>)&[R#-:A-LQ+:"8AH) KPX#UYP +H-00Z31^=YQ.']( A^L3^Y/5KK5L ML80%I[](H:JY,W-0 27>4Y7QXP_H]$P,7\ZIM&]T;'W#R$'Y7BI>=V"=04U8 M^\7O71T& #^\ @@Z0/!1P+@#C*W0-C,K*\4*)['@1R2,MV8S"UL;B]9J"#-_ M<:V$/B4:IY+9"*7+IV66+5.4+5^7+YLENDM!84+E/?J&-NL4W7VYCUVE@QF( MFW?$CRUQ<(7X&8L1&OM?4> %_@7XXN-P[U^XJR7V.H->9V#YPBM\*90@!!0H M@P.P/5P2U#)$EL'<_D/B3T///+%[N!![W,<>WXS]C)ENB ))$ >2@]2WW^8@ M;^@*>^[PT[I:ALE UW0\&ZIJ?TAX)G\V"Z^*G_0)3FXFN.!,ZI8B;( G2S !,_ZL@41\O^G1!HC.E03 Y+\BYFQ\&YP5Q!]UG)I^^NCO")*)0:J W MFNH"B7::M(;BC6W(+5>ZO>VRT@,8A''0YR7GZF28'N]'>O(74$L#!!0 ( M #J(K5)VY&LY= ( ( & 9 >&PO=V]R:W-H965T&.5JZN5:EV>^K](<&5$]42(W.VLA&=%F M*C>^*B62S($8]<,@&/F,%-R+)FXMD=%$;#4M."82U)8Q(E_/D8K=U.M[^X5E ML(_ZL4RDF?D-2U8PY*H0'"2NI]ZL?Q:/;;P+^%G@3AV,P3I9 M"?%D)Y?9U ML0D@QU9:!F,_;OSKOQLB(*8T%_ M%9G.I]ZI!QFNR9;JI=A=8.UG:/E2097[AUT5.QQYD&Z5%JP&FPQ8P:LG>:GK M< P/.V L :$'P4,:L# &:TR<[;F1)-H(L4.I(TV;';@:N/0QDW![2G>:VEV M"X/3T;<>)+/?\<4BOH)D>?>PB!\N[V[M\,=R=@/7=[-;.)JC)@55Q_ 5'N_G M.)K(VXI_+06.J^$PG>$^G CN,X5+'B&60L^[L8/.O"^,=TX#_?.S\-. MPEDI>Q &7\PO#-KRZ8;?$ ,?]!V\WY'.H#F(@>,[>8%M M-:XX1H[#7M#G*#P-A\/ &'AN$3]IQ$\ZQ2^Y1HE*@R0:VW2[X?U>$'SNJ,&P M26/8R?. DK6I=Z-">$4B58?^J-$?=9]!DL#UF\K_1S5NJ,8?JRCA&K#;M=>:ZBO\OO.K-YMW= M%%P!Q;6!!KVQ*;"L^ETUT:)T+6,EM&E ;IB;3P1*&V#VUT+H_<0*-!^=Z"]0 M2P,$% @ .HBM4L<&V?'Z @ ;0@ !D !X;"]W;W)K&ULE59M3]LP$/[,?H45;1)(K'EKVH+:2M""U@^E53LV[:-)KHU% M8F>V0^'?[YR$K- T@B^)7^YY[KF[^)SA3LA'%0-H\IPF7(VL6.OLTK95&$-* M54=DP'%G(V1*-4[EUE:9!!H5H#2Q/K'Z0^X6/V_6Y'0* MFK)$G9'O9(TE 4GNA :%T_OUE)Q^/1O:&IT;"CNL'%V7CKPCCGPR%US'BMSP M"**W>!M%U\J]5^777BOAG,H.\=USXCF>VZ!G\G&XTP"?ML.G$!Z#OXG&K^O@ M%WS=(WPSKD&"TF024[D%U93@DJ%7,)CC_#1V?<=![T_[81]:>=U]JS?RNK6\ M;JN\.0MC"@F9ARE+$LI;(@YJRJ"5<@H/FLRXTC+'-J+/R2T-@5RE(N>Z*?K@ M(*YNX#A'(^O5,GJ?DU%78D4UG).UQE=$EB!#W,9.V*2MW<6@XSC?6C+6KZ7V M6WE6D-$7(U(1L2%&>).6_F']O>!XG@:U\T&K\T6NE:8\8GQ+,LEXR#*:8,O% MCP'+%N6->1D<: EZ1LS;3W9Z:-9W?-<+FA5?U(HO/E?9.=6Y9/J%8*=LE-O. M]]HQOIRK5^[EY/RZOM/ M4U[$J&++N"();)#2Z?3Q7,CR&PO=V]R:W-H M965TU7@KY)NJ #3Z53.N)EZE=7/K M^RJOH"9J(!K@YJ84LB;:;.7*5XT$4CA0S?PP"(9^32CWLK$[>Y+96*PUHQR> M)%+KNB;R]Q28V$X\[.T.%G15:7O@9^.&K& )^KEYDF;G]RP%K8$K*CB24$Z\ M.WP[2VV\"WBAL%5[:V2=O KQ9C??BXD76$' (->6@9C'!F; F"4R,GYVG%Z? MT@+WUSOVK\Z[\?)*%,P$^T$+74V\D8<**,F:Z878?H/.3V+Y8O\\?G^?(6+"9-A!X$UY5"QI>)'P@.K1MK$T6XS1*;.[-ONKCN 3C9!2F?=P[>7$O+[XH[X%PTY(%4B W- =U M1NL[[J3G3CYDO44G>Y;".(R'P.X* AP@,/3UH>]O.%%>3/!E6EIRE>( M\ (U4I2@[ PB[+_*D?;YT@^5(SUZPSB-1S<8'Y3C."[$.![AY* <_E[OUR!7 M;B0JE(LUUVT[]:?]U+USP^;@?&JF<3L\_]*TH]PTRXIRA1B4AC(8I.8ER78\ MMALM&C=A7H4V\\HM*_-% 6D#S'TIA-YM;(+^&Y7] 5!+ P04 " ZB*U2 M-1=V?^4$ "*$0 &0 'AL+W=O[4I_1R,B.SRA,;[9Q!=S1,R)9Z5#TG"X%WW/TNCK/P:R)I!,>OK! [6Y;_18$=$/24"WYX0PO/=6R]ED=3\%;_4T^1N>Y[.5!U=3J@@+Y36TX=F;PM4? MU\.N0B:9O:Y?>KTKO%H7O(X3T0'#_@:681D-\(D>_D@0;ILYW&R 3_7P*?4K M>)/W>SW\KS3N@.E0G"?TD#"1O (F)0I MB7T*? -R1P253?DI++JYQ4Q[]B.SW[,- _GL&ZC8%15;2V6>1FLJ:MAI&3PEF5Y)V H2JT;/D]ZY9\.XZ-BI'#M:Q_=O5/A, M4E@(YM,FOP6^?^+7ZMPXS5[=RJNK]>IE:6YGRAK A$=8;B3)!7LL, %;BB5 MP?H(I^,6Y)@_'A^("+[!G,?M(FMP_S-EZ@BS6"J19F,D*D*JI")QP.(MCLWG MMRDX]RRISL!U![TJO&+6&X;=X&?0G(6;*@LWVBPL*1)F/LXW>(K[K_ <,R7A M:ND]RVO-#NM7]OO_CRSW/UNZA?Z<#W,O+_!!E82!-@F/+&91&FG2:1IUS3'T M$\;D:WLC* 6&NQ2%0H$@JG'7?&+)Z!C.GSI.)W70U,='WCZ+KU9D4R_)_R4^ MO26C8[K:^&II-O7:G%6;>NWYN.ZPHX-%2&*=^5IW3;WP>H7@DSWV!F0=4L"F MMRI&C37V7(?MFY[C9@6]:9V:M1*;GTAQE(3\B,G_!<66TP58*ZVIEUIL>ZC M!JS8^1%5.]Y87CXQ8KIXSJ^=H'KAUH>(!S34L:T5T=1+XKU4 M#-MN%*(]#Y%RB-/>R%9OQC4[??W^JC74U(OHE.U90., CHR&S9G3&\"M;FBI MU$IFZJ5LPF,E\$B3DA!"MFG>EWH3-API$5+7OM5J:.DU[($P 7L2IGG3QAN6 M;$&I-/.A:[,OMTQ6+7V67OH\ZJ>"*88+W),:\1G$@38&3=LP;H?N0ZRB!= M\2TD!WYR#FHK*TI?U,4TZ%F.8D0BX@L%@>7AE8Q(%"DDR>/?'-0J?"K#T_,C M^A_IYN5F5IB3$8V>PT!L>U;;@H"L\3X2/<6#*(PR0[XK<\$"<&J'G!P,T-W \&;N."@9<;>.E&,V;IML98X'Z7T0,P MM5JBJ9,T-JFUW$V8J#0N!)-/0VDG^LBMP?-@/A\\+!=W\#A;3A\?%C!X&,-\ MLEC.IZ/E9 R+Y>/H"SP]3)>+>WC&C.%$P$ E(!3O\&E,! XC_AE^AZ?%&#[] M]KEK"\E->;#]G,X.'!5YJ(+8=)$I! 8S\RVR/7 &#+H!21<8^1&;I& MQ*^8UK6&BT]S69!L_D+-.=$::BB-9)EJ9*UQQ'\':ZU_,R>VO!.,./@-B' [UQ7 MB]4 /(BS=P0U-$AG46@546@9H?]4Q:-]88>M'ZH#M3NHH8]ZN_#7KN+OIX6A M(]365$$=Z?ET"CZ=&_E<5P%F+YTL@89\(:<4?,>(=8R3-F>Y[6G2''V T$F' M0=4%@*O<@A*U465$AIZ/T="L'6,+4 OE\3:DX7B@'Q4C<_P]02P,$% @ .HBM M4A:0_Q,"! M X !D !X;"]W;W)K&ULK5=; M;^HX$/XKHV@?SI$HB1.N%2!QVUVT.@41>JK5:A],8B!J$K.V*>V_7SL)"5V< M-*V6!V(GGF^^&8]G/(,S9<_\0(B URB,^= X"'&\-TWN'4B$>9,>22R_["B+ ML)!3MC?YD1'L)T)1:-J6U3$C',3&:)"\6['1@)Y$&,1DQ8"?H@BSMPD)Z7EH M(./R8AWL#T*],$>#(]X3EXC'XXK)F9FC^$%$8A[0&!C9#8TQNI^BOA)(5OP, MR)E?C4&9LJ7T64T6_M"P%",2$D\H""P?+V1*PE A21[_9*!&KE,)7H\OZ+\F MQDMCMIB3*0V? E\1T.>_,,Y6VL9X)VXH%$F M+!E$09P^\6OFB"L!NUTB8&<"=ET!)Q-P$D-39HE9,RSP:,#H&9A:+='4(/%- M(BVM"6*UC:Y@\FL@Y<0(V4UX&J_7XX>-VX#E:K-8/K@P?IC!>NYNUHOI9CX# M=[.<_@&/#XN->P^NC"3_%!*@.W /F)$[Y48?IC22L<6QVIT&N()ZS[ \JAEO MP%CM5B#>X-N,"!R$_#O1GJ2DK9+2#OP@\;BP&$> M^\37R$^KY9%= 6!*#^9NM"]NG-B5B#\P:X*#&F!;-M(1JA:?$2\7MRKH./FN M.@F>4X*W(:\")J':@K_&6RZ8/"U_5^"V!!"IE/(R0E;+ZCG]@?FB(=+.B;3K$WE*SJH,P?$+83+W MP/R5,"_@!%8L\$A-IJG"WA53IVEW]30[.MJ^9'^*W?F8 M#K**Y&I5$IJJ8 M#O?F9[+7]=\CN.4Z)UJN4CNII_9(;,O#K.$#-;LE!0'9! MRJY_8N?)L^HT9FCOSH=TCKRE"0@B%2%!;L%/G[3 M(4T_0.IG2-T4B8/=TT"]=T=1/M GZL=XOV=DCP6!12Q8(*^H'OS$X4F_B^V* M-)$9=KNDU>FVR[))44Q0=37)0@YO0SVSVY+B6%)Q63XI:@JJ+BI7>K^646XK MB]/LEU065)065*NVE-#Z3$A7ZVEG@=B_!"+2Q?1[(XJ*A6J5K-2(SP7BQ_7* MO.H+(L+V2;O$P:.G6*0M0OXV;\G&22-B%LO3?DY><.4=BD-(=E+4DA<# UC: M(J4308])E[&E0O8LR? @VTK"U +Y?4>IN$R4@KQ1'?T+4$L#!!0 ( #J( MK5)":J!JJP, $<- 9 >&PO=V]R:W-H965T2OLEP>!GYIGQS,,PV#/^(C:42OB1I;D86ALIMS>V+:(-S8CHL2W-U9,5 MXQF1:LG7MMAR2F(#RE(;.T[?SDB26Z.!N3?GHP';R33)Z9R#V&49X6\3FK+] MT$+6X<8B66^DOF&/!ENRIB&5C]LY5RN[LA(G&@0WEF[$4O[N*AY6A&-*61U":(^GNE4YJFVI+B\4]IU*I\:F#]^F#] MBPE>!?-,!)VR]"F)Y69H!1;$=$5VJ5RP_5^T#,C3]B*6"O,+^W*O8T&T$Y)E M)5@QR)*\^"<_RD34 *C? L E /\$P%X+P"T!K@FT8&;"FA%)1@/.]L#U;F5- M7YC<&+2*)LGU,8:2JZ>)PLD1PO T7BS&]\OP A[FR[N'^Q#&]S-8W(;+Q=UT M>3N#[^^6X0V$JI#B74J!K6!!A>1))&D,H631"SSFB107,-9GD\@W M^#2CDB2I^ R7\ ?8(#:$4S&PI6*N_=M1R7)2L,0M+%WXRG*Y$7";QS1NP$^[ M\2K*=@.V2EF5-WS(VP1W6OQ*> ]<= '8P:B)4#=\1J,*[G30<:MC=(V]JQ9[ M#SLI),GC)%]?P).I774HXU?*52^J<](-K9[!DO(,DAR^4$;SZ';30!O&@BX M#S%Y:S(P/<^ "UEQ'LAKL/0N!5=5"JXZ3?_)22X;BV-2 #T#U+KV.D+!-?(& M]FN#/Z_RYW7ZFY(\4NK3[-$[\>@T>^M7WOJ=WII;#3XMPD?QN2-[?F7?/[^ M)G2=Y*9>)B3583:%Z)^$Z'F>Z[7$&50\@E\HY+E* 3V37^$GJ/%S>V[0S.ZZ M8G?]>]JLVPTR70(H:.VRL_#XT&38_Z\F0\[Q?>'\WS8KD?62P('G."TE@6KO M*'2.S[:":.2"3HX?]UR_A0D^,L&=3+ZI-FP)'I\$?^DZ[<$?E1UU2V;A\D.Q MNPVE[Z 6(D=]1=T"VREXZ%1C+Z^PUQK^4671F3+[H0P4-J_?-W^+X*.C!J-N M$7[7_K?FOTN!2FOUG/A]/ZA)9#F[G.[KDE)TU'3T 5%O$],SXO";Z@G_'$73 MKA/!M6NC:D;YVDSP B*VRV4QM59WJZ^$L9F-[>/VXA-#C6#J-2 @I2L%=7J^ M2B OIO9B(=G6#+[/3*HQVEQNU)<.Y7J#>KYB3!X6VD'U[33Z%U!+ P04 M" ZB*U248;(UN0" \" &0 'AL+W=O4K6ZPYD,2 Z["-I%D!4X[$)L$_ST RK9= MR[7V"[-LE4J]8/LK5S*Y8DBR'0F2L0!R67:OOWD6ACCXJ MEV)%0T>EH>>\*[E; MAEM_M*\]C-N^%W3LU\.43L-\UW6<][ /TOU*NE\K/6)"FIM *(@:*YH57_,3 MK2BYFP&3/F;"F[WO'5\8^*,0Y\)7I3P(MV*:0976J M5JL6V#>5_VA]H%ICV:H]TO&Y'ZB-ZC^,/3^ 5!+ P04 " ZB*U293KF7Y0# ") M"P &0 'AL+W=O;7&*>(?N<";?K"E+D9!#MC'YCF$4 M:U":F(YE]BEDACF9 M6O=0,/F62)P8V]T.3"?A[0PF#P$$MW=/W^FD#4H)C,J\TV+?,X[^;IP3S.QY3#/8AR?XTU9>R7 M>1,P=5H)[Q'K0->^ L=R[(9Z9A^'6PWPH!T>X.@]^)F:;K4<7!@-4!3N,6Z*"G)U)+? 4/-+LN%,+\9T[$ 6XS+EBN8O@5 M/.:""ZF<9!L9FZHQWD# MK^OTFGWPJH*]/_8!?L$]R4B:IRV.^%4"_\..Q&^.\,J1*\"OF$6$8]@Q$N$F MAXH$_JE#'Y'0VCL>V]5_;4V8XE>YV_/Z% M/[^+.J__Y-JQ6^M?8KGQ223D(1$*&CW#4T:D29^7X1/_TN:0<\S@_#_.J[+. MLYUJJ<^ET_6X_EG8N1''*\5NOU.4BA=IM]3'CJYS[7JN7&\LNGY_>'W/[]6* MKL?9EN_7RS9/>I04LXWN]3A$-,]$<=M7LU4_.=%=U,7\U+Z9%5WAD:9H4N5= MOB%RVR5X+2FMCB>K8D7?5PP$W>E.:$6%[*OTXU;VRIBI /E^3>6N*@@, "$* 9 >&PO=V]R:W-H965T MM$'2@W\RKG0$^]@S/'!]W5Z MH#G1'7FD M_LI,J)P:7:^_JH*,F<4\[]* CZ?DZ8\*9CM[=6T[$L#&>"KA7H M(L^)^F=.N3Q/O-![W=BP_<'8#7\Z/I(]3:AY/JX5KOP:)6,Y%9I) 8KN)MXL M?%B$D75P%G\Q>M87SV"E;*5\L8O';.(%EA'E-#46@N#?B2XHYQ8)>?RL0+WZ MF];Q\OD5_4\G'L5LB:8+R?]FF3E,O*$'&=V1@IN-/'^AE:">Q4LEU^X7SI5M MX$%::"/SRAD9Y$R4_^17%8@+!\1I=H@JA^C:H7O#(:X<8B>T9.9D+8DAT[&2 M9U#6&M'L@XN-\T8U3-@T)D;A6X9^9AK&'9C/DL<%S)Z6L'S\^OQCM82GU0_X M^CU)UJL-)%]FFQ4\0((5E!6<@MS!BBC!Q%[#FBI(#D313S GFJ5 1 9+Q@M# M,[A;4D,8U_?P&9Z3)=S]<3_V#9*VG_;3BN"\)!C=(!C#-RG,0<-*9#1[[^^C MV%IQ]*IX'K4"?B.J W'X":(@"AOX+#[N'K30B>L$Q XOOH'W5.14$2/50PM8 MMP;K.K#N+3#L>RZU!F*,8MO"D"TFS$A(99YCTVB;JH/D&56Z*14E>M^AVP%P MFGX>14$<8IQ.ER%JL N'O: ?Q;7A._Z]FG^OE?^2"HE%;L,!.*)L@V)-I82G M!2>N[<^N+[&XR G#MJ>-,LJ/]"[HA5'0#8-!]TI'@V$0#[K=T:!91[_6T6]- MJNL '$^P*..>&)F^ /U9L!/A5!C=ENQ!_9%!:["^'VU$M&NY,U&*(&Y3- :_ MB0RNPM!F\8[:L*8V;*6VH1KK+[5YTDYZ(9C1<,)MW,*Z!"$-,*V+ZY8N*0__ MDW*;Q3O*HYKRZ'^57E8-L;;B*_NI,>BCCY9@@V%K"8;!VV0/VB<+#H,[.PWN M@0D< +2EYL*+\R)LC9,;\XUCO/0;7@Z%H!,,K_0VFX7#&VJC-UY1>_[*?#4R MBS[&K-'L-V;^Q6&+HWOO[B :)VPA3'D*U;OU/6?F3O>K_;F]_[A#_ VFO#SA M&;-GV-F<[A RZ RP/%1Y'RD71A[=D;Z5!B\([O& =SBJK &^WTEI7A?V _6M M&PO=V]R:W-H965T MFI@J4M)(JG3-+0[T,3:&1);XH%V%4KU^'.>,RZ'7\W%3W.FIE!9<[TQP"%VG2#1K"?F/%E9MU$V.L4;(ESM*_%5-,HK% 2GJ,T7$G0F':#?N-N MT';Y/N$[QXTYB,'M9*'4NQN,DFY0=X)08&P= J//&N]1" =$,G[M,(.*TA4> MQGOT1[]WVLN"&;Q7XHTG-NL&MP$DF+*5L#.U^8J[_7B!L1+&_\.FS&W7 XA7 MQJI\5TP*AVM-J!=-J&YP&_55Y,X M+MVES*VF54YUMM=HU6#V,.Z/)J/)$TP?9H_/LW%_+ M(5K&A;GLA)9(76D8[P@&)4%T@J )8R5M9N!!)IC\6Q^2V$IQM%<\B,X"CIFN M0;-Q!5$]:KS.AW#QZ?(,;+,ZB*:';9Z '7(3"V56&N$%MQ8&0L7O\*._,%;3 MT_EYAJ)54;0\1>L4!::H-28PPS7*%1X[S!+AVB,X0ZU[C9M6W?TZX?H(=[OB M;I_EWE$2=:R6DCM'7,'_@N@YFUCSPJT>$W>>X@T!MP6Y#:PBOWJ>WTA1B>TL M6!1:;3EY"<4'W#8^@TK!9B[']0\NER"5_!(S&:-@"X%0*.W-6^89FD#M.Q%E M@%H(OF1NW8!:H_90TEU>U(+JE M[Q@&8K62MK15-5LUI7[IQ;_I94>CE[KDI$U@2J7UV@V=GRZ[1#FPJO#.7"A+ M/O=A1HT5M4N@]50INQ\X@JI5]_X 4$L#!!0 ( #J(K5)D8B1.@ ( .D& M 9 >&PO=V]R:W-H965TX[//<;7R9:+ M5UD"*/16428'3JG4ZLYU95Y"A66/KX#IE047%59Z*I:N7 G A055U T\+W8K M3)B3)C8V$6G"UXH2!A.!Y+JJL/@] LJW \=W=H$I69;*!-PT6>$ES$"]K"9" MS]R6I2 5,$DX0P(6 V?HWXUCDV\3?A#8RKTQ,I7,.7\UD_MBX'A&$%#(E6' M^K.!#"@U1%K&KX;3:;ON'+.97V%VWKW/#60?E:*EXU8*V@(JS^XK?&ASV YND&! T@> ^(3@#" M!A!^%! U@,@Z4Y=B?1ACA=-$\"T2)ENSF8$UTZ)U^8298Y\IH5>)QJG4[_=0 M]O28?7U\G@Z?[Y\>9^AB# H3*B_1%_0R&Z.+3Y>)J_1>!N'F#>^HY@U.\(;H M@3-52O25%5 MR^[S?'[8\[S/7;;\ W=] MC#LH*&H+BLX2#?.B'<9MW(+7?2NV?]][>*A#H^!#.&!&W[/%_,R+N,*+O>=X['X[3 MKJ/]K%JGN]<$='5+VTPELFKJ:]9&VWX]M&WJ77SDWV5UV_U+4S\"^A(M"9.( MPD)3>KUK;;2H&VL]47QE6\V<*VVQ'9;Z+0)A$O3Z@G.UFY@-VM?"UO @ @@4 !D !X;"]W;W)K&ULC51M;YLP$/XK)[0/K;2&EV395A&D),VT:'V)DG;3/KIP@%5C,]LD MW;^?;0B+-!J-#^ [W_/XN3-W\4'(%U4B:GBM&%9 M%WI'QY86I;8./XEK4N .]5.]D<;R>Y:,5L@5%1PDYC-O'EXO)S;>!7RG>% G M:["9/ OQ8HUU-O,"*P@9IMHR$//9XQ(9LT1&QJ^.T^N/M,#3]9']B\O=Y/), M%"X%^T$S7'<9^]KHMJ?[::=QT6J,WM((=X+K4AF^#+,!_/(\?GP&[YMZ]46+CD5;1&<) M'U(]@G'X'J(@_#RDYSS\CL@C/ K/R!GW=SAV?),W^#9"Z:N4"45Y 3GEA*>4 M,*A1NB[G*0[5O.6<.D[;Z_MD$K@G]O<#8B:]F,E9,2NEJ>DNS" G5,*>L 9! MY(!$K%:Q+8 H7!-@KMAWTK2BP[ EGR9+E+^NNGDQSGI;K2 M]<.6SB&U=(_NN4=WY\IDW.@UIS=+2G6PJKAH)N%2Z_IC%#6+):U(# 4X, M($:>/H_\*6Y+'74)FHX+*?;S! 83FU0TN"=\$LX(9W/%P*L@%>-K9QZ"82&Y M5($V!3)B8K T#PZ.W0QJU_%43$AE8[L([N^\6WX ;&8@D''>"QR&SC =UT1K MJL25F=C%UO@("KKQ[;HV"DM%UO'P(MPZV)L),IRC@#46E9FD#-22D&LAHU'-S"T"\KY#33VCV*/>U7L5'4 -17]T CJAH[& M38!_E\UQ[](.7L0;U.Q>ZL^MV8ZPJUHP59VOBIZ 1A[C+.3NN;K3YR5 MHJ)N\\\..!V3C5^PE(H]F&C0*@MCH"H,[JG2;+%K^:5(?4M7>M-.JP+7/'R% MFO]NGDLJJ")\5[3I_6/.\HL5)Q_^E63[7^50L%=C=UH=N\B+UR R/7Z127:4 M&J/NU-DYVO8.MMX:P O$)/P.+RM\&S28MXQK)KK9DN4Y%8_.-T.OR=R\#N[Q MF_4Y+4C+]6T/3L+M^!O-65ME_:IK2$2W:CO^"MN+T_[MQ<1B(J!PB%S9RX]@/@[S(X!A<3 %F(_SPN+\3_L9H?MQ&*9MY$5&J,\( M]7%>/F1F/U@:-/E_G;@2=&A(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T M>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0 ( #J(K5*6W7YCL 0 M ,\B / >&PO=V]R:V)O;VLN>&ULQ9I;CYLX%(#_BL535]I-PB69BYI* MA'BFJ 2R0&8U3Q&3.!.K!"+CS+3]]7N IC5:YFA?/'D*&$0^CHV_RN/M<%AM]NR058/RR HXLBO%(9.P*YZ'U5&P;%OM&9.' M?&B-1I/A(>.%\>GC^5I+,51W2LDVDI<%--8-#YR]5K^/U[ODA5?\B>=&V1YX8$+RS7^:DQHR MS9ZJID5F3W$&(%-C,H(+[KBH9'-&<_T,&%\8G-SNG61YQW/)Q#R3[%Z4IR,O MGNO+P%T,E=MHXG#^;8-X*_Y/&,O=CF_8O-R<#JR0;1P%RVO HMKS8V60(CNP MJ7$^A63%EM!"0I"(7[27@G/K.X6_]K?M74O 56(H;CD<$/ZV =<'Z47AG(8) MG1/82J+ G[LI[,S
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end XML 64 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 65 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 66 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.1 html 80 305 1 false 29 0 false 4 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://cynergistek.com/20161231/role/idr_DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) Sheet http://cynergistek.com/role/CondensedConsolidatedBalanceSheets CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) Statements 2 false false R3.htm 00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) Sheet http://cynergistek.com/role/CondensedConsolidatedBalanceSheetsParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) Sheet http://cynergistek.com/role/CondensedConsolidatedStatementsOfOperations CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) Statements 4 false false R5.htm 00000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (UNAUDITED) Sheet http://cynergistek.com/role/CondensedConsolidatedStatementsOfStockholdersEquity CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (UNAUDITED) Statements 5 false false R6.htm 00000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) Sheet http://cynergistek.com/role/CondensedConsolidatedStatementsOfCashFlows CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) Statements 6 false false R7.htm 00000007 - Disclosure - 1. BASIS OF PRESENTATION Sheet http://cynergistek.com/role/BasisOfPresentation 1. BASIS OF PRESENTATION Notes 7 false false R8.htm 00000008 - Disclosure - 2. RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS Sheet http://cynergistek.com/role/RecentlyIssuedAccountingPronouncements 2. RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS Notes 8 false false R9.htm 00000009 - Disclosure - 3. ACCOUNTS RECEIVABLE Sheet http://cynergistek.com/role/AccountsReceivable 3. ACCOUNTS RECEIVABLE Notes 9 false false R10.htm 00000010 - Disclosure - 4. DEFERRED COMMISSIONS Sheet http://cynergistek.com/role/DeferredCommissions 4. DEFERRED COMMISSIONS Notes 10 false false R11.htm 00000011 - Disclosure - 5. PROPERTY AND EQUIPMENT Sheet http://cynergistek.com/role/PropertyAndEquipment 5. PROPERTY AND EQUIPMENT Notes 11 false false R12.htm 00000012 - Disclosure - 6. LEASES Sheet http://cynergistek.com/role/Leases 6. LEASES Notes 12 false false R13.htm 00000013 - Disclosure - 7. INTANGIBLE ASSETS Sheet http://cynergistek.com/role/IntangibleAssets 7. INTANGIBLE ASSETS Notes 13 false false R14.htm 00000014 - Disclosure - 8. DEFERRED REVENUE Sheet http://cynergistek.com/role/DeferredRevenue 8. DEFERRED REVENUE Notes 14 false false R15.htm 00000015 - Disclosure - 9. PAYCHECK PROTECTION PROGRAM LOAN Sheet http://cynergistek.com/role/TermLoan 9. PAYCHECK PROTECTION PROGRAM LOAN Notes 15 false false R16.htm 00000016 - Disclosure - 10. PROMISSORY NOTES Notes http://cynergistek.com/role/PromissoryNotes 10. PROMISSORY NOTES Notes 16 false false R17.htm 00000017 - Disclosure - 11. REVENUES Sheet http://cynergistek.com/role/Revenues 11. REVENUES Notes 17 false false R18.htm 00000018 - Disclosure - 12. WARRANTS, OPTIONS AND RESTRICTED STOCK UNITS Sheet http://cynergistek.com/role/WarrantsOptionsAndRestrictedStockUnits 12. WARRANTS, OPTIONS AND RESTRICTED STOCK UNITS Notes 18 false false R19.htm 00000019 - Disclosure - 13. BASIC AND DILUTED NET LOSS PER SHARE Sheet http://cynergistek.com/role/BasicAndDilutedNetLossPerShare 13. BASIC AND DILUTED NET LOSS PER SHARE Notes 19 false false R20.htm 00000020 - Disclosure - 14. REMAINING PERFORMANCE OBLIGATIONS Sheet http://cynergistek.com/role/RemainingPerformanceObligations 14. REMAINING PERFORMANCE OBLIGATIONS Notes 20 false false R21.htm 00000021 - Disclosure - 15. CONCENTRATIONS Sheet http://cynergistek.com/role/Concentrations 15. CONCENTRATIONS Notes 21 false false R22.htm 00000022 - Disclosure - 16. Earnout Liability ??? Backbone Enterprises Sheet http://cynergistek.com/role/EarnoutLiabilityBackboneEnterprises 16. Earnout Liability ??? Backbone Enterprises Notes 22 false false R23.htm 00000023 - Disclosure - 3. ACCOUNTS RECEIVABLE (Tables) Sheet http://cynergistek.com/role/AccountsReceivableTables 3. ACCOUNTS RECEIVABLE (Tables) Tables http://cynergistek.com/role/AccountsReceivable 23 false false R24.htm 00000024 - Disclosure - 5. PROPERTY AND EQUIPMENT (Tables) Sheet http://cynergistek.com/role/PropertyAndEquipmentTables 5. PROPERTY AND EQUIPMENT (Tables) Tables http://cynergistek.com/role/PropertyAndEquipment 24 false false R25.htm 00000025 - Disclosure - 6. LEASES (Tables) Sheet http://cynergistek.com/role/LeasesTables 6. LEASES (Tables) Tables http://cynergistek.com/role/Leases 25 false false R26.htm 00000026 - Disclosure - 7. INTANGIBLE ASSETS (Tables) Sheet http://cynergistek.com/role/IntangibleAssetsTables 7. INTANGIBLE ASSETS (Tables) Tables http://cynergistek.com/role/IntangibleAssets 26 false false R27.htm 00000027 - Disclosure - 11. REVENUES (Tables) Sheet http://cynergistek.com/role/RevenuesTables 11. REVENUES (Tables) Tables http://cynergistek.com/role/Revenues 27 false false R28.htm 00000028 - Disclosure - 12. WARRANTS, OPTIONS AND RESTRICTED STOCK UNITS (Tables) Sheet http://cynergistek.com/role/OptionsWarrantsAndRestrictedStockUnitsTables 12. WARRANTS, OPTIONS AND RESTRICTED STOCK UNITS (Tables) Tables http://cynergistek.com/role/WarrantsOptionsAndRestrictedStockUnits 28 false false R29.htm 00000029 - Disclosure - 13. BASIC AND DILUTED NET LOSS PER SHARE (Tables) Sheet http://cynergistek.com/role/BasicAndDilutedNetLossPerShareTables 13. BASIC AND DILUTED NET LOSS PER SHARE (Tables) Tables http://cynergistek.com/role/BasicAndDilutedNetLossPerShare 29 false false R30.htm 00000030 - Disclosure - 1. BASIS OF PRESENTATION (Details) Sheet http://cynergistek.com/role/BasisOfPresentationDetails 1. BASIS OF PRESENTATION (Details) Details http://cynergistek.com/role/BasisOfPresentation 30 false false R31.htm 00000031 - Disclosure - 3. ACCOUNTS RECEIVABLE: Schedule of Accounts Receivable (Details) Sheet http://cynergistek.com/role/AccountsReceivableScheduleOfAccountsReceivableDetails 3. ACCOUNTS RECEIVABLE: Schedule of Accounts Receivable (Details) Details 31 false false R32.htm 00000032 - Disclosure - 4. DEFERRED COMMISSIONS (Details) Sheet http://cynergistek.com/role/DeferredCommissionsDetails 4. DEFERRED COMMISSIONS (Details) Details http://cynergistek.com/role/DeferredCommissions 32 false false R33.htm 00000033 - Disclosure - 5. PROPERTY AND EQUIPMENT : Property, Plant and Equipment (Details) Sheet http://cynergistek.com/role/PropertyAndEquipmentPropertyPlantAndEquipmentDetails 5. PROPERTY AND EQUIPMENT : Property, Plant and Equipment (Details) Details 33 false false R34.htm 00000034 - Disclosure - 6. LEASES (Details) Sheet http://cynergistek.com/role/LeasesDetails 6. LEASES (Details) Details http://cynergistek.com/role/LeasesTables 34 false false R35.htm 00000035 - Disclosure - 6. LEASES: Operating lease expense (Details) Sheet http://cynergistek.com/role/LeasesOperatingLeaseExpenseDetails 6. LEASES: Operating lease expense (Details) Details 35 false false R36.htm 00000036 - Disclosure - 6. LEASES: Maturities of lease liabilities (Details) Sheet http://cynergistek.com/role/LeasesMaturitiesOfLeaseLiabilitiesDetails 6. LEASES: Maturities of lease liabilities (Details) Details 36 false false R37.htm 00000037 - Disclosure - 7. INTANGIBLE ASSETS (Details) Sheet http://cynergistek.com/role/IntangibleAssetsDetails 7. INTANGIBLE ASSETS (Details) Details http://cynergistek.com/role/IntangibleAssetsTables 37 false false R38.htm 00000038 - Disclosure - 7. INTANGIBLE ASSETS : Schedule of Intangible Assets (Details) Sheet http://cynergistek.com/role/IntangibleAssetsScheduleOfIntangibleAssetsDetails 7. INTANGIBLE ASSETS : Schedule of Intangible Assets (Details) Details 38 false false R39.htm 00000039 - Disclosure - 8. DEFERRED REVENUE (Details) Sheet http://cynergistek.com/role/DeferredRevenueDetails 8. DEFERRED REVENUE (Details) Details http://cynergistek.com/role/DeferredRevenue 39 false false R40.htm 00000040 - Disclosure - 9. PAYCHECK PROTECTION PROGRAM LOAN (Details) Sheet http://cynergistek.com/role/PaycheckProtectionProgramLoanDetails 9. PAYCHECK PROTECTION PROGRAM LOAN (Details) Details http://cynergistek.com/role/TermLoan 40 false false R41.htm 00000041 - Disclosure - 10. PROMISSORY NOTES (Details) Notes http://cynergistek.com/role/PromissoryNotesDetails 10. PROMISSORY NOTES (Details) Details http://cynergistek.com/role/PromissoryNotes 41 false false R42.htm 00000042 - Disclosure - 11. REVENUES: Schedule of Revenue (Details) Sheet http://cynergistek.com/role/RevenuesScheduleOfRevenueDetails 11. REVENUES: Schedule of Revenue (Details) Details 42 false false R43.htm 00000043 - Disclosure - 12. WARRANTS, OPTIONS AND RESTRICTED STOCK UNITS (Details) Sheet http://cynergistek.com/role/WarrantsOptionsAndRestrictedStockUnitsDetails 12. WARRANTS, OPTIONS AND RESTRICTED STOCK UNITS (Details) Details http://cynergistek.com/role/OptionsWarrantsAndRestrictedStockUnitsTables 43 false false R44.htm 00000044 - Disclosure - 12. WARRANTS, OPTIONS AND RESTRICTED STOCK UNITS: Warrant Activity (Details) Sheet http://cynergistek.com/role/OptionsWarrantsAndRestrictedStockUnitsWarrantActivityDetails 12. WARRANTS, OPTIONS AND RESTRICTED STOCK UNITS: Warrant Activity (Details) Details 44 false false R45.htm 00000045 - Disclosure - 12. WARRANTS, OPTIONS AND RESTRICTED STOCK UNITS: Schedule of Share-based Compensation, Stock Options, Activity (Details) Sheet http://cynergistek.com/role/OptionsWarrantsAndRestrictedStockUnitsScheduleOfShare-basedCompensationStockOptionsActivityDetails 12. WARRANTS, OPTIONS AND RESTRICTED STOCK UNITS: Schedule of Share-based Compensation, Stock Options, Activity (Details) Details 45 false false R46.htm 00000046 - Disclosure - 12 WARRANTS, OPTIONS AND RESTRICTED STOCK UNITS: Schedule of Restricted Stock Units, Activity (Details) Sheet http://cynergistek.com/role/OptionsWarrantsAndRestrictedStockUnitsScheduleOfRestrictedStockUnitsActivityDetails 12 WARRANTS, OPTIONS AND RESTRICTED STOCK UNITS: Schedule of Restricted Stock Units, Activity (Details) Details 46 false false R47.htm 00000047 - Disclosure - 12. WARRANTS, OPTIONS AND RESTRICTED STOCK UNITS: Schedule of Share-based Compensation expenses (Details) Sheet http://cynergistek.com/role/OptionsWarrantsAndRestrictedStockUnitsScheduleOfShare-basedCompensationExpensesDetails 12. WARRANTS, OPTIONS AND RESTRICTED STOCK UNITS: Schedule of Share-based Compensation expenses (Details) Details 47 false false R48.htm 00000048 - Disclosure - 13. BASIC AND DILUTED NET LOSSPER SHARE (Details) Sheet http://cynergistek.com/role/BasicAndDilutedNetLossperShareDetails 13. BASIC AND DILUTED NET LOSSPER SHARE (Details) Details 48 false false R49.htm 00000049 - Disclosure - 13. BASIC AND DILUTED NET LOSSPER SHARE : Schedule of Earnings Per Share, Basic and Diluted (Details) Sheet http://cynergistek.com/role/NetIncomeLossPerShareScheduleOfEarningsPerShareBasicAndDilutedDetails 13. BASIC AND DILUTED NET LOSSPER SHARE : Schedule of Earnings Per Share, Basic and Diluted (Details) Details 49 false false R50.htm 00000050 - Disclosure - 14. REMAINING PERFORMANCE OBLIGATIONS (Details) Sheet http://cynergistek.com/role/RemainingPerformanceObligationsDetails 14. REMAINING PERFORMANCE OBLIGATIONS (Details) Details http://cynergistek.com/role/RemainingPerformanceObligations 50 false false R51.htm 00000051 - Disclosure - 15. CONCENTRATIONS (Details) Sheet http://cynergistek.com/role/ConcentrationsDetails 15. CONCENTRATIONS (Details) Details http://cynergistek.com/role/Concentrations 51 false false R52.htm 00000052 - Disclosure - 16. EARNOUT LIABILITY - BACKBONE ENTERPRISES (Details) Sheet http://cynergistek.com/role/EarnoutLiability-BackboneEnterprisesDetails 16. EARNOUT LIABILITY - BACKBONE ENTERPRISES (Details) Details 52 false false All Reports Book All Reports ctek-20210331.xml ctek-20210331.xsd ctek-20210331_cal.xml ctek-20210331_def.xml ctek-20210331_lab.xml ctek-20210331_pre.xml http://fasb.org/us-gaap/2021-01-31 http://fasb.org/srt/2021-01-31 http://xbrl.sec.gov/dei/2021 true true ZIP 68 0001096906-21-001108-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001096906-21-001108-xbrl.zip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end